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ABSTRACT
Nanotechnology has grown exponentially since its inception in the early 1970’s.
Since then, bionanotechnological devices and treatment options have significantly
improved disease treatments and patient outcomes; however, this rapid growth in consumer
related products has also prompted concern. Zinc oxide nanoparticles (nZnO), known for
their inherent toxicity and prevalent global use in consumer products and medical
applications, have received much of this attention. Significant research efforts have focused
on both toxicity remediation through material property modification and the exploitation
of these same factors to create potential cancer therapeutics. There is general agreement
that the physicochemical properties of nZnO strongly contribute to NP-induced toxicity;
however, inconsistencies in the material property characterization methods employed, and
an understanding of how those properties influence cytotoxicity in mammalian cells has
led to discrepancies in the literature. Additionally, more research is needed to connect the
material properties of nZnO to downstream cellular responses. Here, a panel of variably
synthesized nZnO was utilized to thoroughly investigate the material properties of the
particles as they relate to cytotoxicity, oxidative stress, and transcriptome changes in
different mammalian cell types. The goals of this study are three-fold: i) reduce NP
agglomeration and sedimentation tendencies within complex media and achieve dispersion
stability, ii) define which material property interactions have the greatest potential to affect
cellular toxicity, and to iii) examine the preferential toxicity of nZnO towards Jurkat
leukemic cells through genetic expression studies.
vi

Chapter 2 highlights the importance of dispersion stability and the effect of fetal
bovine serum (FBS) proteins on the dispersion stability, dosimetry and NP-induced
cytotoxicity of nZnO in suspension and adherent in vitro cell culture models. The presence
of surface adsorbed proteins from the FBS on the nZnO decreased agglomeration and
sedimentation potential. Furthermore, FBS-stabilized nZnO dispersions resulted in toxicity
increases in suspension cells when compared to unstable dispersions; however, toxicity
was decreased in adherent cell models with stable dispersions. These observations indicate
that improved dispersion stability leads to increased NP bioavailability for suspension cells
and reduced NP sedimentation onto adherent cell layers resulting in more accurate in vitro
toxicity assessments.
In Chapter 3, we utilized an expanded panel of nZnO synthesized through wet
chemical and high temperature methods, followed by thorough characterization to examine
the importance of material property changes in NP-induced toxicity. We found our diverse
set of nZnO displayed significant differences in surface reactivity, dissolution potential and
cytotoxicity towards cancerous and primary T cells. Additionally, principal component
analysis (PCA) suggested that the synthesis procedure conferred unique material
properties, and can be a determinant of cellular cytotoxicity. Furthermore, we showed that
attributing NP-induced toxicity to one specific material property is shortsighted and that
complex interactions between these properties needs to be considered.
Finally, Chapter 4 introduces future work dedicated to investigating transcriptome
changes in cancerous and primary T cells exposed to nZnO. Both cell types demonstrated
significant up- and down-regulation of genes in a dose-dependent manner. Many
significant differentially expressed genes (SDEGs) corresponded to proteins involved in
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the sequestration and transport of ionic zinc confirming the importance of nZnO in the
cytotoxic response. Additional analysis will focus on the importance of specific SDEGs
involved in the regulation of oxidative stress pathways, cellular metabolism, inflammation,
T cell activation, and protein misfolding in the NP-induced toxicity mechanism.
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CHAPTER 1

INTRODUCTION

Zinc Oxide Nanoparticles - Cancer Therapeutic or Environmental Health Crisis?
Zinc oxide nanoparticles (nZnO) are used worldwide in numerous applications and
have a market value estimated at approximately $2.1 billion. The nZnO market is
forecasted to exceed $7.5 billion by 2022 [1]. Figure 1.1 illustrates the consumer usage by
region and highlights the global distribution of nZnO. The industrial and research focus on
nZnO encompasses nearly every consumer space and on any given day, the average person
will likely interact with many of these products (Figure 1.2). Indeed, nZnO are ubiquitous
in products which impact human health and lifestyle. Significant advancement in the
research areas of biomedicine, electronic devices, and energy storage, along with the
growing pharmaceutical and cosmetic industry currently drives the demand for the nearly
105 tons of nZnO manufactured each year [1, 2].
Some nanomaterials show promise as potential drug delivery agents or cancer
therapeutics due to their small sizes (0-100 nm) and their ability to be functionalized to
target cell receptors and improve cellular uptake. In cancer research, nZnO has garnered
much attention due to its selective toxicity towards a wide range of malignant cell types
when compared to primary cells of the same lineage [3-6]. In contrast, other works
demonstrate that nZnO is equally toxic to primary cells lines and multiple organisms [711]. Such disparate results leave the research world divided – is nZnO a promising cancer
therapeutic or a toxic agent leading to a potential environmental health crisis? The ultimate
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answer to both questions is most likely yes. Without extensive studies to elucidate the
complex mechanisms that govern its inherent toxicity, nZnO could become an
environmental problem. However, with an understanding of how to tailor nZnO fabrication
to control its toxicity, potential therapeutic uses are possible. Achieving this endpoint will
be a challenging endeavor. Interdisciplinary, collaborative efforts will be required to gain
a better understanding of mechanisms of toxicity and the long-term consequences of direct
exposure of cells to nZnO [12].
nZnO Material Synthesis
Since the inception of nanotechnology research in the 1970’s, considerable
attention has been devoted to the development of novel NP fabrication methods [13] which
can be grouped into three broad classifications (physical, liquid and gas) based primarily
on the reaction phase of the method.(Table 1.1). Physical phase methods are typically top
down approaches to NP fabrication. The one physical phase model in Table 1.1 is the
mechanochemical method that breaks down bulk zinc oxide into smaller nanosized
particles, and uses the addition of molecular and chemical compounds to influence the
nZnO material properties [14-18]. In comparison, the remaining methods are bottom up
approaches that form nanomaterials from the atomic level.
Synthesis methods in the liquid phase offer the advantage of relatively inexpensive
precursors and solvent systems without the need for expensive fabrication systems. The
simplest of these is the precipitation method which involves a zinc precursor salt, such as
Zn(NO3)2, dissolved in a basic solution (e.g. NaOH) [19-21]. These reactions normally
proceed at low temperatures over extended periods of time. Surfactants or other organics
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may be used to limit NP growth or modify the NP surface during the ripening stage of the
nZnO fabrication [19-21].
Another widely used method, sol-gel synthesis, involves the forced hydrolysis of
zinc precursors such as metal halogens (M – Cl), alkoxides (M – OR) or weak acids (M –
OOCCH3) to form a colloidal ZnO sol within the solvent system (Eq. 1.1). This is followed
by the condensation (Eq. 1.2 & 1.3) of zinc hydroxide (Zn – OH) intermediates to produce
Zn − O − Zn nuclei [22-27]. During the NP growth phase, these Zn − O − Zn building
blocks combine to form gels in a continuous liquid phase. The final fate of the synthesis
depends on the desired downstream application of the NPs as these gels can be precipitated
to form particles or used to create thin films or ceramics [2].
𝑍𝑛 − 𝑂𝑅 + 𝐻2 𝑂 → 𝑍𝑛 − 𝑂𝐻 + 𝑅𝑂𝐻

Eq, 1.1

𝑍𝑛 − 𝑂𝐻 + 𝑂𝐻 − 𝑍𝑛 → 𝑍𝑛 − 𝑂 − 𝑍𝑛 + 𝐻2 𝑂

Eq, 1.2

𝑍𝑛 − 𝑂𝑅 + 𝑂𝐻 − 𝑍𝑛 → 𝑍𝑛 − 𝑂 − 𝑍𝑛 + 𝑅𝑂𝐻

Eq, 1.3

Common variations of this method include the addition of LiOH to an ethanolic
zinc acetate solution [28], or zinc acetate combined with a polyols such as diethyleneglycol
(DEG) [29, 30]. In the first method, the basic addition of the LiOH facilitates the hydroxide
formation followed by the condensation reaction. Afterwards, the resulting gel is aged in
an alkane solvent such as n-heptane to precipitate the particles [28]. In the later synthesis,
Caruntu et al. (2002) proposed that the zinc acetate precursor forms a complex with a DEG
dianion prior to hydrolysis. The subsequent condensation reaction releases the dianion
leaving the 𝑍𝑛 − 𝑂 − 𝑍𝑛 species. Nanoparticles made with this method then rapidly
precipitate out of the gel in the polar environment of the DEG solvent [30].
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Solvothermal techniques employ varying degrees of temperature (typically
between 100 °C to 1000 °C) and pressure (normally between 1 atm and 10,000 atm) within
reaction vessels to convert synthesis precursors to nZnO [2, 31-34]. When water is used as
a solvent, the method is referred to as hydrothermal. Nanomaterials fabricated in this
manner are favored for electronic and optical applications as they often possess
thermodynamically stable and metastable states [2]. Finally, microemulsions are created
by combining an aqueous layer, an oil layer and a surfactant to create stable, transparent
isotropic liquids [2, 35-37]. When the synthesis precursor and solvent are added to this
liquid, microemulsions form spontaneously with NP formation occurring when synthesis
precursor and solvent exchange takes place within the droplets [35].
The appeal of liquid phase methods is the ability to control the size and morphology
of the nZnO through simple modifications in the synthesis method such as water addition,
temperature and pressure control, capping agents or particle precipitation in organic
solvents [22, 28-30, 38-42]. Additionally, these fabrication methods can result in defect
states needed for effective photocatalysis [22, 43, 44]. The primary disadvantage is the low
production yield of nanomaterial especially when compared to large scale industrial
processes [22].
Gas phase synthesis methods (i.e. inert gas condensation and flame spray pyrolysis)
both result in the zinc precursor entering a gaseous phase prior to NP formation and
collection [45]. During inert gas condensation, the synthesis precursor is vaporized in the
presence of an inert gas using a high frequency induction coil [46]. Upon leaving the
induction system, the gaseous precursor is carried by convection in the inert gas to a cooling
tank where particle formation and collection occurs [46]. An alternative gas phase method
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is high temperature flame spray pyrolysis. In this technique (Figure 1.3), the synthesis
precursor immediately evaporates once it is injected into the high temperature flame.
Following atomization, individual molecules participate in molecular collisions or
nucleation driven events to initiate particle formation [47, 48]. In the lower temperature
environment, further from the flame, formed particles undergo agglomeration followed by
collection on a filter [49-51]. FSP is favored in industrial settings because of its simplistic
methodology with fewer process steps, scalability, easy collection systems, high yield, and
purity of the final product [47-52]. Varying the burner dimensions, precursor
concentration, injection rate of the precursor, and composition of the carrier gas change the
reaction dynamics in the FSP method and provide synthesis control to obtain the desired
product [48, 50-52]. Additionally, silica vapor may be introduced during the coagulation
phase to achieve silica (SiO2) coated nanomaterials [53, 54].
Electronic Structure and Surface Reactivity
Intrinsic Surface Defects and Photocatalytic Activity
In the electronic band structure of semiconductors, the highest occupied energy
band is the valence band (VB) while the lowest occupied level is the conduction band (CB)
with the difference between the VB top and the CB bottom defined as the electronic band
gap (Eg) [55]. When nZnO is excited with an energy source greater than or equal to the Eg,
four potential photophysical processes may occur (Figure 1.4). Process I occurs when an
electron is excited from the VB to an energy level within the CB (Figure 1.4, gray arrows).
−
This excitation results in valence band holes (h+
vb ) and conduction bands electrons (ecb ).

The e−
cb are very unstable, however, and undergo relaxation and recombination with the
−
h+
vb . Additionally, ecb can undergo non-radiative energy release (blue arrows) from higher

6

CB levels to the CB bottom followed by a radiative energy transfer to the top of the VB.
This dissipation of light energy, termed the band −band photoluminescence process or
process II (Figure 1.4, green arrow), produces the characteristic photoluminescence
emission of nZnO at the Eg of ~3.3 eV [55]. In the excitonic photoluminescence process
III (red arrow), a non-radiative transition from the CB bottom to a sub band, proceeds the
radiative emission to VB top. It is generally believed that intrinsic defects can trap e−
cb and
contribute strongly to excitonic emissions [55]. Finally, process IV (blue arrows) refers to
non-radiative energy transitions from the CB to the VB.
Chemical catalysis utilizes the presence of a catalyst to intensify a catalytic
reaction. This process depends on the ability of the catalyst to absorb the supplied energy
and facilitate the desired reaction. By measuring how fast the catalysis proceeds, a kinetic
constant can be determined to rate the efficiency of the catalyst. The band gap of nZnO
(~3.3 eV) can be exceeded with UV radiation or ultrasonic energy making it an ideal
catalyst. Photoexcitation employs the use of either UV-A or near ultraviolet (315 – 400
nm) or UV-B or medium ultra violet (280 – 315 nm) irradiation [56, 57]. Sonoexcition
involves the application of ultrasonic energy (20 kHz – 1GHz) to an aqueous suspension
of the nZnO. This facilitates the formation and growth of acoustic cavitation microbubbles
[58]. The inertia of the surrounding medium exerts high pressure and temperature on the
microbubbles causing them to implode and emit picosecond bursts of sonoluminescent
light [59]. Successive microbubble expansion and collapse (emission) result in sufficient
energy to excite the semiconductor bandgap [59] (Figure 1.5).
−
The valence band holes (h+
vb ) and conduction band electrons (ecb ) produced upon

excitation freely participate in redox reactions at the NP surface (Figure 1.5) [43, 60]. As
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−
good reducers, e−
cb react with adsorbed O2 to produce the anionic superoxide radical (O2 ),

whereas h+
vb , good oxidizers, will react with surface adsorbed hydroxide ions or water to
produce hydroxyl radicals (OH) [43, 60, 61] . The superoxide radical (O−
2 ) further reacts
to form hydrogen peroxide (H2O2). H2O2 can then be further reduced to produce additional
stores of OH − and OH. Additionally, the superoxide (O−
2 ) can undergo oxidation to
produce the perhydroxyl radical (OOH) which reacts with H+ and e−
cb to produce more
H2O2 [62].
Nanomaterials with intrinsic defects often exhibit faster catalytic rates [43, 44, 55,
60]. Metastable defects such as oxygen vacancies or interstitial oxygen are highly efficient
at trapping photoelectrons observed in process III photoluminescence [55, 63]. Oxygen
vacancies (VO ) can trap one or two electrons (Eq. 1.4), whereas interstitial oxygen anions
+
(O′′
i ) combine with hvb (Eq. 1.5)
−
−
𝑉𝑂 + 𝑒𝑐𝑏
→ 𝑉𝑂 + 𝑒𝑐𝑏
→ 𝑉𝑂

Eq, 1.4

+
𝑂𝑖′′ + ℎ𝑣𝑏
→ 𝑂𝑖′

Eq, 1.5

The electrostatic forces between the surface state and photoelectrons reduce
electron – hole recombination rates extending the lifetime of these excitons and improving
their catalytic ability [43, 55, 64]. Moreover, acceptor (O2) and donor (𝑂𝐻 − ) molecules
will chemically adsorbed to the defect states resulting in superoxide ( O2− ) and hydroxyl
(OH) radicals (Eq. 1.6 & 1.7) [44, 63]
𝑉𝑂 + 𝑂2 → 𝑉𝑂 +  𝑂2−

Eq, 1.6

𝑂𝑖′ + 𝑂𝐻 − → 𝑂𝑖′′ +  𝑂𝐻

Eq, 1.7

Modifications to nZnO synthesis methods designed to improve their catalytic
activity and antimicrobial properties has been an active area of interest [39-42, 65-70].
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Changing the overall synthesis method [40, 41, 69], solvent system [39, 42], precursor
concentration [68] and synthesis temperature [68] have all been shown to significantly
change the photo reactivity of nZnO and its microbial toxicity. Additionally, nanomaterials
with multiple defect states have been shown to participate in abiotic ROS producing
reactions at the NP surface without UV irradiation [43, 60, 61]. Even with antimicrobial
studies demonstrating strong connections between NP-induced toxicity and photo
reactivity, photocatalytic assays and defect state assessments are rarely performed in
mammalian systems.
Zeta Potential
When fabricated on the nanoscale, ZnO develops high surface area to volume
ratios, and NP surfaces become modified with charged ions or functional groups left behind
from the synthesis. The addition of these groups and negatively charged surface defects
modifies the overall charge density of the NPs. Once dispersed in an aqueous solution,
adsorption of solvent ions and NP surface ionization creates an enhanced surface charge
resulting in an electrical potential difference between the aqueous solution and the slipping
plane surrounding the nanoparticle [43]. Often referred to as surface charge or zeta
potential (ζ-potential), these measurements assess the electrophoretic mobility of nZnO
within the dispersive media. Another useful measure is the isoelectric potential (IEP) or
the pH at which the NPs will have a ζ-potential of zero. At the IEP, nZnO has neutral OH
groups resulting in Zn−OH bonds. As the pH of the dispersive media increases above the
IEP, adsorbed H+ ions will move into the media thus forming negatively charged Zn−O−
surface bonds [43]. Below the IEP, H+ ions will transfer to the NP surface resulting in
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Zn−OH2+ bonds and a positive surface charge. Since nZnO typically has an IEP at a pH
between 8 and 10, the resulting ζ-potential will be positive at physiologic pH.
Studies connecting NP-induced toxicity to electrophoretic mobility remain
inconclusive. Cationic NPs have demonstrated the potential to interact strongly with
anionic cell membranes causing increased hole formation [71], endocytosis [72, 73] ,
phagocytosis [74], membrane depolarization [75], and passive entry into the cells [71, 76].
Bhattacharjee et al. (2010) demonstrated this contention with differentially coated silica
NPs resulting in positively (Si-NH2), neutrally (Si-N3) and negatively (Si-COOH) charged
surfaces. The cationic silica NPs demonstrated more toxicity, intracellular ROS
production, and phagocytosis in rat alveolar NR8383 macrophages with Si-NH2 > Si-N3 >
Si-COOH for all measured variables [74]. In a similar study using a non-phagocytic cell
line (SK-BR-3 breast cancer cells), positive charged gold NPs showed significantly
increased amounts of membrane-association and endocytotic uptake when compared to
neutral or negatively charged NPs [77].
In contrast, Wingett et al. (2016) demonstrated that cellular toxicity increased with
decreasing electrophoretic mobility (-9 mV ≈ -30 mV > +44 mV) [78]. Furthermore,
modeling studies comparing the uptake of cationic and anionic NPs with neutral bilayers
showed faster and more complete disruption of the bilayer with negatively charged NPs
[72]. One limitation of many of these surface charge studies is the absence of experiments
accessing NP dispersion and agglomeration behavior. Indeed, Wingett et al. (2016),
demonstrated that their negatively charged NPs formed smaller agglomerates and
decreased sedimentation when compared to the cationic NPs. Therefore, it is highly
probable that this improved dispersion stability would increase cellular interactions of the
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anionic NPs thereby increasing their toxicity by a mechanism that is unrelated to surface
charge [78].
Agglomeration Behavior
Colloidal Stability
The DLVO theory, named for Derjaguin, Landau, Verwey, and Overbeek, provides
a mathematical model to describe the stability of colloidal suspensions (Figure 1.6).
Dispersion stability depends upon the balance of two competing forces, electrostatic
repulsion (blue dotted line) and van der Waals attraction (red dashed line). As two NPs
draw close to one another, their ionic double layers will begin to overlap creating a
repulsive force (VR). Meanwhile, attractive Van der Waal forces (VA) occur between the
induced dipoles on the particles. The total potential energy of the dispersion (VT; solid
purple line) represents the summation of these opposing forces. As seen in Figure 1.6, when
the attractive force is greater than the repulsive force, a deep attractive well, termed the
primary minimum, results. At larger distances, the repulsive force is larger than the
attractive force creating a maximum positive energy barrier followed by a shallow
secondary minimum [79].
For NPs to agglomerate and sediment out of the colloid, the NPs must have
sufficient kinetic energy to overcome the energy barrier. Colloidal stability can be lost
through various mechanisms. First, if the NPs have enough kinetic energy to overcome the
energy barrier, the NPs will irreversibly agglomerate due to net attractive forces, become
trapped in the deep potential well and undergo precipitation [79]. If the energy barrier is
sufficiently large due to strong repulsive forces, the particles rebound yet may remain in
the secondary minimum. Here particles are held together by much weaker bonds and tend
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to flocculate or form loosely packed NP agglomerates. Flocculation is reversible and can
be overcome if enough dispersive energy is supplied. However, if flocculation becomes
extensive the NPs could gain enough kinetic energy to overcome the barrier, due to their
diffusion velocity and increasing mass, resulting in irreversible agglomeration. [79].
Finding ways to improve repulsive forces between NPs while minimizing attractive
forces can be challenging. One way to accomplish this task is to introduce a form of steric
repulsion to the NP system by means of a surface coating (Figure 1.6). Surface coating
improves colloidal stability by shielding reactive NP surfaces thus prohibiting Van der
Waals forces or by increasing repulsive forces through surface charge modulation.
Cho et al. (2011) highlighted the importance of dispersion stability by examining
the relationship between diffusion and sedimentation velocity in NP colloids using an
adherent cell model. In solution, NPs will move either by diffusion through the media in
any direction or by sedimentation to the bottom of the cell well. Diffusion velocity (VD ) is
determined primary by the diffusion coefficient (D) which is inversely proportional to the
hydrodynamic diameter (d(h)) (Eq. 1.8). Therefore, as the diameter increases the diffusion
velocity decreases. The sedimentation velocity (VS ) is also strongly influenced by the
hydrodynamic diameter, but since this term is squared (d2(h) ), even small increases in
hydrodynamic diameter will exponentially increase the rate of NP sedimentation (Eq. 1.9).
By looking at the ratio of sedimentation to diffusion (Eq. 1.10), Cho et al. developed a
quantitative measure of NP stability with smaller ratios representing more stable
suspensions [80].
𝑉𝐷 =
𝑉𝑆 =

2𝐷

𝑘 𝑇

𝐵
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(ℎ) )

2
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and x = distance traveled by the NPs

Eq, 1.8

Eq, 1.9
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𝑉𝑆
𝑉𝐷

Eq, 1.10

In their model, they evaluated coated and uncoated gold NP (AuNP) uptake in
adherent cells grown in a traditional adherent model and cells grown on a glass slide that
had been inverted within the cell well (Figure 1.7). They determined that NP suspensions
with strong diffusion tendencies and low sedimentation (small VS/VD ratios) showed no
appreciable differences in NP uptake between the two different cell culture models;
however, for unstable dispersions, higher VS/VD ratios, the traditional model demonstrated
significantly more NP uptake compared to the inverted model. Furthermore, polyethylene
glycol (PEG) coating reduced the sedimentation velocity of the suspensions due to reduced
attractive forces and increased steric repulsion [80].
They hypothesized that the differences observed favoring the traditional adherent
model were a result of excessive amounts of NPs in the unstable suspensions driven by
sedimentation onto the cell layer resulting in significant increases in uptake (Figure 1.8)
[80]. This same reasoning can be applied to a suspension cell model. Nanoparticles that are
dominated by strong diffusion tendencies will be free to interact with the suspended cells.
Unstable dispersions dominated by sedimentation will result in less NP bioavailability.
Both potential outcomes, excessive NP sedimentation onto the adherent cell layer or less
NP bioavailability in suspension cells, will result in inconsistent results.
Strategies to Achieve Dispersion Stability
During in vitro studies, the treatment condition must remain bioavailable to the
treated cells over an extended period. For many drug or chemical treatments, this requires
finding the appropriate solution to solubilize the therapeutic agent. Since NPs remain in
particle form in suspension, the goal then becomes creating NP dispersions without
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appreciable agglomeration or sedimentation. Achieving this requires management of the
complex interplay between NP agglomerate and complex formation (hydrodynamic
diameter) and their sedimentation behavior over time [81]. Factors that influence
dispersion stability are numerous and include NP size [82, 83], surface structure [84, 85],
capping agents [86], solution pH and ionic strength [79], organic and protein components
[83, 85, 87], and free ions in the solution system [88]. To this end, numerous investigations
have employed various coating materials, such as polyethylene glycol (PEG) [80],
trinoctylphosphine oxide (TOPO) [86], silica (SiO2), and poly (acrylic acid) (PAA) [78],
to increase steric stabilization of the NP surface.
The drawback of this approach is that it changes the NP surface reactivity and adds
a layer of complexity to NP-cell interactions. Therefore, it is necessary to find a means to
stabilize particles that does not involve a chemical or physical change to the pristine NP
surface and is compatible with cells. Additionally, any method developed should ideally
be transferable to an in vivo model [85]. In most in vitro experiments, cells are treated in a
culture medium to which NPs are introduced in a prepared dispersion. Once NPs are
introduced, a biomolecular corona consisting of proteins and ionic complexes from the
cellular media will quickly form [79, 88-92]. Biomolecular coronas appear to be
multidimensional consisting of a tightly bound near monolayer called a hard corona
underneath a dynamic and rapidly changing soft corona [90, 93]. Typically, protein
components make up the bulk of the hard corona providing steric stabilization [94], while
other molecular species comprise the soft corona and influence NP-cell interactions [83,
88, 89].
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Given this, it is probable that cellular media proteins such as fetal bovine serum
(FBS), may provide a solution to dispersion instability with uncoated NPs. Indeed, studies
have shown that NPs introduced to media without FBS develop highly ionic coronas and
unstable colloids. However; suspending NPs in FBS prior to dispersion in the desired
solution would provide steric stabilization and reduce agglomeration. Utilizing this
approach could allow the use of ionic solutions such as PBS for NP stock solutions without
unwanted dispersion instability.
Dissolution Potential
Once dispersed, nZnO will undergo dissolution and leach zinc ions into the
dispersion media. Several solution-related factors including the ionic strength, pH,
concentration, temperature and solvated constituent molecules influence the degree to
which dissolution occurs [95, 96]. The presence and composition of these solvated
molecules is a strong determinant of a solution’s ability to solubilize nZnO [97, 98]. ZnO
NPs in media with low levels of phosphate (DMEM) appear to dissolve to a higher extent
than those with high phosphate levels (RPMI). However, ionic zinc rapidly reacts with
phosphate to form highly insoluble zinc phosphate that rapidly precipitates from the
dispersion [99, 100] making nZnO dissolution comparisons across multiple solutions
difficult. More recent research suggests that non-essential media additives significantly
increase NP dissolution, alter the biomolecular corona composition and structure, and
increase NP-induced toxicity [99]. Additionally, amino acid rich solutions can also increase
dissolution whereas protein components, such as FBS or BSA, may decrease dissolution if
sufficient NP coating results [95]. Given this complexity, the dissolution balance of NP
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dispersions could be one of reduced solubility through protein stabilization of NP clusters
or increased dissolution though ligand-mediated processes [95].
The physicochemical properties of the nZnO can also alter their dissolution
potential including size, shape, zeta potential and transition metal doping [10, 101-103].
Hydrodynamic size is perhaps the most important material property determinant of NP
solubility. Indeed, David et al. (2012) demonstrated that NP dispersions eventually reach
a steady state condition where the dissolution kinetic balance is entirely dependent upon
the radius of the NP agglomerates and the concentration [104]. Furthermore, they assessed
dissolution across multiple NP samples and concluded that any observed dissolution trends
could be explained by their mathematical model [105]. Therefore, it remains imperative
that NP studies characterize all material properties and media components that have the
potential to influence agglomeration potential and thus NP dissolution.
Introducing cells to a rapidly changing NP dispersion presents multiple challenges
in determining the active ZnO species encountered by the cells. Once dispersed into
cellular media, nZnO will leach ionic zinc and change the dynamics of the colloidal
dispersion. The original mass of zinc now exists in both ionic and non-ionic forms (Figure
1.9). Inevitably, some of this extracellular Zn2+ will enter cells to become intracellular free
Zn2+ within the cytosol or endocytotic vesicles [106-108] (right side of Figure 1.9).
Additionally, liberated Zn2+ reacts freely with carbonate and phosphate anions to produce
partially insoluble molecular zinc carbonates and phosphates [109]. These insoluble
species along with other media components, surface adsorb to large agglomerates of intact
nZnO (i.e., nonionic zinc) to form amorphous complexes of encapsulated ZnO [107, 110,
111] (left side of Figure 1.9). Zinc molecular species conversion and ZnO complex
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formation is a dynamic process for up to 4 to 6-hours post-treatment and needs to be
considered in comprehensive nanotoxicology studies.
Inherent Toxicity of nZnO
The cytotoxicity of nZnO has been extensively studied in multiple mammalian cell
types representing nearly every major organ system [3, 4, 8, 11, 67, 112-123]. Additionally,
nZnO toxicity has been observed in microbial systems [6, 41, 42, 67, 70, 124] , zebra fish
[7, 125, 126], yeast [127, 128], nematodes [129], microalgae [130, 131], and crustaceans
[132]. To this extent, the inherent toxicity of nZnO is well established; however, the
underlying mechanism of nZnO toxicity remains elusive. Strong evidence suggests that
nZnO-induced apoptotic cell death is secondary to processes such as cellular ROS
formation, antioxidant systems imbalance, and overwhelming oxidative stress [3, 6, 43, 93,
133-136]. Efforts to assign specific material properties or even underlying cellular
processes to the increased ROS production have been inconclusive. Surface property
studies suggest that abiotic ROS production and dissolution at reactive NP surfaces lead to
lipid peroxidation and cell membrane disruptions [6, 11, 104, 137]. Alternatively, large
influxes of ionic zinc from both extracellular and intracellular pools are known contributors
to mitochondrial dysfunction and intracellular ROS production [102, 135, 138-141]. These
seemingly opposing views of nZnO-induced cytotoxicity has resulted in a polarized
research community.
Surface Property Contributions to nZnO Toxicity and Oxidative Stress
Several studies attribute nZnO toxicity to their capacity to generate either abiotic
ROS at the NP surface or intracellular ROS resulting in oxidative stress leading to
apoptosis and cell death. Several factors contribute to the surface reactivity and abiotic
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ROS generation of nZnO. The narrow electronic band structure of nZnO allows for photo+
or ultrasonic excitation to create hvb
and e−
cb redox pairs capable of radical formation.

Additionally, discontinuous crystal planes facilitate the adsorption of ionic functional
groups [61]. Finally, altered electronic states secondary to crystal defect states contribute
to redox cycling at the NP surface (Figure 1.10A) [61]. These unique surface characteristics
have been shown to increase the concentration of free radicals in NP dispersions capable
of oxidizing lipids, proteins, DNA and other essential biomolecules [142].
ROS-induced lipid peroxidation results in the loss of cell membrane integrity
facilitating the uptake of ROS species, NPs and ionized zinc (Figure 1.10B) [6, 115, 143].
Additionally, ROS may be taken up by cells through aquaporins or chloride channels
(Figure 1.10C) [144]. Internalized ROS will cause oxidative damage to cellular
components or activate stress-induced signaling, such as Nox, which produces ROS as a
byproduct (Figure 1.10D) [115, 134, 145]. Genotoxicity, verified through DNA damage
and cell cycle arrest, has been observed in multiple studies [117, 146, 147]. Normally,
oxidative DNA damage is attributed to ROS; however, evidence also suggests that
malondialdehyde (MDA), a lipid peroxidation byproduct, [115, 148] or ionic zinc also
contribute to DNA damage [117, 146, 147]. Finally, changes in the NP charge density due
to surface adsorbed groups and defect states can increase electrostatic interactions between
normally positively charged ZnO NPs and the negatively charged cellular membrane
leading to membrane damage or induced NP uptake [149-151].
Dissolution Contributions to nZnO Toxicity and Oxidative Stress
The solubility of nZnO in NP dispersions introduces multiple forms of ZnO and
ionic zinc available for cellular interactions. Identifying toxicity mechanisms that consider
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the balance of all these species has created considerable debate in the research community.
One proposed mechanism is that large pools of ionic zinc are liberated within the
extracellular environment and then taken up by the cell primarily through non-specific ion
transporters (Figure 1.11A) or specialized zinc importers termed Zips (Figure 1.11B) [106108]. Song et al. (2010) demonstrated this connection by analyzing ZnCl2 and
commercially available nZnO samples. They found ZnCl2 to be significantly more toxic
than all the NP samples. Furthermore, they discovered that the supernatants isolated after
24 hours from nZnO-treated cellular media were also toxic but to a lesser extent than the
NP treated cells. As a result, they concluded that extracellular dissolution was primarily
responsible for the NP-induced toxicity [106].
The alternative hypothesis suggests that NP-cell contact results in the active uptake
of NP agglomerates in endocytotic vesicles (Figure 1.11C) followed by rapid dissolution
of non-ionic zinc in the acidic endosome or through passive transport through the cellular
membrane (Figure 1.11D) [23, 36, 39, 43]. Many of these studies are somewhat
inconclusive as they have relied solely on endocytosis to explain the presence of
intracellular zinc without offering direct evidence of the actual uptake mechanism or a
comparative analysis of extracellular zinc studies. The strongest evidence for this model is
observed in macrophage studies or other phagocytic cell types that can engulf large
amounts of extracellular material through a variety of mechanisms [102, 141, 152, 153].
For example, Wang et al. (2014) used cellular uptake inhibitors to demonstrate that
macrophages utilize both macropinocytosis and phagocytosis for NP uptake [141].
However, this mechanism would also result in the uptake of large nZnO agglomerates and
extracellular Zn2+ making it difficult to attribute any intracellular zinc increases to one
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specific zinc source. Furthermore, these results may not be indicative of NP uptake
mechanisms in non-phagocytic cell types. As an illustration, Othman et al. (2016),
demonstrated that bare nZnO was selectively taken up by breast cancer cells through
clathrin-independent endocytosis which resulted in gradual time-dependent increases in
intracellular zinc, eventually leading to cell death [140]. However, they found a similar
trend in cells treated with ZnCl2. Thus, they could not differentiate between intracellular
ionic zinc resulting from nZnO uptake or Zn2+ entering the cell from the extracellular
environment.
In non-phagocytic Jurkat cells, Buerki-Thurnherr et al. (2013) explored both
dissolution models with bare and coated nZnO. They employed zinc chelators
diethylenetriaminepentaacetic acid (DTPA) and N,N,N′,N′-tetrakis(2-pyridinylmethyl)1,2-ethanediamine (TPEN) for extracellular and intracellular zinc, respectively, while
monitoring the corresponding ionic zinc levels and NP-induced toxicity. Both DTPA and
TPEN chelation used independently completely abrogated NP-induced cytotoxicity.
Similar results were obtained when cells were treated with equimolar concentrations of
ZnCl2; however less toxicity was observed and significantly lower amounts of chelating
agents were needed with the coated-nZnO. Ultimately, they concluded that NP-induced
toxicity was primarily dependent upon extracellularly released zinc that induces cell death
by apoptosis [12].
Once internalized, ionic zinc will cause a vast number of cellular responses.
Initially, cells will attempt to regulate ionic zinc excesses through various mechanisms
such as zinc transport out of the cell or into zincosomes via zinc-specific efflux proteins
(ZnTs) (Figure 1.11E), and through metallothionein protein sequestration (Figure 1.11F)
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[154-159]. Inevitably, increasing ionic zinc levels will overwhelm the zinc homeostasis of
the cells and cause toxic effects. Kao et al. (2011) established that increases in cytosolic
zinc were systematically followed by elevated levels of mitochondrial zinc and collapse of
the mitochondrial membrane potential (Figure 1.11G). Additional studies have also linked
increased cytosolic zinc levels to mitochondrial swelling, mitochondrial membrane
transition, impairment of inner membrane H+ conductance, impaired respiration, adenosine
triphosphate (ATP) depletion and cytochrome c release to signal apoptosis [139, 152, 160,
161]. Genotoxicity and organelle damage has also been linked to nZnO dissolution
although it is unknown if this type of damage is a direct result of ionic zinc or related to
substantial oxidative stress after mitochondrial dysfunction (Figure 1.11H).
Cellular Regulation of and Response to Zinc and nZnO
Maintaining Zinc Homeostasis
Zinc is an essential metal for humans with zinc deficiencies being linked to growth
retardation, poor immune system function, delayed wound healing, loss of appetite,
impaired taste acuity, reproduction issues, and impaired insulin function and blood glucose
regulation [162, 163]. As the only biologically essential transition metal that does not
participate in redox activity, zinc is an ideal choice for use as a protein cofactor with
approximately 10% or 2,800 human genes encoding for proteins with zinc -binding
capability (Figure 1.12) [164]. It is estimated that the total amount of cellular regulated
zinc is between 200 – 300 µM [165], yet steady state concentrations of free ionic zinc are
consistently measured in the nanomolar to picomolar range with variably dependent upon
the zinc reserves needed for cellular function. To function as an effective second
messenger, labile zinc stores have to remain at concentrations sufficient for use during
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signaling yet low enough to demonstrate the desired zinc level fluctuations without
inhibition of other zinc-sensitive secondary messaging components [166]. For instance,
skin (32 µg/g zinc) and blood (5-6 µg/g zinc) have strong immunological importance and
low steady-state labile zinc; however, immune-privileged cells in the retina and prostate
exhibit high useable zinc concentrations at 290 and 700 µg/g zinc, respectively [166].
Given the extensive involvement of zinc in cellular processes yet very low amounts of free
zinc, tight cellular regulation is needed to ensure that sufficient amounts of zinc are
available when needed.
Managing both steady state and non-steady state (i.e., deficiencies and excesses)
levels of cytosolic zinc is accomplished by a considerable network of proteins responsible
for zinc sensing, binding and transport in and out of the cytosol. Steady state control of
zinc levels or intracellular zinc buffering is managed by a group of cytosolic zinc-binding
proteins including the zinc sensor, metal-responsive transcription factor-1 (MTF-1),
metallothioneins (MT), and various cell signaling mechanisms [154, 164]. Research
suggests that MTF-1 has an affinity for ionic zinc in the low nanomolar range and controls
the upper limit of steady state zinc concentrations. MTF-1 binds excess zinc in the cytosol,
and translocates to the nucleus where it regulates the transcription of both metallothioneins
and zinc tranporter-1 (ZnT1) through the metal responsive element (MRE) [156, 167-169].
Zinc deficiencies and excesses (non-steady state Zn2+ levels) are managed through a
process termed muffling which results in the redistribution of intracellular zinc through the
use of zinc transporters [164].
Metallothioneins and Zinc Transporters
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Metallothioneins (MTs) are small proteins whose cysteine-rich α and β domains
can effectively coordinate up to seven zinc ions [159]. Four isoforms and additional subisoforms exist in mammals, and differ in size, coordination ability, organism and tissue
distribution [164]. In addition to zinc homeostasis, these proteins participate in metal
detoxification and oxidative stress remediation. Heavy metal detoxification is mediated by
MT’s ability to effectively coordinate all group 11 and 12 metals with preferential binding
towards more toxic metal species such as mercury, lead and arsenic. In the absence of
heavy metals, MTs bind mostly Zn2+ or to a lesser extent Cu2+ or Zn2+/Cu2+ combinations
[159]. When exposed to heavy metals, MTs release bound zinc triggering MTF-1 nuclear
translocation and subsequent transcription of the MRE promoter. This results in increased
transcription of the MT gene and upregulation of mRNA products.
The mechanism by which MTs mediate oxidative stress remains unclear. It has been
hypothesized that bound ATP and glutathione (GSH) are required for MT coordination of
Zn2+ and that ATP and GSH release are subsequently needed for zinc release from the
proteins [170]. GSH neutralizes ROS to become oxidized glutathione disulfide (GSSG)
and the GSH/GSSG is often used to measure the oxidative stress of cells. Activated MTF1 along with other transcription factors upregulate MT expression through the antioxidant
response element (ARE) promoter located on the MT gene [156, 159, 171]. The abundant
cysteine content in metal free (apo-) MT proteins leads to their enhanced reactivity with
the oxygen-rich ROS. The ability of MTs to mediate hydroxyl radical damage has actually
been shown to be functionally similar to superoxide dismutase in yeast cells [167].
Restoration of zinc homeostasis following oxidative stress remediation is eventually
achieved through MT replenishment from increased mRNA translation or GSH reduction
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of the previously oxidized proteins [159]. While MTs assert many of their functions in the
cytosolic space of cells, they can be imported into the mitochondrial intramembrane space
and release zinc ions to inhibit mitochondrial respiration [164] (Figure 1.13).
Zinc importers (SLC39) and exporters (SLC30), commonly referred to as Zip and
ZnT proteins, respectively, are a part of the solute-linked carrier family of proteins and
participate in muffling processes to manage non-steady state concentrations of cytosolic
zinc (Figure 1.13). Zips are responsible for zinc transport into the cytoplasm from
extracellular spaces or from cellular organelles [172]. Fourteen importers (Zip1 – Zip14)
have been identified in the human genome and consist of approximately eight
transmembrane domains, a histidine-rich loop region and an amphipathic channel to allow
ion transport [172]. Studies have demonstrated that zinc transport with Zip1 (SLC39A1),
Zip2 (SLC39A2), and Zip8 (SLC39A8) is energy independent and likely stimulated with
bicarbonate anions indicating a possible zinc/bicarbonate symport mechanism [157, 172].
In addition to zinc responsiveness, most Zips also respond to other hormones and
inflammatory cytokines [172]. ZnTs are responsible for zinc efflux to either the
extracellular environment or endosomal compartments [157, 173]. The nine ZnTs
(SLC30A1 – SLC 30A9) identified in humans have six or more transmembrane amphipathic
domains that facilitate transport and are suspected to act as dimers and trimers [157]. ZnTs
show strong sensitivity to dietary changes in zinc [157] and ZnT1 expression has been
linked to changes in MT expression and MTF-1 [167].
Zinc Signaling and Influences on Zinc Homeostasis
In addition to buffering and muffling actions, several signaling pathways rely on
zinc as a second messenger and alter intracellular zinc accordingly. Zn signaling falls into
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two broad categories termed early and late Zn signaling [174]. Early Zn signaling (Figure
1.14A) occurs in response to an external stimulus, such as ligand binding to a receptor, that
results in the subsequent release of ionic zinc into the cytosol from common zinc stores
such as metallothioneins or the endoplasmic reticulum. Early zinc signaling is transcription
independent and normally occurs within minutes after the external stimulus [174].
Released zinc then acts as a second messenger to facilitate the desired cellular response.
Yamasaki et al. (2008) illustrated how mast cells utilize ionic zinc release to facilitate
cytokine production and secretion. They found that engagement of antigen-bound
immunoglobulin E (IgE) with the high-affinity IgE receptor (FcԑRI) in mast cells resulted
in large Ca2+ and mitogen-activated protein kinase kinase (MAPKK) dependent increases
of intracellular zinc originating from the perinuclear region of the cells within several
minutes of FCԑRI stimulation [175]. Using the intracellular zinc chelators and calcium
channel inhibitors, they demonstrated that this released zinc enhanced the NF-κβ binding
of DNA needed for cytokine regulation [175, 176]. In T cells, intracellular zinc increases
via plasma membrane localized Zip 6 within one minute of T cell activation and influences
CD69 and CD25 expression [177].
In contrast, late zinc signaling is transcription dependent and describes Znfacilitated cellular responses that occurs after the transcription of zinc transporters (Figure
1.14B). Toll-like receptor four (TLC4) is activated by the bacterial endotoxin
lipopolysaccharide (LPS) in dendritic cells (DC) and initiates myeloid differentiation factor
88 (MyD88) and Toll/IL-1 receptor (TIR) domain-containing adapter inducing interferon
β (TRIF)-mediated signaling to induce DC maturation [178]. MyD88- and TRIP-mediated
signaling results in the transcription of major histocompatibility complex (MHC)-II,
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upregulation of ZnT1, ZnT4 and ZnT6 and the suppressed transcription of Zip6 and Zip10
[178]. The net result of the Zip downregulation and ZnT upregulation would be an increase
in zinc efflux from the cell to reduce cytosolic zinc concentrations. Indeed, experiments
with an ionic zinc surplus or Zip6 overexpression decreased MHC-II trafficking to the
plasma membrane and DC maturation [178]. These results linking LPS-induced expression
of zinc transport proteins to intracellular zinc decreases and DC activation highlight late
zinc signaling in these processes.
ZnO Nanoparticles and Genetic Expression
Given the importance of zinc in cellular function, many researchers have sought to
determine the genomic or proteomic consequences of excess ionic zinc or nZnO in
mammalian cells [156, 179-184]. The observed genetic responses across these studies is
widely variable, however, a few common themes exist. First, the differential expression of
MTF-1, metallothioneins, and zinc responsive transport proteins was observed across
numerous cell types, zinc concentration levels and time points underscoring the importance
of these proteins in the regulation of steady-state zinc levels [158, 169, 173, 179-181, 183,
185]. In addition, differentially expressed genes associated with stress response pathways
outweigh contributions from other cellular processes. In immune cells, apoptotic and cell
death pathway genes are consistently upregulated or downregulated depending on the cell
type or time of treatment [181, 183], and these results confirmed through proteomic studies
[182]. The significant upregulation of mRNA and translation of chaperones and other
proteins involved in proteasome degradation indicate that nZnO can disrupt normal protein
folding or function [181-183]. Cell cycle [183] and metabolic impairment are evident
through the upregulation of G1 phase mediator cyclin-dependent kinase inhibitor 1
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(CDKN1A) and increased enzymatic activity in the glycolysis pathways post nZnO
treatment [182]. Furthermore, high levels of the metabolite pyruvate following nZnO
treatment is believed to function as a survival factor against zinc-induced stress [182].
Finally, ionic zinc is capable of mimicking other signaling molecules including cytokines,
growth factors, hormones and influencing various intracellular signaling pathways [174,
186]. This could allow ionic zinc to directly bind to and alter the structure and biological
function of several cytokines and growth factors [187].
Moving Forward
Controlling NP-induced toxicity is imperative for achieving safe and effective use
of nZnO for either consumer or biomedical applications. To achieve this, a thorough
understanding of the material properties that influence toxicity and a connection to
observed cellular responses is required (Figure 1.15). Research has demonstrated that NPinduced toxicity can be altered through material property modifications such as transition
metal doping or surface coatings to a single nZnO sample. This formulation controlled
approach has been instrumental in identifying how certain physicochemical modifications
result in cellular damage. These types of modifications, however, can permanently alter the
intrinsic nZnO core or surface structure and often fail to explain how comparable studies
using similar NP-modifications but differently synthesized nZnO samples often result in
different cytotoxic responses.
To address these disparities, in 2012 the research community examined the
importance of materials characterization and developed a minimal set of methods needed
for every nanomaterial study. These characterizations included particle size and
distribution, morphology, chemical composition and impurities, agglomeration tendencies,
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surface chemistry, surface area, surface reactivity and persistence [188]. Schrurs and Lison
(2012) examined 38 research studies on silica nanoparticles across six different parameters
and discovered significant disparity in the reported results in relation to cytotoxicity,
cellular uptake, agglomeration potential, surface reactivity and redox potential. Two of
these properties, agglomeration potential and surface reactivity, were found to be woefully
underrepresented in the literature. For agglomeration potential, 19 studies documented
stability in cellular media, four studies examined agglomeration tendencies, two studies
evaluated the impact of stability on cytotoxicity, and only 13 measured surface reactivity
[189]. Additionally, they found that very few authors arrived at the same conclusions as to
which material properties most influenced NP-induced toxicity. Similar recommendations
have been made for downstream biological experiments and include cell death, oxidative
stress, proliferation, DNA damage, cell adhesion, inflammatory potential, NP uptake,
energy metabolism and genetic expression assays [190, 191]. However, more diversity is
expected regarding these experiments as the anticipated cellular responses will vary with
the biological model studied.
These discrepancies have resulted in uncertainty as to which specific material
properties within a very diverse set of nZnO formulations have the greatest influence on
toxicity. As an illustration, two comparable studies, George et al. (2010) and Thurber et al.
(2012), examined the effect of Fe-doping in nZnO on the NP-induced cytotoxicity in
different mammalian cell types. Both studies employed small, spherical nZnO (<20 nm)
and similar Fe-doping percentages (<10 %). However, one study found that Fe-doping
decreased both the NP-induced cytotoxicity and oxidative stress responses when compared
to the un-doped nZnO [10], whereas the other study found increasing cytotoxic trends with
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the Fe-doping [5]. Interestingly, one major difference between the two studies was the
nZnO synthesis method. Flame spray pyrolysis (FSP) was utilized in the first study [10],
while a wet chemical method was employed for the later work [5]. This suggests that
physicochemical differences between the two formulations may have been present before
doping that could have potentially affected the outcome. Additionally, the characterization
methods and cellular response assays differed between the two works which resulted in
different conclusions as to the cause of the toxicity. Given these disparate results, it is
difficult to make definitive conclusions regarding the effects of Fe-doping on NP-induced
toxicity without first understanding how alterations in the synthesis method changed the
underlying material properties of the nZnO.
The inconsistencies observed in the literature indicate that a comprehensive
investigation of the material properties that influence the toxicity of nZnO NP towards
mammalian cells is needed. The overall objectives of the work presented here were to i)
evaluate the physicochemical properties of differentially synthesized nZnO fabricated
through both bottom-up and top-down methods and matched for size distribution, crystal
structure and band gap, ii) reduce NP agglomeration tendencies within complex media and
achieve dispersion stability, iii) define which material property interactions have the
greatest potential to affect cellular toxicity, and to iv) examine the preferential toxicity of
nZnO towards human leukemic cells through genetic expression studies. With this
knowledge, it may be possible to systematically engineer and control the physicochemical
properties of nZnO to maximize cell selectivity and cytotoxicity to achieve levels that are
ideal for practical applications towards future biomedical use and environmental safety.
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Tables and Figures

Figure 1.1
Worldwide distribution of nZnO usage (data adapted from
Kołodziejczak-Radzimska (2014).

nZnO Applications
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Pharmaceutical and
cosmetics

Ointments, creams, sunscreens, dental pastes,
nutritional supplements

Textiles

Self-cleaning, water-repellent and UV
radiation protection products

Electronics and
electrotechnology

Photoelectronics, field emitters, solar cells,
UV lasers and sensors

Rubber

Thermal conductivity, insulation and tensile
strength

Photocatalysis

Organic pollutant oxidation, antimicrobial
surfaces and disinfecting agents

Construction

Cements, paints

Miscellaneous

Meat-packing, cigarette filters, fingerprint
analysis

Figure 1.2

Schematic representation of the application of nZnO

Table 1.1
literature.

Common liquid and gas phase chemical synthesis methods for nZnO including potential applications found in

Classification

Synthesis Category

Applications

Reference

Physical phase

Mechanochemical process

Photocatalyst and heterogenous catalyst

[14-18]

Precipitation process

Photocatalysis, dielectrics and antimicrobial activity

[19-21]

Sol-gel

Sarin degradation, cellular imaging and water treatment

[22-27]

Electronics, photocatalysis and gas sensing

[31-34]

Microemulsions

Voltage surge devices, photocatalysis and gas sensing

[35-37]

Green synthesis

Antimicrobial and antifungal treatments

[41]

Inert gas condensation

Electrical, optical and magnetic application

[46]

Flame spray pyrolysis

Aerosol treatment for in vivo studies and catalysts

Solvothermal,
Liquid phase

hydrothermal and
microwave techniques

Gas Phase
[49, 52-54]
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Figure 1.3

Reaction steps in the formation of nZnO during flame spray pyrolysis.
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Figure 1.4
The main photophysical processes of nZnO when excited by UV
radiation where hv ≥ Eg. The four processes represent are: I) photo-excited process
(gray arrows), II) band −band photoluminescence process (green arrow), III)
excitonic process (red arrow), and IV) non-radiative transition process (blue arrows).
The empty spheres in the valance band (VB) represent valance band holes (𝐡+
𝐯𝐛 ) and
solid spheres in the conduction band (CB) denote conduction band electrons (𝐞−
𝐜𝐛 ).

Figure 1.5
Sonocatalytic and photocatalysis reaction processes for nZnO including redox reactions, reactive intermediates,
and reactive oxygen species.
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DLVO graph depicting colloidal stability for a NP dispersion.
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Figure 1.6
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Figure 1.7
Schematic illustrating the transport dynamics of nanoparticles when
introduced to adherent cell culture models in both the upright (left side) and inverted
(right side) configurations. Cho article Figure 4. Reprinted by permission from
Macmillan Publishers Ltd: Nature Nanotechnology (Cho, E. C.; Zhang, Q.; Xia, Y.
The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles.
Nature Nanotechnology 2011, 6, 385-391.), copyright 2011.
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Figure 1.8

Schematic illustrating dispersion dynamics within cell culture.
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Figure 1.9

Schematic depicting the dissolution processes associated with nZno.
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(A)

(B)

(E)
(D)

(C)

Figure 1.10 Schematic illustrating the various mechanisms by which (A) exogenous
ROS generated at the nZnO surface and the nZnO particles themselves can induce
cellular damage including (B) membrane disruption and lipid peroxidation. (C)
Internalized ROS via membrane bound transporters will cause (D) oxidative damage
to cellular components or activate stress-induced signaling. (E) Electrostatic
interactions of NPs with cellular membranes will facilitate NP adsorption and cellular
membrane damage.
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(A)

(C)
(D)
(H)

(E)

(B)

(G)

(F)

Figure 1.11 Schematic illustrating the various mechanisms by which extracellular,
intracellular free, and cell-associated zinc induce cellular damage. Extracellular free
zinc can enter cells through (A) non-specific ion channels, and (B) specialized zinc
importers (Zips). Intact NPs or amorphous complexes may be internalized through
(C) active or (D) passive transport mechanisms. Elevated intracellular free zinc
concentrations are remediated through sequestration into (E) zincosomes or by (F)
metallothioneins. Disruption of zinc homeostasis can result in (G) mitochondrial and
organelle damage or (H) genotoxicity.

Figure 1.12

The number of human genes encoding for proteins with a zinc-binding site.
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Figure 1.13 Schematic illustrating the cellular localization of the SLC39 (Zips) and SLC30 (ZnTs) families of zinc
transporters. Zip proteins (blue) elevate cytosolic zinc levels by importing ionic zinc from the extracellular
environment or cellular compartments. ZnT transporters lower cytosolic zinc through efflux into cellular
compartments or out of the cell. Metallothioneins contribute to intracellular zinc level management by sequestering
zinc ions. Hojya and Fukada article Figure 2. Reprinted by permission from Hindawi Publishers: Journal of
Immunology Research (Shintaro Hojyo and Toshiyuki Fukada, “Roles of Zinc Signaling in the Immune System,”
Journal of Immunology Research, vol. 2016, Article ID 6762343, 21 pages, 2016. doi:10.1155/2016/6762343),
copyright 2016.

Figure 1.14

Early (A) and late (B) zinc signaling.
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Figure 1.15 Schematic overview summarizing the toxic effect of nZnO. The key material factors implicated in NP- induced
toxicity include particle size and shape, agglomeration potential, surface structure and reactivity, and NP dissolution. The
observed cellular responses include disruption of zinc homeostasis, metallothionein and zinc transport regulation, zinc related
cell signaling, and oxidative stress.
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Abstract
Agglomeration and sedimentation of nanoparticles (NPs) within biological
solutions is a major limitation in their use in many downstream applications. It has been
proposed that serum proteins associate with the NP surface to form a protein corona that
limits agglomeration and sedimentation. Here, we investigate the effect of fetal bovine
serum (FBS) proteins on the dispersion stability, dosimetry and NP-induced cytotoxicity
of cationic zinc oxide nanoparticles (nZnO) synthesized via forced hydrolysis with a core
size of 10 nm. Two different in vitro cell culture models, suspension and adherent, were
evaluated by comparing a (phosphate buffered saline PBS) nZnO dispersion (nZnO/PBS)
and an FBS-stabilized PBS nZnO dispersion (nZnO – FBS/PBS). Surface interactions of
FBS on nZnO were analyzed via spectroscopic and optical techniques. FTIR confirmed the
adsorption of negatively charged protein components on the cationic nZnO surface through
the disappearance of surfaced-adsorbed carboxyl functional groups and the subsequent
detection of vibrational modes associated with the protein backbone of FBS-associated
proteins. Further confirmation of these interactions was noted in the isoelectric point shift
of the nZnO from the characteristic pH of 9.5 to a pH of 6.1. In nZnO – FBS/PBS
dispersions, the FBS reduced agglomeration and sedimentation behaviors to impart long
term improvements (>24 hours) to the nZnO dispersion stability. Furthermore,
mathematical dosimetry models indicate that nZnO – FBS/PBS dispersions had consistent
NP deposition patterns over time unlike unstable nZnO/PBS dispersions. In suspension cell
models, the stable nZnO – FBS/PBS dispersion resulted in a ~33 % increase in the NPinduced cytotoxicity for both Jurkat leukemic and Hut-78 lymphoma cancer cells. In
contrast, the nZnO – FBS/PBS dispersion resulted in 49 % and 71 % reductions in the
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cytotoxicity observed towards the adherent breast (T-47D) and prostate (LNCaP) cancer
cells lines, respectively. Presence of FBS in the NP dispersions also increased the reactive
oxygen species generation. These observations indicate that the improved dispersion
stability leads to increased NP bioavailability for suspension cell models and reduced NP
sedimentation onto adherent cell layers resulting in more accurate in vitro toxicity
assessments.
Keywords
Zinc oxide nanoparticles, dispersion stability, nanotoxicity, dosimetry
Background
When prepared in nanostructured form, many materials develop novel and unique
physico-chemical properties leading to their use in nanotechnology applications such as
quantum dots and MRI contrast agents for imaging [1], biosensors that use surface plasmon
resonance [2], and nanomedicinal approaches that employ hyperthermia and photothermal
therapy [3]. Efficient use of NPs and nanocarriers in biomedical applications, such as
delivery of therapeutic and imaging agents into tumor sites and genetic materials into cells,
has been successfully demonstrated in recent years [4-6]. Interestingly, cytotoxicity is a
property that is inherent in many of these commonly used materials when they are
synthesized with their crystallite size in the nanoscale range [7-9]. This has raised
significant scientific and public concerns on the environmental and health effects of every
nanomaterial before employing them in nanotechnology applications. It is therefore
necessary to evaluate the cytotoxic response of nanomaterials and the underlying
mechanisms of nanomaterial toxicity to accurately address the growing concerns about the
impact of the unwanted cytotoxicity of nanomaterials.
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Numerous studies reported in the literature have shown that NP-induced toxicity
depends on the nanomaterial properties such as crystallite size [10, 11], shape [12], charge
[13], and chemical phase [14]. Some studies have also shown that the toxic response of a
given nanomaterial might vary with the specific cell/organism type such as prokaryotes vs.
eukaryotes [15], gram positive bacteria versus gram negative bacteria, and normal cells
versus cancerous cells [16]. These observations suggest that the role of organism-specific
factors such as surface structure of cells [17, 18] and the proliferation status [10, 16] also
influence the toxic response. Although the cytotoxicity of nanomaterials is an unfavorable
feature for many applications, it could become very useful for certain therapeutic
applications, if the toxicity is cell- or organism-specific. The cytotoxicity reported for most
nanomaterials does not display a cell-specific or organism-specific behavior. However,
many groups [16, 19, 20], including the authors, have demonstrated that certain ZnO NP
formulations show a strong preferential cytotoxicity to cancer cells of identical lineage. For
example, while resting primary human immune cells (T lymphocytes) showed no
appreciable effect when treated with ≤ 5 mM concentrations of ZnO NPs, cancer cells of
the same lineage showed significantly increased NP-induced toxicity resulting in
approximately 28-35-fold increases in NP sensitivity [10, 16]. Thus, toxicity studies are
extremely important both to assess the environmental and health impacts of NPs and to
modify the nanomaterial design to make them safer, as well as to develop novel
nanomedicinal approaches utilizing cell-specific cytotoxicity.
Considering the large number and types of new nanomaterials being developed and
coming to the market, in vitro studies are essential in assessing the toxicity in highthroughput systems as they provide rapid and cost-effective screening. In most in vitro
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cytotoxicity experiments, cells are cultured in a culture medium to which a prepared
dispersion of the NPs in a suitable solution is introduced. In contrast, in vivo toxicology
studies frequently employ NPs dispersed in a suitable medium that are subsequently
injected into the blood vessels or tissues of the animal model. If successful, the dispersed
NPs will reach tumor sites and achieve deep penetration and entrapment in the cancerous
tissue by means of the enhanced permeability and retention (EPR) effect, characterized by
increased vascular permeability and compressed lymphatic networks in solid tumors [21].
However, making highly stable and efficient dispersions of nanoparticles to achieve
efficient nanoparticle delivery for both in vitro and in vivo applications has been a
challenging task. A major difference that NPs possess compared to the well-studied
conventional toxic chemicals (which are well soluble molecules and ions) is the difficulty
in dispersing them in suitable solutions and culture media, and to maintain them as stable
dispersions for sufficient durations [22]. For most in vitro studies, NP suspensions should
remain stable at least for 24 hours while in vivo studies require stability for much longer
durations [23]. Formation of large agglomerates and their sedimentation over longer
periods often prevents a significant fraction of the NPs from participating in efficient
interactions with the test cells and the resulting cytotoxic response.
Nanoparticle dispersion stability is a complex interplay between the agglomerate
size of NP complexes in dispersion (hydrodynamic size) and their sedimentation behavior
over time [24]. Factors that affect NP stability include NP size [25, 26], surface structure
[18, 27], capping agents [28], pH [29], ionic strength [29], organic and protein components
[26, 27, 30], and free ions in the solution system [31]. Although it is now known that the
physicochemical properties of the nanomaterial, the specific cell/organism type and the
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membrane properties [10, 17, 18] of the test organism play a crucial role in the resulting
cytotoxic response, very few studies have focused on the important role of NP dispersion
characteristics and dispersion stability and the effects of NP agglomeration and
sedimentation in the resulting toxicity [32, 33]. Furthermore, Cho et al. [34] have recently
shown that the cellular uptake of gold NP in breast cancer cells measured using
conventional upright in vitro cell culture configuration was significantly higher than that
obtained when an inverted set-up was used, suggesting the effect of NP sedimentation and
diffusion in the media play a significant role in the NP-cell interaction. In addition,
suspension stability has been shown to directly influence effective administered dose of
NPs to adherent cells grown in vitro [22, 32, 33].
When NPs are introduced to biological fluids such as human plasma, a
biomolecular corona consisting of proteins and small molecules rapidly forms on the NP
surface [27, 35-37]. Since the blood circulatory system is the most probable treatment
administration option for NPs into the human body, it is important to investigate how
adsorption of blood proteins on NPs will affect the cellular response, and more importantly,
the differential cytotoxicity of ZnO NPs between cancerous and normal cells. The effect of
having serum in culture medium and/or adsorption of the serum proteins on some NP
systems such as silica [38], carbon nanotubes [39], graphene oxide [40] and ZnO [41, 42]
have been studied recently. In all these cases, the primary effects of serum addition
included improved dispersion stability and a clear reduction of the NP-induced
cytotoxicity. Interestingly, the above-mentioned studies were conducted using adherent
cell models; therefore, comprehensive studies are needed to determine if similar responses
are present for suspension cell models as well. Hypothetically, increases in the NP-induced
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toxicity in suspension cell models would be observed as NP sedimentation decreases,
thereby improving the bioavailability of the NPs to the cells.
In this study, we investigated the use of FBS as a ZnO NP coating agent and the
effects of this FBS coating the surface structure of the uncoated NPs, the dispersive stability
of the NPs in solution and the effective dosimetry of the NPs in cellular toxicity assays.
Since NP dispersion stability and dosimetry is highly dependent upon a balance of NP
diffusion and sedimentation velocities within solution [32-34, 43, 44], the use of multiple
suspension and adherent cell models was necessary to fully characterize any observations
attributable to the addition of the FBS. A complete NP characterization profile was
employed to fully interrogate NP-surface changes as a result of the FBS coating. In
addition, we examined the agglomeration and sedimentation behavior of the FBS-coated
ZnO NPs (nZnO-FBS) compared to uncoated ZnO NP (nZnO) in biologically relevant
solutions. Finally, we investigated the effects that FBS coating would have on the solubility
of the nZnO, the NP-induced toxicity and nZnO-induced reactive oxygen species
production. As a whole, this work provides a comprehensive look at effects of FBS as a
dispersion stabilizing agent in nanotoxicology studies.
Methods
Synthesis and Characterization of nZnO
The nZnO sample used in this study was produced using the forced hydrolysis of
Zn acetate dehydrate precursor in diethylene glycol (DEG). The solution was held at 150 °C
for 90 minutes. Nanopure water was added to the solution at 80 °C to obtain the desired
crystallite size. This synthesis method allows for excellent control of the crystallite size by
carefully regulating the temperature parameters and the hydrolysis ratio of the reaction
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media [10]. Once cooled to room temperature, the nZnO were separated from solution via
centrifuging at 20,000 rpm and subsequent washings with ethanol. A dried FBS-coated
(nZnO – FBSdried) sample was prepared by sonicating the nZnO with FBS for 10 minutes.
The resulting suspension was then centrifuged and the resulting pellet rinsed several times
with nanopure water to remove any unbound FBS. The pellet was dried overnight at 60 ̊C
to create a powdered nZnO – FBSdried form for materials characterization. Both NP samples
were thoroughly characterized and investigated in detail using x-ray diffraction (XRD),
transmission electron microscopy (TEM), zeta potential measurements, UV-vis
spectrophotometry, and Fourier transformed infrared spectroscopy (FTIR). X-ray
diffraction (XRD) spectra were recorded at room temperature on a Philips X’Pert x-ray
diffractometer with a Cu K source ( = 1.5418 Å) in Bragg-Brentano geometry. The loose
powder samples were leveled in the sample holder to ensure a smooth surface and mounted
on a fixed horizontal sample plane. Lattice parameters and crystal size were analyzed with
Rietveld refinement using Materials Analysis Using Diffraction (MAUD) software,
corrected for instrumental broadening [45]. TEM and high-resolution TEM analysis was
carried out using an FEI Tecnai and FEI Titan respectively. The operating voltage of the
Tecnai microscope was 120 kV and 300 kV on the Titan. Image processing was carried out
using the Digital Micrograph software from Gatan (Pleasant, California, USA). Roomtemperature optical spectra in the ultraviolet and visible light wavelength ranges were
collected using a CARY 5000 spectrophotometer. Zeta potentials of the powdered samples
of nZnO were measured in nanopure water as a function of pH with a Malvern Zetasizer
NanoZS. The temperature was equilibrated to 25 °C, and the pH was varied in the 6 to 12
range using 1.0 N HCl and 1.0 N NaOH prior to collecting the data. At least six data
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collections per run were performed on three separate aliquots of the ZnO suspension for
each sample. The Zetasizer unit was also used to measure the hydrodynamic size of nZnO
aggregates dispersed in selected media. Several solution systems were used for NP stock
preparation and analyzed during this experiment.
NP Stock Preparation
To achieve the most stable dispersion for each solution, the critical material specific
delivered sonication energy (DSEcr) for the ZnO NPs was predetermined for the
calorimetrically calibrated JSP Super-sonic bath sonication device employed for this study.
A DSEcr of 181 J/mL was established through established protocols outlined by Taurozzi
et al. (2011) [46] and employed in multiple dosimetry studies [33, 47]. To achieve the
needed DSEcr, ZnO NPs were suspended at concentrations of 25 mM and sonicated in the
bath sonicator delivering a power of 1.05 W for a total 30 minutes. Several biologically
relevant solutions were prepared per manufacturer’s instructions unless otherwise defined.
They include nanopure water, PBS, FBS, RPMI (RPMI 1640 buffered with sodium
bicarbonate and HEPES, pH adjusted to 7.3), RPMI-based cellular media (RPMI 1640
media supplemented with 10% FBS and 2 mM L-glutamine, 1.5 g/l sodium bicarbonate,
4.5 g/l glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate and penicillin-streptomycin)
and DMEM-based cellular media.
In addition to single solution NP dispersions, several NP stock dispersions were
prepared with FBS. Based on most of the reported protocols found in the literature and our
own preliminary data, 10% FBS addition was found to provide optimal results and was
used to prepare these stock dispersions. The stock dispersions involved first suspending
the desired quantity of NPs in a volume of FBS equivalent to 10 % of the final solution
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volume and sonicating at 1.05 W for 10 minutes. After sonication, the FBS suspension was
diluted to the calculated volume with the desired medium (90 % of the total volume) and
re-sonicated at 1.05 W for an additional 20 minutes. These stock dispersions are referred
to as either nZnO – FBS/water or nZnO – FBS/PBS for stocks prepared in nanopure water
or PBS, respectively. Additionally, two nZnO - FBS formulations were created by
removing the excess FBS prior to re-suspension and sonication in the appropriate solution.
One formulation involved centrifuging the nZnO/FBS suspension after the initial
sonication period followed by several washes with nanopure water to remove any unbound
FBS. The remaining pellet was then re-suspended in the desired solution to the appropriate
concentration to create nZnO – FBSwashed/water or nZnO – FBSwashed/PBS for nanopure
water and PBS dispersions, respectively. Finally, stock dispersions for the dried sample,
described in the previous section, are designated as nZnO – FBSdried/water and nZnO –
FBSdried/PBS for nanopure and PBS dispersions, respectively.
Extracellular Dissolution
For extracellular dissolution experiments, nZnO stock dispersions were prepared as
previously described at 6 mM concentrations. To simulate cellular assay conditions, an
aliquot of each stock dispersion was added to cellular media at a final nZnO concentration
of 0.6 mM. All dispersions were stirred continuously to prevent nZnO sedimentation. At
desired time points, an aliquot of the sample was removed and centrifuged at 5,000 x g for
20 minutes using an Amicon™ Ultra-4 Centrifugal Filter Unit with a 3-Kd molecular
weight cutoff (0.1 nm pore size) to remove any undissolved nZnO while allowing free zinc
ions to pass through. Quantitative analysis of the dissolved Zn2+ ions was conducted on a
Thermo X Series 2 quadrupole inductively-coupled plasma mass spectrometer (ICP-MS)
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under normal operating conditions (i.e., no CCT) with the Xt cone set. Instrument
performance was evaluated and optimized for each run. The instrument was calibrated
using multi-element calibration standards containing Zn, Cr, Mn, Fe, Co and Ni in 2 %
HNO3 at concentrations of approximately 1, 10, 100 and 1000 ppb. Instrument drift was
monitored and corrected using 20 ppb indium as an internal standard introduced online.
Dosimetry Analysis and Empirical Deposition Fractions
Since NPs suspended in solution often form loosely packed agglomerates
consisting of NP clusters and entrapped media, two empirical methods, the Harvard
Volume Centrifugation Method (VCM) [32, 33] and the in vitro sedimentation, diffusion
and dosimetry (ISDD) computational model [43] were employed to determine the effective
NP density of the agglomerates (ρe, g/cm3), agglomerate porosity parameter (εagg, unitless),
diffusion rate (D, cm2/s), sedimentation velocity (V, cm/s), deposition factor, (, h-1), and
the deposition fraction curve [fD(t)]. Harvard VCM, which utilizes experimental methods
to measure the effective volume of NP pellets (Vpellet), was employed to estimate the ρe of
the NP agglomerates. To measure the Vpellet, NP suspensions were prepared at a
concentration of 100 g/mL in nanopure water and sonicated with 1.05 W of power for 30
minutes. The resulting stock dispersions were introduced to RPMI-based cellular media at
a concentration of 1.25mM and then centrifuged at 2,000 × g for one hour in TPP (Techno
Plastic Products, Trasadingen, Switzerland) packed cell volume tubes and the resulting NP
pellets were measured utilizing the TPP "easy read" measuring device by the same
manufacturer.
Once the Vpellet for a NP dispersion was measured, the ρe of the NP agglomerates
was then calculated using the following equation (DeLoid et al.) [32]:
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𝑀𝑍𝑛𝑂 − 𝑀𝑍𝑛𝑂𝑆𝑜𝑙

𝜌𝑒 = 𝜌𝑚𝑒𝑑𝑖𝑎 + [(

𝑉𝑝𝑒𝑙𝑙𝑒𝑡 𝑆𝐹

) (1 −

𝜌𝑚𝑒𝑑𝑖𝑎
𝜌𝑍𝑛𝑂

)]

(Eq 1)

This calculation represents the ρe as a function of the media density (𝜌𝑚𝑒𝑑𝑖𝑎 ) and density
represented by the NP material. Since ZnO is partially soluble in nanopure water, the mass
of solubilized ZnO (𝑀𝑍𝑛𝑂𝑆𝑜𝑙 ) determined by ICP-MS as outlined above was subtracted
from the original mass of ZnO (𝑀𝑍𝑛𝑂 ). A theoretical stacking factor (SF) of 0.634 to
approximate random close stacking employed by many dosimetry models [32, 33] was
utilized. The density value for ZnO NPs (𝜌𝑍𝑛𝑂 ) of 5.606 g/cm3 was used. The deposition
factor, () [43], a function of the sedimentation velocity (V), diffusion rate (D), and height
of the media in the cell well (L)
𝛼=

𝐷

(Eq 2)

𝑉𝐿

was then utilized to generate deposition fraction curves [fD(t)]:
𝑓𝐷 (𝑡) = 1 − 𝑒 −∝𝑡

(Eq 3)

and time values needed to observe 90 % deposition of suspended NPs in solution (t90) [47]:
𝑡=

−ln(1− 𝑓𝐷 (𝑡))
∝

(Eq 4)

To model dosimetry kinetics for suspension cell models, the curves representing the
fraction of available NPs [fA(t)] were created using the following equation:
𝑓𝐴 (𝑡) = 𝑒 −∝𝑡

(Eq 5)

To determine the effective density, the in vitro sedimentation, diffusion and
dosimetry (ISDD) computational model employs the unitless agglomerate porosity
parameter (εagg)
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𝑑𝐻

𝜀𝑎𝑔𝑔 = 1 − (𝑑

𝑋𝑅𝐷

𝐷𝐹−3

)

(Eq 6)

where 𝑑𝐻 represents the hydrodynamic size, 𝑑𝑋𝑅𝐷 refers to the NP crystalline size
measured by XRD, and DF is the specific fractal dimension. A DF value of 2.3, often
employed to model metal oxide suspensions [47], was used in this study. Once 𝜀𝑎𝑔𝑔 had
been calculated, the 𝜌𝑒 was calculated utilizing equation 7
𝜌𝑒 = (1 − 𝜀𝑎𝑔𝑔 )𝜌𝑍𝑛𝑂 + 𝜀𝑎𝑔𝑔 𝜌𝑚𝑒𝑑𝑖𝑎

(Eq 7)

The 𝜌𝑒 value was then employed to calculate the sedimentation velocity (V, m/s)
via equation 8
𝑉=

𝑔(𝜌𝑍𝑛𝑂 − 𝜌𝑚𝑒𝑑𝑖𝑎 )𝑑𝐻 2
18𝜇

(Eq 8)

with g = 9.8 m/s2 and 𝜇 defined as the media viscosity (Pa·s). Finally, the diffusion rate
(D, m2/s) was determined by
𝐷=

𝑅𝑇
3𝑁𝐴 𝜋𝜇𝑑𝐻

(Eq 9)

where R is the gas constant (L·kPa/K/mol), NA is Avogadro’s number and T (K) is the
temperature.
Cell Culture and Cytotoxicity Studies
For cell cytotoxicity assays, Jurkat T cell leukemia, Hut-78 T cell lymphoma, T47D epithelial mammary gland carcinoma and the LNCaP epithelial prostate cancer cell
line (ATCC, Rockville, MD) were cultured in cellular medium. Additionally, the T-47D
media was supplemented with 0.2 units/mL bovine insulin. Cells were maintained in log
phase at 37 °C and 5 % CO2, and seeded at a concentration of 5 x 105 cells/well in 96-well
plates for Jurkat and Hut-78 cells. For the T-47D and LNCaP cells, the cells were first
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trypsinized using 0.25 % trypsin/0.53 mM ethylenediaminetetraacetic acid (EDTA) (MP
Biomedicals, LLC; Santa Ana, CA), re-suspended in fresh media and then seeded at a
concentration of 2.5 x 105 cells/well in 24-well plates. The cells were then incubated
overnight to allow the cells to re-adhere to the plate. Prior to treatment, the growth medium
was gently aspirated from each well and replaced with 400 μL of fresh medium. Cells were
subsequently treated with freshly sonicated (30-min) NPs reconstituted in the desired
solution. Jurkat cells and Hut-78 cells were treated with NPs immediately after plating. For
example, for a 2 mg/ml ZnO NP stock dispersion, 3.2 mg of NP were re-suspended in 1.58
ml of solution medium and sonicated at 50 W for 30 minutes. Then working dilutions were
prepared from the NP stock dispersion and added to 200 µl of cell suspensions in 96–well
plates or 400 µl of cell suspensions in 24–well plates and cultured for 24 hours. After 24
hours, the effects of the various NP stock dispersions on cell viability using two different
viability assays, alamar blue and flow cytometry. The alamar blue metabolic assay was
employed to assess viability based on the fluorogenic redox indicator dye resazurin being
converted to the fluorescent resofurin upon reduction by mitochondrial enzymes in
metabolically active cells. In this assay, cell populations were seeded into the desired plate
at the concentrations indicated above, treated with NPs for 20 hours, and the incubated
with alamar blue (10 % of total volume) for an additional 4 hours. Changes in fluorescence
were evaluated spectrophotometrically using excitation/emission at 530/590 nm in a Biotek
Synergy MX® plate reader (Winooski, VT).
Flow cytometry was employed as an alternate viability assay to verify experimental
results. NP treated cells were dually stained with a fluorescein isothiocyanate-labeled antiHLA ABC antibody and 50 µg/mL propidium iodide (PI) to monitor losses in membrane
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integrity. Fluorescent CountBright counting beads (Invitrogen, Carlsbad, CA) were added
to samples to enable determinations of absolute cell numbers, and changes in PI staining
were used to quantify cell death. Nanoparticles were excluded from analysis based on
absence of fluorescence signal and light forward scatter (FS) and side scatter (SSC)
characteristics, and samples were analyzed using a BD FACS Caliber flow cytometer.
For CD4+ T cell cytotoxicity experiments, written informed consent was obtained
from all blood donors and the University Institutional Review Board approved this study.
Peripheral blood mononuclear cells were obtained from healthy human blood samples via
Ficoll-Hypaque density centrifugation (Histopaque-1077, Sigma, St Louis, MO), and
CD4+ T cells isolated by negative immunomagnetic selection as previously reported [16].
Purified CD4+ T cells (>95 % purity) were cultured in RPMI/10 % FBS and suspended at
a final concentration of 1 x 106 cells/ml. CD4+ T cells were then incubated for 24 hour with
increasing amounts of each of the nZnO suspensions (24-800 g/mL) in order to establish
an IC50. CD4+ T cells were then stained and viability analyzed by flow cytometry.
Reactive Oxygen Species (ROS) Detection
Mitochondrial superoxide levels were determined by flow cytometry using
MitoSOX Red (Invitrogen, Eugene, OR) staining. MitoSOX Red is a cell permeable
fluorescent dye that becomes oxidized by interacting with mitochondrial superoxide [48].
The resulting fluorescent signal occurs upon binding of the oxidized dye to nucleic acids.
As a positive control, samples were treated with 0.2 nM of the mitochondrial electron
transport inhibitor antimycin-A to ensure that the cells were capable of producing ROS.
Jurkat cells were incubated with 0.4 mM nZnO or nZnO-FBS for 6, 18 and 24 hours and
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then dually stained with CD3 antibody and 2.5 µM MitoSOX Red for 30 min.
Mitochondrial superoxide levels were determined by flow cytometry.
Statistical Analyses
Statistical analyses were performed using Jump Pro 10 software (SAS; Cary, NC).
The cytotoxicity data were analyzed using repeated measures of variance with post hoc
comparisons and significance levels defined as p < 0.05 to determine statistical differences
between the means and allow within-sample variation to be separated from betweensample variation. Data for Figure 2.10, Figure 2.11, and Figure 2.12 were analyzed using
a two-way analysis of variance (ANOVA) to test for statistical significance of the model,
and post hoc comparisons were used to test for statistically significant effects of treatment
on cell viability (p < 0.05) with an asterisk denoting statistical significance in the indicated
figures.
Results and Discussion
ZnO Nanoparticle Synthesis and Characterization
The pure ZnO NPs (nZnO) and the FBS-coated formulation (nZnO – FBSdried) were
thoroughly characterized prior to use. Analysis of the powder x-ray diffraction spectra of
the NPs revealed the expected hexagonal wurtzite crystal structure (Figure 2.1A). The
MAUD software, which employs the Rietveld method [49] showed the particles had an
average crystallite size of 10.0  0.74 nm and lattice parameters a = 3.2580 Å and c = 5.226
Å. The nZnO – FBSdried sample also showed similar crystallite size and lattice parameters
suggesting that the FBS coating did not alter the crystalline structure of the nZnO
nanoparticles. Additionally, TEM analysis confirmed that the NPs in both formulations
were primarily spherical in morphology with similar size distributions (Figure 2.1B, C).
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Surface charge for nZnO and the nZnO – FBSdried NP samples, measured in
nanopure water, were found to be 43.8 ± 0.55 mV and -11.8  0.39 mV, respectively.
Bovine serum albumin (BSA), the predominant component of FBS has an isoelectric point
(IEP) of 5.1 indicating that BSA would be positively charged at lower pH (<5.1) and
negatively charged at higher pH values (>5.1) [50]. Therefore, the positive to negative shift
in the zeta potential observed for the nZnO – FBSdried NPs is indicative of the absorption
of negatively charged protein components on the surface of the nZnO [51]. To determine
the IEP of each NP suspension, the pH was varied from 3-12 using 0.1 M HCl or 0.1 M
NaOH and the zeta potential was measured at several points in three independent trials
(Figure 2.2A). An IEP of 9.5 was observed for nZnO indicating these NPs would carry a
positive charge below pH 9.5 and a negative charge at pH > 9.5. In contrast, the nZnO –
FBSdried formulation had an IEP of pH 6.1, resulting in positively charged particles at much
lower pH values (below 6.1) and negatively charged particles at pH > 6.1. Below pH 6.5,
partial NP dissolution was observed for nZnO but not for the nZnO – FBSdried sample. The
decreasing zeta potential trend observed at low pH values for nZnO has been documented
for nZnO prepared using this synthesis method [28].
The FTIR spectra of nZnO and nZnO – FBSdried are shown in Figure 2.2B. Both
samples contain a strong band characteristic of Zn-O vibrations [52] at 456 cm-1 (nZnO)
and 451 cm-1 (nZnO – FBSdried). The nZnO sample exhibits two bands commonly
associated with the carboxyl functional group, specifically 1412 cm-1 [s(COO-)] and 1597
cm-1 [as(COO-)] [53, 54]. Additionally, weaker bands consistent with (CH2) and
(C – OH) at 903 and 1076 cm-1, respectively, indicate the presence of surface-adsorbed
carboxyl groups originating from the zinc acetate precursor or the DEG solvent [52-54].
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Furthermore, the absence of the (C=OOH) band at ~1720 cm-1 suggests that the carboxyl
groups are in an expected deprotonated form as a result of the alkaline synthesis procedure
[53]. Noticeably absent in the nZnO – FBSdried samples are the strong symmetric and
asymmetric stretching modes of the carboxyl group with new bands appearing in the
spectrum at 1646 cm-1 and 1533 cm-1 representing the amide I and amide II regions that
arise from vibrations of the peptide bonds of the protein backbone [55, 56]. The amide I
region, often used for secondary structure prediction, exhibits a maximum at 1650- 1656
cm-1 when -helices predominate in the protein secondary structure [56]. At 1646 cm-1, the
amide I band of the nZnO – FBSdried particles is close to this wavenumber maximum and
suggestive of the presence of a protein with the -helical structure components found in
BSA. The slight shift of this maximum is consistent with a more random secondary
structure (1644–1648 cm-1) and has been observed in protein adsorption and binding
studies with albumin [57]. Taken together, these findings clearly establish the displacement
of adsorbed carboxyl groups and strong binding of the FBS protein components [58, 59]
on the nanoparticle surface.
Agglomeration and Sedimentation Profiles
As previously discussed, determining the best media components and dispersion
conditions for the preparation of stable nZnO dispersions was a major goal of this study.
Reported cellular toxicity studies using Jurkat and Hut-78 cells have frequently employed
a variety of different biological solutions used to disperse NP powder samples prior to
treatment. Considerations in choosing stock solution components include maintaining a
viable environment for the cells as well as creating a stable NP dispersion for treatment
conditions. Commonly used stock solutions consist of nanopure water, PBS or un-
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supplemented cellular media. In addition, various capping agents [60] or protein
components are often utilized to reduce steric attractions between charged particles and
solution components and reduce NP agglomeration [51, 60, 61]. Solutions such as PBS or
un-supplemented media are generally preferred as they do not result in unwanted pH
changes during the toxicity study or affect cellular osmolality. Likewise, media proteins
such as BSA and FBS are frequently used as stabilizing agents.
The average hydrodynamic size of the nZnO sample in six different 25 mM stock
dispersions was measured every 10 minutes for a 24-hour time period using dynamic light
scattering (DLS) technique (Figure 2.3A). From this data, inferences can be made about
the agglomeration tendencies of the NPs over time in different biological solution systems.
Two of the solutions, RPMI and PBS, exhibited unstable average hydrodynamic size
profiles over time evidenced by the immediate formation of very large agglomerates of
2,031 nm and 3,578 nm, respectively. The agglomerate sizes in PBS increased over time
from 3,578 nm to 5,811 nm and eventually stabilized to a variable range of 2,500 – 4,200
nm over the remaining test period. In RPMI, the nZnO agglomerate size increased
dramatically over time from 2,031 nm to sizes exceeding the limits of the Zetasizer
(~10,000 nm) by the end of the time period. These data indicate that agglomeration
behavior of NP systems increases with increasing ionic strength of the dispersion solution
(nanopure water < PBS < RPMI). All other test dispersions exhibit stable average
hydrodynamic size profiles over time with average size profiles of 306 nm (nanopure
water), 150-200 nm (DMEM-based cellular media), 263 nm (RPMI-based cellular media)
and 78 nm (FBS). To evaluate the effect of FBS on dispersion stability, all three nZnO/FBS
formulations, nZnO - FBSdried (dried FBS-coated nZnO), nZnO – FBSwashed (FBS-coated
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nZnO with excess FBS removed) and nZnO – FBS (nZnO coated with 10 % FBS per
volume of desired solution), were dispersed in both PBS and nanopure water at
concentrations of 25 mM. For PBS stock dispersions, the FBS-coating provided long-term
hydrodynamic size stability (up to ~15 hours) regardless of the formulation employed when
compared to the nZnO/PBS dispersion (Figure 2.3B). Beyond 15 hours, the nZnO –
FBSdried/PBS dispersions demonstrated some instability in agglomeration behavior with
average agglomerate sizes increasing from approximately 400 nm to 800 nm. The addition
of FBS in nanopure water dispersions did not appreciably change the agglomerate stability
of the NP suspensions. Relatively stable agglomeration profiles were observed between
~200 - 350 nm for all dispersions (Figure 2.3C). Interestingly, the nZnO – FBSdried
formulation also displayed a mild degree of dispersion instability at ~13 hours. These
findings, along with those for the PBS-based suspension, suggest that the nZnO – FBSdried
formulation is not the most ideal preparation for downstream applications which require
long-term dispersion stability.
Although average size profiles highlight the agglomeration tendencies of NP
dispersions, they fail to depict how agglomerate formation affects NP sedimentation,
changes in the net nZnO concentration in solution over time and the ever-changing size
distribution of a complex NP dispersion. To address these shortcomings, experiments
evaluating the sedimentation behavior of nZnO dispersions were performed by measuring
changes in the optical absorbance intensity at λmax (~378 nm corresponding to the band gap
energy of nZnO) relative to the initial absorbance intensity. Decreases in the relative
absorbance intensity at λmax as a function of time have been correlated to decreasing NP
concentrations in solution as a result of NP sedimentation [23, 62]. The sedimentation

84

tendencies over a two-hour time period for various stock dispersions are depicted in Figure
2.4A. As expected, nZnO in RPMI rapidly settles out of solution with 100 % sedimentation
noted by the one-hour time point. Other dispersions that displayed sedimentation behavior
were nZnO dispersions in both RPMI-based cellular media (29 % at 2 hours) and PBS (49
% at 2 hours). None of the nZnO - FBS formulations (nZnO – FBSdried, nZnO – FBSwashed
or nZnO – FBS) showed any appreciable sedimentation behavior over the 2-hour time
period in PBS or nanopure water (Figure 2.4A, B).
Further evidence of NP dispersion stability can be observed in the hydrodynamic
size distribution profiles at various time intervals (Figure 2.5, 6 and 7). Stable dispersions,
such as those observed for the nanopure water (Figure 2.5A), demonstrate similar size
distribution trends across the evaluated time period. Strong agglomeration and
sedimentation tendencies result in broader distributions initially as a result of immediate
agglomerate formation, followed by narrower distributions as large agglomerates settle out
of the dispersion. This trend is readily apparent for the PBS dispersion (Figure 2.5B) and
present to a lesser degree for the cellular media stock (Figure 2.5C) which reflects the
improved stability of the nZnO in RPMI-based cellular media, containing 10% FBS,
compared to the PBS stock. The size distribution trends observed for the nZnO – FBSdried,
nZnO – FBSwashed and nZnO – FBS dispersions in PBS (Figure 2.6) and water (Figure 2.7)
affirm the findings previously observed. Both the nZnO – FBSdried/PBS (Figure 2.6A) and
nZnO – FBSdried/water (Figure 2.7A) dispersions begin to show dispersion instability at
~12 hours which is readily apparent by 24 hours. Taken together, the agglomeration
profiles obtained from DLS and the sedimentation trends observed by UV-Vis
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spectrophotometry provide an accurate qualitative assessment of the NP dispersion
stability.
After evaluating several stock dispersions independently, the behavior of the NPs
was assessed under conditions used for cellular toxicity assays. In short, aliquots of the 25
mM nZnO/PBS and nZnO – FBS/PBS stock dispersions were introduced to RPMI-based
cellular media at concentrations of 0.6 mM and the agglomeration and sedimentation
tendencies of the NPs were observed for 24 hours (Figure 2.8). Analysis of the data
collected under in vitro experimental conditions reveal that NPs dispersed in nZnO/PBS
display strong agglomeration potential in the cellular media compared to those prepared
using the nZnO – FBS/PBS stock. NPs in the dispersion prepared using the PBS stock
formed large agglomerates immediately (>500 nm) (Figure 2.8A, C), which precipitated
rapidly from the cellular media (Figure 2.8B), reducing the percent intensity and changing
the maximum in the agglomerate size distribution (Figure 2.8C). At the 12-hour time point,
the hydrodynamic size profile revealed a large distribution of NP sizes present within
solution with a 54 % decrease in the nZnO absorbance. Significant decreases in the
hydrodynamic size distribution can be seen by the 24-hour time point suggesting that large
agglomerates had precipitated from the cellular media (Figure 2.8A and C). The
sedimentation profile (Figure 2.8B) confirms that by 24 hours nearly 60 % of the nZnO
was no longer present in the cellular media. Comparatively, the experimental dispersion
(0.6 mM) prepared from the nZnO – FBS/PBS stock exhibited considerably more size
stability over time (Figure 2.8A and D) resulting in less sedimentation behavior (39 %) by
24 hours (Figure 2.8B). In the context of in vitro cytotoxicity studies, these results imply
that using FBS as a NP stabilizing agent prior to solution dispersion results in more NPs
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being bioavailable to interact with cells cultured in suspension. Although most of the ZnO
NPs are in the 100 - 250 nm range at the 24-hour time point, there are some significantly
large agglomerates (3,000 – 6,000 nm) in the hydrodynamic size profiles (inset in Figure
2.8D) of nZnO - FBS samples. However, their percent abundance is <5 % of the total
number of observed aggregates at 24 hours.
Dissolution Studies
Experiments were conducted to investigate if Zn2+ ions are released from the ZnO
NP, when dispersed in stock solutions prepared at concentrations typically employed for
downstream biological assays (6 mM of nZnO). Zn2+ dissolution was measured using a
PBS stock dispersion and compared to the same after adding 10 % FBS to improve
dispersion stability. Figure 2.9 shows the Zn2+ dissolution data (displayed as percentage of
the total nZnO concentration in each solution as a function of time). Among these, the
nZnO – FBS/PBS stock dispersion showed the highest Zn2+ dissolution (0.151  0.029 %
at 24 hours) while the nZnO/PBS stock (0.033  0.004 % at 24 hours) showed significantly
less Zn2+ ion release. These dissolution studies were then extended to samples prepared
under actual experimental conditions (0.6 mM nZnO) used for the in vitro toxicity assay
studies as previously described. This lowering of the nZnO concentration by 10-fold caused
significant increases in percentage Zn2+ dissolution for both dispersion combinations, as
shown in Figure 2.9. Decreasing nZnO concentration in solution will decrease NP
agglomeration tendencies and subsequently increase the interaction of the nanoparticles
with the medium, resulting in more Zn2+ ion formation in the dispersion [63]. Interestingly,
the FBS/PBS sample showed lower Zn2+ dissolution (8.668  0.247 % at 24 hours) than
the pure PBS sample (10.041  2.905 % at 24 hours). Since FBS addition increases
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dispersion stability and reduces hydrodynamic size, an increase in the Zn2+ dissolution is
expected if interaction of the NPs with the dispersed medium alone is the most important
factor. The observed lower Zn2+ dissolution of the nZnO - FBS/PBS sample may be due to
the presence of serum proteins from FBS on the nZnO surface, reducing direct NP-media
interaction and thus protecting them from Zn2+ dissolution. Both FTIR and zeta potential
measurements have shown that 10 % FBS addition produces a surface layer of serum
proteins on the nZnO surface. Thus, the lower Zn2+ dissolution of nZnO – FBS/PBS
dispersion (0.6 mM) is likely attributed to the serum coating of the nZnO and the resulting
reduction in the NP-medium interactions. Another potential contributing factor in these
systems is the propensity of free zinc ions to form insoluble zinc carbonate (ZnCO3) or
zinc phosphate (Zn3(PO4)2) precipitates in biologically relevant solutions [61, 64].
Precipitation of these species may explain dissolution potential differences between the
prepared nZnO/PBS and nZnO – FBS/PBS stock dispersions given the assumption that the
FBS present in suspension may provide a protective function against nZnO and Zn2+/ media
interactions, thus reducing the amount of insoluble complexes formed and increasing the
concentration of ionic Zn2+ [65]. However, if this were the sole contributing factor, the
same dissolution pattern would be expected when the stock dispersions were introduced
into the cellular media. The reversal of the dissolution potential trend going into the cellular
media underscores the complex nature of nZnO dissolution in biologically relevant
solutions. While our results appear to contradict a recent study by Hsiao and Huang [41]
in which a much larger Zn2+ dissolution was observed when FBS-coated ZnO NPs were
dispersed in DMEM media, these apparent discrepancies may be attributable to solutionrelated dissolution differences. Additional studies conducted in our laboratory have shown

88

that nZnO dispersed in the RPMI-based cellular media employed in this study exhibit
significantly less dissolution potential than nZnO dispersed in the DMEM used by Hsiao
and Huang (data not shown). The decrease in ionic zinc in the RPMI-based media
compared to DMEM could be attributed to increased precipitation of insoluble Zn3(PO4)2
in the phosphate-rich RPMI system [61, 65]. Furthermore, NP dissolution in the presence
of serum proteins appears to be a competition between two processes. Serum proteins
reduce agglomerate size allowing more interaction between NP surface and the dispersing
medium. However, serum proteins will also attach to the nanocrystal surface effectively
reducing the interaction of surface bound Zn ions and the medium.
Reactive Oxygen Species (ROS)
The potential role of intracellular ROS generation in the cytotoxicity of nZnO was
demonstrated in our earlier reports [10, 15, 16] and through several other studies for a
variety of cells types [66-68] by using fluorescent dyes to directly detect ROS. Since redox
reactions at the NP surface are a primary driver in extracellular and intracellular ROS
production, changes in the NP surface structure as a result of protein coating could change
ROS generation and, in turn, also influence the cytotoxicity. To evaluate the amount of
ROS produced by nZnO and nZnO-FBS, Jurkat cells were exposed to 0.4 mM ZnO for 6,
18 and 24 hours and subsequently stained with MitoSOX Red. As Figure 2.10 illustrates,
appreciable differences exist between the amounts of ROS produced at 6 hours (Figure
2.10A and B), as measured by the mean MitoSOX fluorescence intensity (MFI), between
the nZnO dispersion (PBS stock; 33.9 ± 2.66 MFI) versus the nZnO-FBS dispersion
(FBS/PBS stock; 49.9 ± 4.98 MFI) representing a 47.2 % increase in the amount of NPinduced ROS present in cells treated with the nZnO-FBS dispersion. As the exposure time
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increases, the differences in the ROS production increase significantly. The greatest
disparity, noted at 24 hours (Figure 2.10A and D), represents an 88.2 % increase in the
amount of ROS induced by the nZnO-FBS over the nZnO dispersion. Given that the
agglomerates present in the nZnO-FBS dispersion are significantly smaller and more
bioavailable than those in the nZnO dispersion, more surface area to volume interactions
are possible in the more stable nZnO-FBS which could result in the significant differences
observed in the ROS induction. While many surface modification, such as SiO2 coating
have demonstrated protective benefits such as less cytotoxicity and cellular stress-inducing
ROS production [42, 66], FBS-coating does not appear to impart protective benefits against
ROS generation.
Cellular Toxicity Studies
It has been previously shown in our laboratory that these nZnO synthesized in DEG
media demonstrate strong cytotoxic effects against Jurkat leukemic and Hut-78 lymphoma
T cell cancer lines [16]. Experiments were performed to determine if FBS coating and the
resulting improvements in NP stability and bioavailability influence the cytotoxicity of
NPs in these suspension cell models. Cells were exposed to increasing concentrations of
freshly prepared nZnO/PBS or nZnO - FBS/PBS stock dispersions for 24 hours. NPinduced toxicity was then determined using an alamar blue assay or through flow cytometry
utilizing a T-cell specific fluorescent antibody and propidium iodide (PI) dye uptake [16].
As shown in Figure 2.11, both types of cancer cells showed a significant increase in the
NP-induced cytotoxicity (p = 0.0022 and p = 0.0488 for Jurkat and Hut-78 cells,
respectively) when nZnO – FBS/PBS stock treated cultures were employed, thus
confirming the favorable role of 10 % FBS addition in the stock dispersion preparation.
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The IC50 values for Jurkat cells decreased from 0.39 ± 0.03 mM for nZnO/PBS dispersions
to 0.27 ± 0.02 mM for the nZnO – FBS/PBS dispersion using alamar blue staining (Figure
2.11A) and from 0.38 ± 0.03 mM for uncoated nZnO to 0.25 ± 0.004 mM for nZnO – FBS
using flow cytometry and PI uptake (Figure 2.11B). Similarly, the IC50 value for the Hut
cells (Figure 2.11C) also showed a decrease from 0.21 ± 0.03 mM when treated with the
nZnO/PBS dispersion to 0.14 ± 0.02 mM when treated with the nZnO – FBS/PBS
dispersion. These results clearly demonstrate that coating nZnO with FBS proteins and the
resulting improved dispersion stability increases their toxic response to cancer cells by
~33 % for both cell types. Additionally, FBS coatings may also provide a potential
approach to reduce the IC50 values of nZnO against cancer cells from their current mM
range to more suitable ranges appropriate for therapeutic applications.
Our previous work has shown that ZnO NPs display some selectivity in their toxic
response against cancerous T cells as the IC50 values observed for primary quiescent T cells
under similar conditions are considerably higher. Similar toxicity studies using nZnO –
FBS/PBS dispersions also showed stronger toxic responses (p = 0.0303) to resting CD4+
T lymphocytes (Figure 2.11D). Here, the IC50 values decreased from 4.69 ± 0.85 mM when
treated with nZnO/PBS dispersion to 2.43 ± 0.0.24 mM when nZnO – FBS/PBS
dispersions were used. Thus, the effect of coating NP with serum proteins is evident in
primary cells as well. While these results are consistent with our previously reported
preferential cytotoxicity of nZnO to cancer cells, the therapeutic index of Hut cancer cells
decreased from 22.6 for nZnO/PBS dispersions to 17.0 for the nZnO – FBS/PBS
dispersion. Even with the modest decrease noted in the therapeutic index for the nZnO FBS/PBS dispersion, the resulting therapeutic efficiency of the nZnO appears better than
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some commonly recognized traditional chemotherapeutic agents using comparable in vitro
assays [16]. Thus, the protein interaction with nZnO increases their cytotoxicity in the
suspension cell models evaluated, yet maintains some of the cancer cell selectivity
previously observed.
Some published studies have reported that coating nZnO with organic molecules or
media protein components results in decreased cytotoxicity and ROS accumulation
compared to uncoated nZnO [25, 38, 40-42, 69]. While these studies appear to contradict
our findings, it should be noted that most of these reports evaluated adherent cells while
the primary T cells and cancerous counterparts employed here are all grow as suspension
cultures. In adherent cell cultures, poor dispersion stability results in faster sedimentation
of NP agglomerates onto the cell monolayer. This rapid sedimentation may artificially lead
to higher increases in NP-cell interactions [34] and the observed increased toxicity [39, 41,
42]. When the dispersion stability improves and sedimentation decreases with the addition
of suitable molecules such as FBS, adherent cells will be exposed to lesser amounts of
deposited NPs resulting in more accurate dosimetry kinetics, measured effective
administered doses and observed toxicity values, as reported by many recent studies [25,
38, 40-42, 69]. This possibility was confirmed by comparing the effects of nZnO/PBS and
nZnO – FBS/PBS dispersions in two different adherent epithelial cancer cell lines, T-47D
mammary gland carcinoma and LNCaP prostate cancer cell lines (Figure 2.12). For both
adherent cell lines, the nZnO - FBS/PBS treated cells exhibited less toxicity when
compared to the nZnO/PBS treated cells (p = 0.0020 and p = 0.0008 for the T-47D and
LNCaP cells, respectively). For the T-47D (Figure 2.12A) cells, a 48.7 % increase in the
IC50 was observed for the nZnO – FBS/PBS dispersions over the nZnO/PBS treated cells
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(from 0.39 ± 0.02 mM for nZnO/PBS to 0.58 ± 0.01 mM for nZnO-FBS). Comparatively,
the IC50 for the LNCaP cells (Figure 2.12B) increased from 0.35 ± 0.02 mM nZnO/PBS
treated cells to 0.60 ± 0.06 mM for nZnO – FBS/PBS treated cells representing a 71.4 %
decrease in the toxic response.
In comparison to the suspension cell models, FBS-coating leads to opposite effects
in adherent cells. Suspension cells interact with fewer NPs in experimental conditions
consisting of even minimally unstable dispersions since a portion of the original NP
concentration sediments and may not be bioavailable for cellular interactions. This will
skew toxicity assay results to suggest lower toxicity for suspension cells than expected.
When the stability of the NP dispersion is improved by suitable molecular additives such
as 10 % FBS (Figure 2.11), the cytotoxicity increases significantly for both Jurkat and Hut
cancer cells as well as for the primary T cell lymphocytes. More ZnO NPs are freely
available in the stable NP dispersions to interact with more cells, thus resulting in the higher
cytotoxicity observed in suspension cell models. The stability-induced differences between
suspension and adherent cells underscore the importance of this work. The results from
suspension cell studies alone would seem surprising considering other reports employing
similar serum coatings describe decreases in NP-induced cytotoxicity in adherent cells
lines suggesting that NP coating could be a potential means to control unwanted
cytotoxicity [39]. One such study, Hsiao and Huang [41], demonstrated that 5-10 % FBS
coating on ZnO NPs increased dispersion stability and Zn2+ ion release, and decreased the
NP-induced cytotoxicity. They hypothesized that this reduction in cytotoxicity in the serum
coated NPs was a result of serum-induced increases in cell growth and resulting decreases
in nZnO dosage-per-cell ratios. Additionally, these authors [41] showed larger Zn2+ release
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in their experiments with FBS coated ZnO thus negating Zn2+ release as a primary
contributing mechanism to nZnO cytotoxicity. In this present study, FBS coating appears
to decrease the Zn2+ release while significantly increasing NP-induced cytotoxicity for the
suspension cell model when compared to uncoated nZnO. With the addition of the 10 %
FBS to our phosphate-rich stock dispersion, it is plausible that decreases in formation of
toxic insoluble Zn3(PO4)2 precipitates [70] could translate to perceptible decreases in the
NP-induced cytotoxicity observed for nZnO – FBS/PBS treatment. However, decreases in
Zn3(PO4)2 formation would also result in measured increases in Zn2+ release which was not
observed. Therefore, extracellular Zn2+ dissolution is unlikely to be a primary factor for the
increased cytotoxicity noted for our nZnO – FBS NPs. It is clear from FTIR and zeta
potential studies that FBS molecules bind to the ZnO NP surface. This modification of the
NP surface influences their interaction with other NPs (and on agglomerate formation and
sedimentation effects) as well as with cells.
Modeling and Dosimetry Studies
Given the toxicity trend differences noted for the differing cell models,
mathematical models were investigated as a potential method to confirm the observed
trends and to model the dosimetry kinetics for both the investigated stock dispersions
(nZnO/PBS versus nZnO – FBS/PBS) and the different cellular models. All of the
investigated experimental parameters of dispersion stability can be applied to the in vitro
sedimentation, diffusion and dosimetry (ISDD) computational models, put forth by
Hinderliter et al. (2010), to predict the transport properties of the NPs in various
experimental conditions [43]. The NP and experimental parameters which most influence
the NP transport properties include hydrodynamic size (dh), agglomeration state, effective

94

particle density (ρe) and the media height in the cell well (L) [43]. Central to the effective
dosimetry determination in the ISDD model is the calculation of a NP deposition factor 
(h-1), Equation 2 in “Methods”, which interrelates the diffusion rate (D), sedimentation
velocity (V) and media height [32, 33, 43, 44]. While the diffusion rate is primarily
dependent upon the hydrodynamic size, the sedimentation velocity depends upon both the
hydrodynamic size and the effective particle density occupied by NP agglomerates [43,
44]. The effective particle density (ρe) can be approximated in the ISDD model (Equation
7) using the hydrodynamic size-dependent agglomerate porosity parameter (εagg) [43] or
can be determined experimentally (Equation 1) as a part of the Harvard Volume
Centrifugation Method (VCM) [33, 43]. The Harvard VCM employs an experimental
determination of NP agglomerate volumes to directly determine effective particle density.
Furthermore, the VCM has been modified to incorporate mass lost due to the dissolution
of soluble or partially soluble NPs such as ZnO [32, 33].
To determine dosimetry curves for various experimental conditions, 25 mM
dispersions were prepared and dispersed in complete cellular media at a concentration of
1.25 mM and the effective density (pe) determined using Harvard VCM (Table 2.1) [33].
From the calculated deposition factor, , dosimetry curves were constructed (Figure 2.13)
as described in Cohen et al. (2014) [33]. Originally introduced as a model for adherent cell
culture, the deposition fraction curve [fD(t)] (Equation 3; Figure 2.13A) depicts the fraction
of NPs that are deposited upon an adherent cell layer as a function of time [32, 33].
However, the same  values may be used to model the fraction of NPs that remain
bioavailable [fA(t)] as a function of time for suspension cells (Equation 5; Figure 2.13B).
Based on these curves, a t90 value can be calculated to make accurate determinations of
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effective NP dose either deposited on an adherent cell layer or bioavailable to suspension
cells at desired time points.
The influence of FBS on the dosimetry kinetics is evident in an analysis of the
experimentally stable water, FBS/water and FBS stock dispersions introduced to the
RPMI-based cellular media. Given the dependence of agglomerate behavior and effective
density (pe) on the hydrodynamic size of NPs in dispersion, the water (182.5 nm),
FBS/water (185.1 nm) and FBS (185.5 nm) stock dispersions should exhibit similar
dosimetry kinetics. However, the effective density (pe) of the NPs in the three dispersions
decreased with increasing amounts of FBS in the stock preparation thus increasing the
calculated deposition factor. These disparities are a direct result of measured increases in
the effective volume of the NP pellet with increasing amounts of FBS in solution. So while
the similarities in the hydrodynamic diameters of these three dispersions imply consistent
NP diffusion rates (Equation 9), the differing effective volume measurements suggest
different NP sedimentation velocities (Equation 8) [32]. Therefore, even though all three
dispersions demonstrate dispersion stability experimentally, the effective volume occupied
by the resulting protein corona in the NP agglomerates decreases the sedimentation
velocities of the NPs predicted by the model, thus increasing the deposition factor and
shifting the dosimetry kinetics.
Interestingly, the dose metrics obtained for the unstable stock dispersions of PBS
and RPMI suggest dosimetry trends opposite to what would be expected considering the
experimentally determined agglomeration and sedimentation profiles. However, the VCM
dosimetry model assumes that the dispersions used to obtain the experimental  values are
stable across the time frames defined by the model. As this is not the case with the PBS
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and RPMI stock dispersions, these obtained dosimetry curves cannot be used to accurately
model the dosimetry kinetics under these conditions. To model potentially unstable
dispersions, it is necessary to calculate  values using experimentally determined stability
parameters such as hydrodynamic size at multiple time points. For this, we employed the
ISDD model. This model approximates effective particle density utilizing the
hydrodynamic size-dependent parameter εagg. While the approximation of the ρe employed
in this model lacks the experimental accuracy achieved for ρe measurements afforded by
VCM, the ISDD model does allow for time-resolved approximation of NP transport
parameters within unstable dispersions. Employing the ISDD model,  values were
obtained using time-resolved dh values and the dosimetry curves for both the nZnO/PBS
and nZnO – FBS/PBS stock dispersions in RPMI-based cellular media were modeled for
several time points from 0 to 24 hours. These time-resolved points were compiled to
generate ISDD curves which were then fit to both the fD(t) and fA(t) mathematic models to
obtain  values for each representative graph (Figure 2.13C and D). For the unstable
nZnO/PBS stock, the ISDD  values of 0.290 for adherent cell model conditions and 0.120
for the suspension cell models were significantly higher (1037 % and 1279 % increases for
adherent and suspension cell models, respectively) than those obtained using the Harvard
VCM (Table 2.1). The ISDD modeled t90 values of 7.94 (adherent cells) and 19.12
(suspension cells), were more consistent with the experimental stability data discussed
earlier. Applying the same model to the stable nZnO – FBS/PBS stock dispersion yielded
 values (0.331 and 0.107 for adherent and suspension cell models, respectively) more
closely aligned to the VCM determined values (Table 2.1) with percent increases of 107 %
and 97 % for adherent and suspension cell models, respectively. Surprisingly, the ISDD
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modeled curves for the nZnO/PBS (unstable) and nZnO – FBS/PBS (stable) dispersions
imply similar dosimetry kinetics for both cellular models and, if considered without
experimentally derived stability profiles (e.g. average hydrodynamic size profiles, size
distribution histograms and sedimentation analysis), would not reflect the true dosimetry
for unstable stock dispersions. While the ISDD derived fD(t) curve for the unstable
nZnO/PBS stock dispersion (Figure 2.13C) at face value implies stable dosimetry kinetics,
the individual ISDD curves at each time point reflect the unstable nature of the nZnO/PBS
dispersion (Figure 2.14A). As a result, using either mathematical model to predict the
effective dose for this dispersion would not be advisable. For the stable nZnO - FBS/PBS
dispersion, both the VCM and ISDD models (Figure 2.13 and Figure 2.14B) depict stable
dosimetry kinetics for both suspension and adherent cell models. For adherent cells, the t90
value of 14.5 hours (Table 2.1; VCM) suggests 90 % of the NPs in suspension will come
in contact with and potentially interact with the cell layer by the 24-hour time point
indicating that the experimentally observed toxicity values are an accurate assessment of
the in vitro toxicity for adherent cell types. Mathematical models for stable dispersions in
suspension cells may provide less definitive information regarding effective dose. While
these models can accurately predict the number of NPs remaining in dispersion as a
function of time [fA(t)], the models fail to account for NP-cellular interactions that will
occur within the suspension culture before sedimentation processes remove NPs from the
dispersion. Better mathematical models are needed to predict the fate and transport of NPs
in suspension cell models that include NP sedimentation rates as well as time-resolved NPcellular interactions. Taken together, these observations underscore the importance of time-
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dependent stability studies for NP stock dispersions prior to the implementation of fate and
transport dosimetry models and downstream experimental applications.
Conclusions
Studies reported in this work show that ZnO nanoparticles form very large
agglomerates with hydrodynamic sizes in the 300 to 20,000 nm range which depend
primarily on the solution composition used. Presence of such agglomerates leads to
sedimentation of a significant portion of the nanoparticles which increases in time. For
adherent cells, this will increase the effective NP concentration interacting with the cells at
very early time points and may cause unusually large and potentially inaccurate in vitro
toxicity measurements. This was demonstrated using two adherent epithelial cell lines
(T-47D and LNCaP) with both cell types experiencing significant decreases in NPmediated cell death with the more stable NP stock dispersions. Likewise, this
sedimentation process will reduce the effective NP concentration remaining in the solution
medium. Subsequent investigations using suspension cells showed that this phenomenon
results in an opposite trend due to the reduction in the number of nanocrystals interacting
with the suspension cells and consequently, a lower than actual toxic response is obtained.
Using a 10 % FBS/PBS-stock to disperse the same nZnO, the IC50 values for Jurkat (Hut)
cancer cells decreased from 0.39 mM (0.21 mM) for nZnO/PBS treated cells to 0.27 mM
(0.14 mM) for the nZnO – FBS/PBS dispersion. Their normal counterparts (CD4+ T
lymphocytes) also showed a reduction in IC50 with 10 % FBS addition. Its IC50 decreased
from 4.69 mM for nZnO/PBS dispersions to 2.43 mM when nZnO – FBS/PBS stock was
used. On the other hand, treating the adherent cells T-47D and LNCaP using the nZnO –
FBS/PBS dispersion resulted in 48.7 % and 71.4 % reductions, respectively, in the NP-
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induced toxic response compared to nZnO/PBS dispersion. Surface modification of these
nZnO using serum proteins seems to be a suitable approach to obtain stable dispersions
and accurate cytotoxicity values, thus improving their utility in therapeutic applications.
This study has shown the important role of serum proteins in modifying the ZnO
nanocrystal surface resulting in the formation of considerably smaller agglomerates and
stable NP dispersions. Furthermore, these FBS surface coatings influenced Zn2+ release
from the nanocrystals and induced changes in the mitochondrial function of the cells as
evidenced by the increased ROS production in the nZnO – FBS/PBS treated cells. Given
these findings, it is readily apparent that the addition of serum proteins adds a level of
complexity to our experimental understanding of NP-cell interactions. Further studies are
needed to examine how FBS-coatings change NP-cellular surface interactions, influence
cellular uptake mechanisms and modify molecular interactions with other extracellular
matrix components. Additionally, these studies should be extended to include newer 3D
cellular culture models which often employ complex biomolecular solution systems or
molecular scaffolds to better mimic in vivo-like environments for mechanistic biological
assays [71, 72]. These complex culture systems will influence the formation of the NP
biomolecular corona and change the diffusion and sedimentation rates for NP dispersions
especially those containing additional serum proteins. Furthermore, 3D culture systems
alter cellular growth patterns, metabolism, genetic expression and phenotype organization
changing NP-induced cellular responses which could be further influenced by the addition
of NP-coating materials [72, 73]. Finally, these studies should be extended into other cell
types. Molecular coatings are often considered as a means to achieve safer nZnO structures,
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yet little is known about how these molecular coatings will influence NP-cellular
interactions with endothelial cells [18, 27, 74] and other primary immune system cells [10].
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Tables and Figures

A

B

C

Figure 2.1
Crystal phase composition, size and morphology characterization for
nZnO and nZnO – FBSdried NPs. A) XRD spectra and TEM images for B) nZnO and
C) nZnO – FBSdried.
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A
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Figure 2.2
Surface property analysis for nZnO and nZnO – FBSdried. A) Zeta
potentials measured as a function of pH and B) FTIR spectra with the wavenumbers
of the main peaks marked.
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Figure 2.3
Aggregation profile evaluation for NP stock solutions. Average
hydrodynamic size profiles of 25 mM ZnO stock dispersions (pH = 7.3) for a 24-hour
time period. A) nZnO in various biologically relevant solutions. B) nZnO, nZnO –
FBSdried, nZnO – FBSwashed and nZnO – FBS stock dispersions in PBS and C) nZnO,
nZnO – FBSdried, nZnO – FBSwashed and nZnO – FBS stock dispersions in nanopure
water.
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Figure 2.4
Sedimentation profile evaluation for NP stock dispersions.
Sedimentation profiles of 25 mM ZnO stock dispersions (pH = 7.3) for a 2-hour time
period. A) nZnO, nZnO – FBSdried, nZnO – FBSwashed and nZnO – FBS stock
dispersions in various biologically relevant solutions. B) Sedimentation histograms
for 0, 0.5, 1.0, 1.5 and 2.0 hour time points for nZnO – FBSdried, nZnO – FBSwashed and
nZnO – FBS stock dispersions in PBS and nanopure water.
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Figure 2.5
Hydrodynamic size distribution profiles at 0, 12 and 24 hours. Histograms represent 25 mM stock dispersions
prepared in A) nanopure water B) PBS and C) RPMI-based cellular media.
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Figure 2.6
Hydrodynamic size distribution profiles at 0, 12 and 24 hours. Histograms represent 25 mM stock dispersions
prepared in PBS for A) nZnO – FBSdried, B) nZnO – FBSwashed and C) nZnO – FBS.
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Figure 2.7
Hydrodynamic size distribution profiles at 0, 12 and 24 hours. Histograms represent 25 mM stock dispersions
prepared in water for A) nZnO – FBSdried, B) nZnO – FBSwashed and C) nZnO – FBS.
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Figure 2.8
Dispersion stability analysis for nZnO/PBS and nZnO - FBS/PBS stock
solutions introduced to RPMI-based cellular media at a concentration of 0.6 mM. A)
Average hydrodynamic size profiles for a 24-hour time period. B) Sedimentation
profiles for a 24-hour time period. Hydrodynamic size distribution profiles at 0, 12
and 24 hours for C) nZnO/PBS stock dispersion in RPMI-based cellular media and
D) nZnO – FBS/PBS stock dispersion in RPMI-based cellular media.
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Figure 2.9
Extracellular dissolution of 6 mM nZnO/PBS and nZnO – FBS/PBS
stock dispersions and 0.6 mM of those respective nZnO stock dispersions in RPMIbased cellular media. Zn2+ concentration is expressed as % Zn2+ (total dissolved Zn2+
measured by ICP-MS / total Zn2+ in sample) to normalize for concentration.
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18 h

24 h

Figure 2.10 Cellular production of ROS following ZnO NP exposure. ROS
generation was evaluated in Jurkat cells at 6, 18 and 24 hours following treatment
with nZnO/PBS (PBS) and nZnO - FBS/PBS (FBS/PBS) stock dispersions using
MitoSOX red and flow cytometry (means ± standard error, minimum of n = 3). Cells
were treated with 0.4 mM nZnO and stained with MitoSOX red and CD3 antibody
after the desired time. A) Mean MitoSOX fluorescence intensity for a non-treated
control (NT) and nZnO and nZnO-FBS exposure. To assess relative increases in ROS
following NP treatment, a marker (M1) was set so that background fluorescent in
control samples (MitoSOX loaded/no NP) was between 1 and 3.5 %. Histograms
represent B) 6 hours, C) 18 hours and D) 24 hours.
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Figure 2.11 ZnO NP toxicity using nZnO/PBS and nZnO-FBS/PBS stock
dispersions for 24 hours on various suspension cell types. Cultures were treated
concurrently with varying concentrations of ZnO NP for 24 hours and cell viability
was evaluated (means ± standard error, minimum of n = 3). Statistical analysis was
performed using repeated measures analysis of variance and model-based means post
hoc test (p < 0.05) with an asterisk denoting statistical significance. Jurkat cell
viability was assessed using both (A) alamar blue staining or (B) flow cytometry and
PI uptake to evaluate between assay variability and repeatability. (C) Hut-78 cell
viability using alamar blue staining and (D) CD4+ T Cell viability using flow
cytometry and PI uptake.
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Figure 2.12 ZnO NP toxicity using varying concentrations of nZnO/PBS and nZnO
- FBS/PBS stock dispersions for 24 hours on adherent cell types. (A) T-47D epithelial
mammary gland carcinoma and (B) LNCaP epithelial prostate cancer cells. Cultures
were treated concurrently and cell viability was evaluated (means ± standard error,
minimum of n = 3). Statistical analysis was performed using repeated measures
analysis of variance and model-based means post hoc test (p < 0.05) with an asterisk
denoting statistical significance.
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Figure 2.13 Dosimetry curves for various stock dispersions introduced to RPMIbased cellular media at a concentration of 1.25 mM. A) Curves constructed using α
values calculated for 24-well plates and representing the fraction of NP deposited
[fD(t)] to an adherent cell as a function of time. B) Curves constructed using α values
calculated for 96-well plates and representing the fraction of NPs available [fA(t)] to
cells grown in suspension as a function of time. Dosimetry curves constructed using
both the Harvard VCM and ISDD models for both the nZnO/PBS and nZnO FBS/PBS stocks representing C) NP deposition [fD(t)] and D) NP availability [fA(t)].
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Figure 2.14 Dosimetry curves constructed using both the Harvard VCM and ISDD
models for nZnO/PBS and nZnO – FBS/PBS stock dispersions introduced to RPMIbased cellular media at a concentration of 1.25 mM. Curves were constructed using
α values calculated for 24-well plates at various time points (ISDD) and Harvard
VCM α values (Table 1). These curves represent the fraction of NPs deposited [fD(t)]
to an adherent cell layer as a function of time for A) nZnO – PBS stock dispersions
and B) nZnO – FBS/PBS stock dispersions.

Table 2.1

Delivered Dose Metrics.

Stock Dispersion in

Zeta Potential

complete RPMI

(mV)

dH (nm)

pe (g/cm3)

96-well plate

24-well plate

(L = 6.6 mm)

(L = 2.25 mm)



t90 (h)



t90 (h)

Water

-16.1 ±1.45

182.5

2.021

0.1453

15.6

0.4261

5.4

FBS/Water

-15.1 ± 0.81

185.1

1.692

0.2085

11.1

0.6116

3.8

FBS

-13.9 ± 0.40

185.5

1.464

0.3121

7.4

0.9154

2.5

PBS

-8.1 ± 1.93

663

1.879

0.0087

264.9

0.0255

90.3

FBS/PBS

-9.8 ± 2.08

322

1.743

0.0543

42.4

0.1593

14.5

RPMI

-14.7 ±1.46

770.5

1.623

0.0087

263.8

0.0256

89.9

Complete RPMI

-13.6 ± 2.63

244.4

1.682

0.1116

20.6

0.3273

7.1

Delivered dose metrics: pe: agglomerate effective density (g/cm3); dH: Hydrodynamic diameter (nm); L: media height; : deposition
fraction; t90: Time required for delivery of 90 % of administered dose (h);  and t90 (h) values are designated for each well plate
employed (96-well plate for suspension cells and 24-well plate for adherent cells).
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ZNO NANOPARTICLE PREPARATION ROUTE

INFLUENCES SURFACE REACTIVITY, DISSOLUTION AND
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Abstract
ZnO nanoparticles (nZnO) are commonly used in nanotechnology applications
despite their demonstrated cytotoxicity against multiple cell types. This underscores the
significant need to determine the physicochemical properties that influence nZnO
cytotoxicity. In this study, we analyzed six similarly sized nZnO formulations, along with
SiO2-coated nZnO, bulk ZnO and ZnSO4 as controls. Four of the nZnO samples were
synthesized using various wet chemical methods, while three employed high-temperature
flame spray pyrolysis (FSP) techniques. X-ray diffraction and optical analysis
demonstrated the lattice parameters and electron band gap of the seven nZnO formulations
were similar. However, zeta potential measures, hydrodynamic size, photocatalytic rate
constants, dissolution potential, reactive oxygen species (ROS) production and, more
importantly, the cytotoxicity of the variously synthesized nZnO towards Jurkat leukemic
and primary CD4+ T cells displayed major differences. Surface structure analysis using
FTIR, X-ray photoelectron spectroscopies (XPS) and dynamic light scattering (DLS)
revealed significant differences in the surface-bound chemical groups and the
agglomeration tendencies of the samples. The wet chemical nZnO, with higher cationic
surface charge, faster photocatalytic rates, increased extracellular dissolution and ROS
generation demonstrated greater cytotoxicity towards both cell types than those made with
FSP techniques. Furthermore, principal component analysis (PCA) suggests that the
synthesis procedure employed influences which physicochemical properties contribute
more to the cytotoxic response. These results suggest that the synthesis approach results in
unique surface chemistries and can be a determinant of cellular cytotoxicity and oxidative
stress responses.
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Introduction
Zinc oxide nanoparticles (nZnO) are widely used in industrial processes,
electronics and consumer products due to their unique optical, electronic, and structural
properties that are absent in bulk ZnO (around one micron in size) [1-3]. Given this,
considerable research has centred around the inherent toxicity that nZnO demonstrates
towards various organisms [4, 5], as well as prokaryotic [6-10] and eukaryotic cells [9, 1119]. While many researchers have worked to engineer safer-by-design nanomaterials
through material properties modification [20-22], others have sought to exploit this
differential toxicity for potential use in nZnO-based therapeutics [9, 11, 12]. Central to both
of these long-term objectives are a comprehensive examination of nZnO-specific
physicochemical properties and how material property modifications influence oxidative
stress and nanoparticle (NP)-induced toxicity. Despite the wealth of available research,
however, clear mechanistic determinants of these responses remain elusive. Among the
proposed mechanisms is that intrinsic ROS production originating from redox reactions on
the NP surface contributes directly to cellular membrane, organelle, or DNA damage [2325]. Alternatively, perturbations in intracellular zinc homeostasis from NP dissolution, proinflammatory responses and mitochondrial damage leading to ROS production from the
cell death process have also been implicated [26-32]. Regardless, controlling reactivity at
the NP-surface and nZnO dissolution is critical to influencing biological outcomes.
Most studies investigate changes in NP-induced toxic response as a function of a
single material property modification in a specific nZnO formulation. For example, minor
changes within the same synthesis method can alter both the crystal size and shape [25].
Likewise, surface modification via surface coating, chemical modification, or heat
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treatment has demonstrated efficacy in changing surface charge, surface structure and NP
solubility [23-25, 33, 34]. While this formulation controlled approach has been
instrumental in identifying how specific physicochemical modifications influence cellular
responses, it fails to explain how comparable studies using similar NP modifications and/or
mammalian cell types, but differently synthesized nZnO samples, often result in differing
cytotoxicity. These discrepancies have resulted in uncertainty as to how changes in material
properties, within a very diverse set of nZnO formulations, influence the toxicity of nZnO.
Studies in bacterial models routinely employ step-wise synthesis method changes
to improve nZnO photocatalytic activity and antimicrobial properties [6-8, 10, 35-40].
However, similar studies in mammalian cells remain an underrepresented area in nZnO
research. In previous work, our lab compared two spherical and similarly sized (~9 nm)
pristine nZnO formulations fabricated using different wet-chemical methods [25]. Despite
these similarities, the two formulations exhibited different (i) hydrodynamic size, (ii)
electrophoretic mobility, (iii) isoelectric point (IEP), (iv) surface-adsorbed groups, (v)
photocatalytic activity, and (vi) remarkably different cytotoxicity. This work illustrates the
importance of investigating how changes to the synthesis method can dramatically alter the
surface reactivity, and thus, NP-induced toxicity.
Additionally, there is still much debate as to the roles that extracellular [13, 30],
intracellular free [29, 31], and total cell-associated zinc [13, 31] play in the mechanistic
process of NP-induced toxicity. Once introduced into cell culture, nZnO will begin to
dissolve into ionic zinc (shown as extracellular zinc in Scheme 3.1). Inevitably, some of
this ionic Zn2+ will be taken up by cells to become intracellular free Zn2+ within the cytosol
or endocytotic vesicles [32, 41, 42]. Additionally, Zn2+ ions will interact with carbonate
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and phosphate anions to produce zinc carbonate or phosphate species [43]. While these
species show negligible toxicity towards mammalian cells [44, 45], they do interact with
large agglomerates of intact nZnO (i.e., non-ionic zinc) to form amorphous complexes of
encapsulated crystalline zinc that freely attach to cellular membranes or enter cells through
various uptake mechanisms (designated as cell-associated Zn2+ in Scheme 3.1) [17, 31, 41,
45]. Consequently, a thorough examination of these processes is critical in NP-toxicology
studies.
In this work, we sought to expand upon our previous studies by evaluating a more
diverse panel of nZnO formulations with differential toxicity to include four wet-chemical
samples, two FSP prepared samples, and three control samples, specifically ZnSO4, bulk
ZnO, and a SiO2-coated nZnO formulation. Careful consideration was used in choosing the
nZnO samples for investigation. Wet chemical methods are ubiquitously used in research
studies as they are easily synthesized using inexpensive, common laboratory equipment
and chemicals, and can be readily modified with simple experimental changes. The four
wet chemical methods chosen are among the most popular approaches utilized. All employ
a forced hydrolysis synthesis reaction with variable precursors and solvent systems. FSP
synthesis is favored in industrial settings because of its simplistic methodology with fewer
process steps, scalability, easy collection systems, high yield, and purity of the final product
[46-51]. Additionally, FSP methods employ high temperatures that well exceed any
temperatures employed by most wet chemical methods. The specific FSP methods were
selected based on differing precursor solutions and carrier gas mixtures. The use of
nanomaterials bridging both research application and consumer product use should provide
NP representation across multiple areas of nZnO usage. All the nanoscale samples were
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found to have average sizes in at least one dimension between 16 – 45 nm with similar
bandgaps centred near 3.3 eV. Extensive characterizations were performed to evaluate the
physicochemical differences present in the surface properties of the samples, and explore
the roles that extracellular zinc, free intracellular zinc, and cell-associated zinc play in
cellular toxicity. By looking at a broad panel of pristine nZnO with variable toxic potential,
we have identified how NP-induced toxicity is influenced by both the dissolution potential
and the surface reactivity of nZnO. This understanding could provide critical insight into
previously unexplained discrepancies in the wider body of research as well as define which
material property interactions have the greatest potential to affect cellular toxicity.
Experimental
Synthesis of nZnO
Seven nZnO samples were used in this study. Four of the samples were synthesized
using wet chemical methods. The DEG nZnO sample was produced using the forced
hydrolysis of a zinc acetate dihydrate precursor in diethylene glycol (DEG). The solution
was held at 150 °C for 90 minutes. Nanopure water was added to the solution at 80 °C to
obtain the desired crystallite size [12]. Once cooled to room temperature, the nZnO were
separated from solution via centrifugation and subsequent washings with ethanol.
The second wet chemical method, EtOH nZnO, was synthesized using a similar
hydrolysis method with the same precursor, but denatured ethanol was used as the reaction
solvent along with a strong base, LiOH, to maintain appropriate pH [25]. The solution was
held at 80 °C for 90 minutes, cooled to room temperature, and aged with n-heptane for
several hours. The NPs were removed from suspension via centrifugation, followed by
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subsequent washings with nanopure water and ethanol. After washings, both the DEG and
EtOH nZnO precipitates were dried in an oven at 65 °C for >12 hours.
The third sample, EG nZnO, was synthesized using a wet chemical method
followed by a thermal decomposition. Zinc acetate dehydrate was used as the precursor
with polyvinylpyrrolidone (PVP) as a binding agent. The reaction was carried out by
suspending the precursor and PVP in ethylene glycol (EG), and held at 180 °C for 90
minutes. After cooling to room temperature, the particles were collected by centrifugation,
followed by ethanol washings. The sample pellet was dried overnight at 65 °C and then
annealed at 350 ⁰C for 2 hours to remove any residual organics.
The final wet chemical sample, NaOH nZnO, was synthesized by introducing a 0.5
M zinc nitrate [Zn(NO3)2·6H2O] precursor solution dropwise to an equal volume of 1.0 M
NaOH heated to 80 °C [52]. This solution was continuously stirred for two hours. The
resulting precipitate was removed from solution via centrifugation and repeatedly washed
with ethanol and nanopure water, and dried at 65°C for >12 hours.
The three remaining nZnO samples were prepared using high-temperature flame
spray pyrolysis (FSP). Rod-shaped FSP NPs (FSPR) and a silica-coated formulation of the
FSPR sample (SiO2-FSPR) were prepared by collaborators at the Department of
Environmental Health, Harvard University. Both samples employed a precursor solution
of 0.5 M zinc naphthenate dissolved in ethanol for the formation of the nZnO core with the
addition of hexamethyldisiloxane (HMDSO) utilized to form the silica coating. Specific
synthesis details have been previously reported [21, 22]. A spherical FSP sample (FSPS)
was synthesized by the Nanoscience Research Laboratory at Chiang Mai University in
Thailand as outlined in Liewhiran et al. (2007) [53]. For this formulation, zinc naphthenate
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was dissolved in a toluene /acetonitrile mixture with a ratio of 80/20 vol% at a precursor
concentration of 0.5 M ZnO. Lastly, a bulk ZnO sample was obtained by annealing a
commercially available ZnO powder (Sigma Aldridge; St. Louis, MO) at 500 °C for 5
hours to ensure all nanosized particles less than 200 nm were removed from the sample.
Characterization
X-ray diffraction (XRD), transmission electron microscopy (TEM), dynamic light
scattering (DLS), zeta potential, UV-vis spectrophotometry, and Fourier transform infrared
spectroscopy (FTIR) were employed to evaluate chemical composition, crystal size,
morphology, electrophoretic mobility and surface structure. Philips X’Pert and Rigaku
Miniflex 600 X-ray diffractometers with a Cu Ka source (l = 1.5418 Å) in Bragg-Brentano
geometry were used to record room temperature XRD spectra. Rietveld refinement using
Materials Analysis Using Diffraction (MAUD) software corrected for instrumental
broadening was used to determine crystal size and lattice parameters [54]. An FEI Tecnai
transmission electron microscope operating at 120 kV was employed to collect TEM
images. High-resolution TEM analysis was performed on an FEI Titan microscope
operating at 300 kV. Image processing was carried out using the Digital Micrograph
software from Gatan (Pleasant, CA). The average particle size and the standard deviation
of the nanopowders was determined by measuring 100 plus individual NPs within Image J
software (NIH, Bethesda, MD) [55].
The specific surface areas of the samples were determined via nitrogen gas
physiosorption at 77 K using a Quantachrome NOVA 2200e analyzer. Prior to the analysis,
all samples were vacuum degassed at 250 °C for 3.5 hours. The linear portion
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(P/Po = 0.05 - 0.3) of the Brunauer–Emmett–Teller (BET) model was used for the
calculation of specific surface area with NovaWin Version 11.04 software.
Room-temperature (RT) ultraviolet and visible light optical absorbance spectra
were obtained with a CARY 5000 spectrophotometer. RT diffuse reflectance UV−vis
spectra were collected for band gap determination, and RT UV−vis absorbance spectra
were obtained for photocatalytic rate analysis. Electrophoretic mobility and hydrodynamic
sizes of nZnO dispersions created in nanopure water and cellular media were collected with
a Malvern Zetasizer® NanoZS. Each formulation was measured three times using freshly
prepared NP dispersions and a minimum of six replicates were collected for each
measurement. FTIR spectra were measured using a Bruker Tensor 27 spectrometer.
Cell culture and cytotoxicity studies.
Cells were cultured at 37 °C and 5 % CO2. For cell cytotoxicity assays, Jurkat
leukemia T cells were cultured in supplemented Roswell Park Memorial Institute (RPMI)1640 media (10 % FBS, 2 mM L-glutamine, 1.5 g/L sodium bicarbonate, 4.5 g/L glucose,
10 mM HEPES, 1.0 mM sodium pyruvate, and 1 % penicillin-streptomycin) and
maintained in log phase prior to treatment. Stock solutions for the nZnO samples were
created by suspending the nanomaterial in nanopure water and sonicating for 30 minutes
using a power of 1.05 W. These sonication parameters deliver a determined sonication
energy [56] of 181 J/mL needed to obtain stable nZnO dispersions [57]. Working stock
dilutions were prepared by introducing the NP stock to cellular media and vortex mixing
for 30 seconds. The NPs were then added to cells (5 x 105 cells/mL) and cultured for 24
hours. ZnSO4 was utilized as a positive ionic zinc control. Cell viability was determined
using a metabolic assay in which alamar blue (10 % of total volume) was added to cells
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and incubated for an additional 4 hours. Fluorescence changes were measured with a
Biotek Synergy MX® plate reader (Winooski, VT) using an excitation of 530 nm and
emission collection at 590 nm.
Additional studies were performed using human primary CD4+ T cells. Written
informed consent was obtained from all blood donors and the study was approved by the
University

Institutional

Review

Board.

Ficoll-Hypaque

density

centrifugation

(Histopaque-1077, Sigma Aldridge; St. Louis, MO) was used to isolate peripheral blood
mononuclear cells from normal human blood samples followed by negative
immunomagnetic selection (Stem Cell Technologies; Vancouver, BC, Canada) to obtain
CD4+ T cells [11]. Purified CD4+ T cells (>95 % purity) were cultured at a concentration
of 1 x 106 cells/mL in RPMI with 10% FBS. Cells (1 x 106 cells/ml) were treated with NPs
for 24 hours. Cell were then stained with a fluorescein isothiocyanate (FITC)-labelled
mouse anti-human HLA ABC antibody (Clone: G46-2.6; BD Bioscience; San Jose, CA)
0.04 µg/mL propidium iodide (PI) at 4 °C for 30 minutes. A BD FACSCalibur flow
cytometer (BD Biosciences; San Jose, CA) was used to monitor the loss of cell membrane
integrity, and light forward scatter (FSC) and side scatter (SSC) parameters were used to
exclude any NPs from the analysis. Additionally, each sample was treated with 10 µL of
fluorescent CountBright counting beads (Invitrogen; Carlsbad, CA) to enable
determinations of absolute cell numbers.
Photocatalytic Studies
The photocatalysis method employed was adapted with changes from
Punnoose, et al. (2015) [25]. Using the model fluorescent dye sulfo-Rhodamine B,
nZnO/dye solutions were prepared by adding 2 mg of nanomaterial in 1 mL of nanopure
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water, sonicating for 15 minutes, and then introduced into 20 mL of 2.5 x 10-5 M solution
of sulfo-Rhodamine B dye (excitation/emission maxima ~ 565/586 nm) The nZnO/dye
solution was equilibrated in the dark at room temperature with continuous stirring for 15
minutes. After reaching equilibrium, an aliquot was removed for UV-Vis analysis. The
nZnO/dye solution was then placed in a Rayonet RPR-100 UV reactor equipped with 2537
Å UV lamps to deliver approximately 3.2 mW/cm2. Once the lamps were turned on,
another sample was immediately extracted for analysis for the zero-minute time point.
Aliquots were then removed every 15 minutes for a period of 120 minutes or until complete
dye degradation. All liquid aliquots were centrifuged at 13,000 x g for 90 seconds to
separate NPs from the solution. The supernatant was then transferred to a quartz cuvette,
and optical absorbance was measured using a Cary-5000 UV−vis spectrophotometer. The
photocatalytic rate constant k is given by kt = ln(C0/C), where t = time (minutes), C0 =
initial concentration of fluorescent dye molecules, and C = concentration of the fluorescent
dye molecules following its illumination with the NP sample. As a control, the selfdegradation of sulfo-Rhodamine B under UV irradiation without the presence of ZnO NPs
was measured prior to nZnO studies and was found to be negligible.
Extracellular dissolution of nZnO stock solutions
To simulate cellular assay conditions, aliquots of NP stocks were added to cellular
media. These suspensions were placed in 25 mL culture flasks at a fluid depth of 6.6 mm
to mimic the dispersion dynamics experienced by nZnO in the 96 well cellular assays and
were kept in an incubator. Two mL aliquots were removed at 4 and 24 hours and
centrifuged at 5,000 x g for 20 minutes using an Amicon™ Ultra-4 Centrifugal Filter Unit
with a 3-Kd molecular weight cutoff (0.1 nm pore size) to remove any undissolved nZnO
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while allowing free zinc ions to pass through. Control experiments were performed to
demonstrate that 99 % NP-derived zinc ions are recoverable using this methodology [34].
Quantitative analysis of the dissolved Zn2+ ions was conducted on a Thermo X Series 2
quadrupole inductively-coupled plasma mass spectrometer (ICP-MS) under normal
operating conditions (i.e., no CCT) with the Xt cone set. Instrument performance was
evaluated and optimized for each run. The instrument was calibrated using multi-element
calibration standards containing Zn, Cr, Mn, Fe, Co and Ni in 2 % HNO3 at concentrations
of approximately 1, 10, 100 and 1000 ppb. Instrument drift was monitored and corrected
using 20 ppb indium as an internal standard introduced online.
Intracellular Zn2+ determination
The amount of intracellular Zn2+ present in Jurkat cells post nZnO treatment was
determined using the zinc specific dye FluoZin 3AM (Invitrogen; Eugene, OR). Jurkat cells
were plated at 5 x 105 in 96-well plates and cultured with nZnO. At 4 and 24-hour time
points, cells were harvested, rinsed twice with phosphate-buffered saline (PBS) and
centrifuged at 500 x g for 10 min. The cell pellets were re-suspended in phosphate-free
Dulbecco's Modified Eagle's medium (DMEM), stained with 3.25 µM FluoZin 3AM dye
and incubated at RT for 30 minutes in the dark. Cells were then rinsed with FACS buffer
(PBS supplemented with 3 % FBS and 0.02 % sodium azide), centrifuged at 500 x g for 7
min, re-suspended in FACS buffer, and stained with a FITC-labelled anti-HLA ABC
antibody at RT for 30 min in the dark. Samples were then analyzed using a BD
FACSCalibur flow cytometer with unbound NPs excluded from analysis based on the
absence of fluorescence signal and light forward scatter (FSC) and side scatter (SSC)
characteristics.
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Cell-associated Zn2+
Cell-associated Zn2+ was determined via inductively coupled plasma mass
spectrometry (ICP-MS). Jurkat cells (1 x 105 cells/ml) were treated with nZnO and
incubated. At 4 and 24-hour time points, cells were washed twice in PBS, centrifuged at
500 x g for 10 min, re-suspended in FACS buffer, stained with 10 µL of a FITC-labelled
mouse anti-human HLA ABC antibody, and separated from any remaining extracellular
nZnO via cell-sorting with a BD Influx cell sorter using Spigot software (version 6.1.4).
Recovered live and dead intact cells were counted (>5 times) using a hemocytometer and
a Luna - IITM automated cell counter (Logos Biosystems; Annandale, VA). Sample aliquots
were resuspended in a 10 % HNO3 (double distilled 15.8 N trace metal-grade) solution (pH
~3.0) containing 5 x 105 cells and were mechanically lysed with a probe-tip sonicator at
50W for 2 minutes using 30 seconds on/10 second off pulse cycles. The acidified, lysed
aliquots were stored in acid-rinsed eppendorf tubes overnight to ensure complete
dissolution of any undissolved nZnO. The lysed aliquots were then filtered using a 10 kDa
MW cut-off Eppendorf filter, Sartorius Vivaspin® 500 (Sartorius AG; Goettingen,
Germany), to remove cellular debris prior to analysis. Control experiments were
performed to demonstrate that 99 % NP-derived zinc ions are recoverable using this
methodology [34]. NP-only control samples demonstrated that the sorting procedure did
not significantly affect the ionic zinc levels in the experimental samples. Quantitative
analyses of the solutions were performed via ICP-MS.
Dosimetry
Two empirical methods, the Harvard Volume Centrifugation Method (VCM) [58,
59] and the in vitro sedimentation, diffusion and dosimetry (ISDD) computational model
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[60] were employed to determine the effective NP density of the agglomerates (ρe, g/cm3)
and the amount of nanomaterial deposited within a cell culture scenario, respectively. The
effective volume of NP pellets (Vpellet), was obtained by first creating a nZnO dispersion in
cellular media as previously described [57]. The resulting dispersions were then
centrifuged at 2,000 × g for one hour in TPP (Techno Plastic Products, Trasadingen,
Switzerland) packed cell volume tubes and the resulting NP pellets were measured utilizing
the TPP "easy read" measuring device by the same manufacturer. The ρe of the NP
agglomerates was calculated using the following equation (DeLoid et al.) [59].
𝑀𝑍𝑛𝑂 − 𝑀𝑍𝑛𝑂𝑆𝑜𝑙

𝜌𝑒 = 𝜌𝑚𝑒𝑑𝑖𝑎 + [(

𝑉𝑝𝑒𝑙𝑙𝑒𝑡 𝑆𝐹

) (1 −

𝜌𝑚𝑒𝑑𝑖𝑎
𝜌𝑍𝑛𝑂

)]

(Eq 1)

The ρe is determined as a function of the media density (ρmediaρmedia ) and the
material density of ZnO NPs (ρZnO) of 5.606 g/cm3. To account for the solubility of ZnO,
the mass of solubilized ZnO (MZnOSol) determined by ICP-MS (see “Extracellular
Dissolution” section) was subtracted from the original mass of ZnO (MZnO). A theoretical
stacking factor (SF) of 0.634 was utilized to approximate random close stacking employed
by many dosimetry models [58, 59]. The ISDD model was provided by Justin G
Teeguarden from the Pacific Northwest National Laboratory and is outlined in this paper
[61].
Zinc speciation determination
The molecular speciation into amorphous nZnO, zinc phosphate and zinc carbonate
under cellular assay conditions was evaluated through FTIR, X-ray photoelectron
spectroscopy (XPS) and TEM. For this assay, samples containing 32.4 µg/mL nanopure
water-based nZnO stock solution were introduced to RPMI media and incubated. At 4 and
24 hours, the entire volume of one of the samples was centrifuged at 5000 x g for 30
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minutes to pellet any suspended nZnO or amorphous zinc complexes. The resulting pellet
was rinsed with nanopure water, centrifuged and dried overnight at 60 °C. FTIR pellets
were made by combining 0.2 g of anhydrous KBr with 1.5 mg of dried precipitate and then
grinding into a fine powder. The powder was compressed with 8 tons of pressure for 4
minutes. Vibrational spectra were obtained with a Bruker Tensor 27 spectrometer and peak
deconvolution performed using Opus 7.0.129 software. A Physics Electronics Versaprobe
system outfitted with an Al Kα X-ray source delivering 25 W of power with a beam
diameter of approximately 100 m was used to collect XPS spectra. Pass energy values of
117.5 eV and 23.65 eV were used to obtain survey and high-resolution core level scans,
respectively. Peak deconvolution and integrated peak analysis were performed with
OriginLabPro 2017 software. TEM samples were obtained by dispersing a ~0.5 mg of
sample in EtOH followed by sonication for 10 minutes and deposition onto carbon grids.
Image collection was performed using a JEOL JEM-2100 HR analytical TEM.
Reactive Oxygen Species (ROS) Detection
To assess cellular ROS levels, Jurkat cells (1 x 105 cells/ml) were incubated with
nZnO for 24 hours and then dually stained with 10 µL of an anti-HLA-ABC PE antibody
and 2.5 µM of MitoSOX™ Red (Invitrogen; Eugene, OR). In the presence of mitochondrial
superoxide, MitoSOX Red becomes oxidized and a fluorescent signal appears upon
binding of the oxidized dye to nucleic acids [62]. For a positive control, cells were treated
with 0.2 nM antimycin-A to ensure that the cells were capable of producing ROS. Flow
cytometry was used to measure mitochondrial superoxide levels with the percent positive
MitoSOX cells designated as gated lymphocytes staining positive for both HLA-ABC and
MitoSOX red.
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Statistical analyses
Statistical analyses were performed using JMP Pro 12 software (SAS; Cary, NC).
The cytotoxicity data were analysed using repeated measures of variance with post hoc
comparisons and significance levels defined as p < 0.05 to determine statistical differences
between the means and allow within-sample variation to be separated from betweensample variation. Data for Fig. 3.1-3.5 were analyzed using a two-way analysis of variance
(ANOVA) to test for statistical significance of the model, and post hoc comparisons were
used to test for statistically significant effects of treatment on the experimental outcome
(p < 0.05) with lowercase letters denoting statistical significance in the indicated figures.
Linear least squares regression was employed to determine statistical significance between
individual synthesis and control sample groups (Fig. 3.1-3.5). A linear regression was
employed to determine the Pearson correlation coefficient (R2) value for Fig. S3.3.
Principal component analysis (PCA) was used to reduce dimensionality of our
multivariate data set to obtain canonical variables that are statistically independent of each
other yet still representative of the experimental data [63]. Using the correlation method,
PCA was performed with JMP Pro 12 software followed by common factor analysis using
squared multiple correlation communality estimates and a varimax rotation method to
obtain rotated principal components (PCs). A standard least squares regression model was
used to evaluate the linearity of the measured IC 50 values of the Jurkat cells against the
obtained PCs to obtain a predictive model for NP-induced toxicity (Table S3.1 in the
electronic supplementary information (ESI)).
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Results
X-ray Diffraction, XPS and TEM Analysis for Crystal Structure, Composition, and
Morphology
A diverse panel of nZnO was synthesized by both wet chemical and high
temperature flame spray hydrolysis. Four of the formulations (DEG, EtOH, EG and NaOH)
were produced using wet chemical forced hydrolysis synthesis (designated green in Table
3.1), while two nZnO samples, a spherical FSP (FSPS) and a rod-shaped FSP (FSPR), were
prepared via flame spray pyrolysis (FSP; blue in Table 3.1). Finally, a nanosized silicacoated version of the FSPR sample (SiO2-FSPR) and bulk ZnO (bulk) were employed as
control samples (shown in dark grey in Table 3.1) given their reported tendencies to be
biologically safer than most nanoscale ZnO formulations [21, 22]. Prior to the
implementation of biological assays, all formulations were thoroughly characterized. The
crystal structure, phase purity and compositional purity of the formulation panel were
evaluated using XRD analysis and confirmed that all formulations were nZnO and
displayed a wurtzite crystal phase without alternate crystal phases present (Fig. S3.1(a-b)
in ESI) and XPS (Fig. S3.2). TEM (Fig. S3.1(c-j)) revealed that the nanoscale samples had
average particle sizes in at least one dimension between 16 – 45 nm. The bulk ZnO sample
was found to contain very large particles (mostly >500 nm) of mixed morphology (Fig.
S3.1j). TEM images showed that the nZnO samples were spherical in morphology except
for the NaOH, FSPR and SiO2-FSPR samples which exhibited rod-like morphology (Fig.
S3.1(f, h & i)).
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Cellular toxicity and oxidative stress responses
To evaluate the toxicity and oxidative stress induced by the nZnO formulations,
Jurkat leukemia T cells (Fig. 3.1(a)) and primary non-transformed CD4+ T cells (Fig.
3.1(b)) were treated with increasing concentrations of nZnO for 24 hours (see Table S3.1
for millimolar concentration values and therapeutic indices). The cytotoxic response of
both cell types to the different NP formulations can be roughly divided into three groups
Nanoparticles prepared with wet chemical methods (DEG, EG, EtOH and NaOH) showed
the greatest level of toxicity, followed by the FSP samples. Interestingly, the rod-shaped
nZnO appeared less cytotoxic in both the wet chemical method group (NaOH) and the FSP
group (FSPR) than the spherical NPs synthesized in a similar fashion (EtOH and FSPS,
respectively); however, these differences were more pronounced in the primary cells.
Consistent with the literature, the SiO2-FSPR and bulk control samples were significantly
less toxic than the nZnO formulations, whereas the positive ionic zinc ZnSO 4 control
exhibited the most toxicity. Additionally, the IC50 value obtained for SiO2-FSPR is in line
with those values obtained for silica NP of comparable size indicating an efficient and
hermetic coating [64, 65]. Linear contrast analysis found the differences observed between
three ZnO groupings, wet chemical, FSP and control samples to be statistically significant.
Intracellular ROS generation is considered a primary contributor to NP-induced
toxicity in mammalian cells [11, 12, 16, 66]. ROS produced by structural or functional
damage to mitochondria can be assessed through the measurement of mitochondrial
superoxide [12, 66, 67]. Figure 3.2 illustrates that the nZnO samples generated ROS in a
formulation-dependent manner. Specifically, the most toxic formulation, DEG nZnO
(Jurkat IC50 = 20.7 ± 3.1 µg/mL), produced the highest percentage of ROS positive cells at
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39.1 ± 2.5 %, while treatment with the least toxic nanoscaled sample, FSPR (86.4 ± 4.7
µg/mL), resulted in only 12.1 ± 0.6 % ROS producing cells. These findings directly
correlated increases in NP-induced toxicity to corresponding increases in mitochondrial
superoxide generation. The one exception, the SiO2-FSPR nZnO, produced only
6.1 ± 0.2 % of ROS positive cells despite showing significantly more toxicity than bulk
ZnO, possibly due to complexation or shielding of the electron donor or acceptor sites
needed for mitochondrial damage [23, 68].
Surface characterization and reactivity
As different synthesis methods are expected to result in unique surface chemistry,
several characterizations were performed to elucidate these differences. Surface bound
species and hydroxylation were identified using FTIR analysis. Present in all formulations
was the characteristic broad Zn-O vibrational mode (Fig. 3.3) centered between 451 cm-1
and 475 cm-1, and the broad FTIR peak associated with surface adsorbed OH groups at
3410 cm-1 [69-72]. Notable differences present only in the wet chemically synthesized
samples (Fig. 3.3(a)) included the O-H bending mode and the vs(COO-) of carboxylic acid
at 910 cm-1 at 1412 cm-1, respectively [71, 72]. Additionally, the DEG sample displayed a
v(C-OH) mode at 1076 cm-1 and the vas(COO-) band at 1591 cm-1 [70-72]. The above
mentioned peaks can be attributed to function group remnants of the synthesis precursor or
the reaction solvent [25]. Finally, the SiO2 coating was confirmed through the presence of
the Si-O-Si bending and Si-O-Si stretching modes found at 800 and 1081 cm-1, respectively
[69].
The FTIR data confirmed that the NP formulations differed in the type and quantity
of surface adsorbed functional groups and charged ions. These modifications, along with
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intrinsic surface defects are often conferred by the synthesis procedure, and alter the
surface charge density and ionization potential of the nanocrystals resulting in the
generation of an enhanced surface charge [25]. Zeta potential (ζ-potential) measurements
(Table 3.1) verified these synthesis method-dependent differences. The positive ζ-potential
values of the uncoated samples were higher for samples with more surface-adsorbed
functional groups and hydroxylation. When the IC50 in Jurkat cells was plotted as a function
of ζ-potential (Fig. S3.3 in ESI), a linear correlation (R2 = 0.72; p <0.0001) was observed
for the uncoated nZnO samples. This correlation is interesting considering that all samples
experienced similar electrophoretic mobility shifts when suspended in cellular media
(Table 3.1). While this normalization of the NP surface charge in cellular media may be
due in part to protein corona formation, these findings may also be skewed by free protein
remaining in the media. Indeed, control experiments using a dried protein-coated DEG
nZnO sample revealed a ζ-potential measurement of -11.8 ± 0.39 mV as compared to the
value of -6.80  0.85 obtained for the wet sample [57]. This commonly observed surface
charge normalization has prompted speculation that ζ-potential values measured in aqueous
solutions contribute little to NP-induced toxicity [23], however, our results clearly do not
fit with this speculation. A possible explanation for this is intrinsic surface defects that
contribute to the nZnO surface charge, may still be present in the interior of the nZnO
crystals and contribute to their toxic response when internalized into cells. Additionally,
the variably charged surfaces noted for the different formulations could result in
differential attractive forces to organic and biological molecules present in the extracellular
milieu and/or cellular environment. Indeed, Han et.al (2014), observed that differently
charged nZnO experienced variable adsorption of humic acid at circumneutral pH. In their
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study, a positively charged nZnO sample adsorbed higher amounts of the negatively
charged humic acid along with concentration-dependent shifts in the measured zeta
potential when compared to a negatively charged nZnO sample [73].
In addition to their ability to influence surface charge, intrinsic defects such as
oxygen vacancies or interstitial Zn ions, increase the number of possible electron donor or
receptor sites available to participate in abiotic redox reactions at the NP surface [25, 74,
75]. Seen as an indirect measurement of redox potential, photocatalytic activity has been
connected to synthesis modification and resulting biological outcomes [25]. The highly
+
−
reactive valance band holes (ℎ𝑣𝑏
) and conduction band electrons (𝑒𝑐𝑏
) produced during UV

irradiation participate in redox reactions at the NP surface to produce multiple ROS
species, resulting in sulfo-rhodamine B fluorescent dye degradation [25, 74, 75]. Figure
3.3(c), demonstrates this time-dependent degradation of the dye for the EG formulation.
The average catalytic rate constants (k, min-1) for the uncoated nZnO formulations varied
from 0.076 min-1 (DEG) to 0.036 min-1 (FSPR) (Fig. 3.3(d)), while the SiO2-FSPR sample
did not exhibit any significant photocatalytic activity. All reported k values are consistent
with current literature [25, 36, 74]. Additionally, rod-shaped NPs exhibited lower k values
compared to spherical nZnO samples demonstrating a strong dependence of k values on
NP shape [36]. The k values for the spherical nZnO plus the bulk control, (Inset; Fig.
3.3(d)), demonstrated a positive correlation with the observed cytotoxicity for both the cell
types, and is consistent with our previous findings [25]. ZnSO4 treatment did not result in
any appreciable dye degradation with or without UV illumination thus eliminating ionic
zinc as a contributor to the photocatalytic process.
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Dissolution potential and zinc speciation
ZnO NPs are known to release Zn2+ in many biologically relevant solutions [76]
and induce cellular damage both extracellularly and intracellularly [13, 29-31]. To
determine if a relationship existed between these two dissolution measures, extracellular
(bars in Fig. 3.4) and intracellular free Zn2+ (line graph in Fig. 3.4) dissolution assays were
performed concurrently. As seen in Fig. 3.4, a clear trend exists between extracellular zinc
release and the measured intracellular free Zn2+ for all samples. Additionally, the wet
chemically synthesized NPs exhibited higher extracellular and intracellular free Zn2+ levels
than the FSP or control samples with two notable exceptions. First, the EtOH sample was
less soluble than the FSP nZnO despite being a wet chemical formulation and having a
larger specific surface area (SSA) of 67.1 m2/g. However, the increased hydrodynamic size
of this sample (Table 3.1) reduces its surface area-to-volume ratio thereby decreasing its
dissolution potential. Secondly, the SiO2-FSPR released relatively low amounts of Zn2+,
despite its small hydrodynamic size, due to the protective benefits of the silica coating [22].
The same general trend was apparent for all samples at both time points, with modest
increases between 1.5 and 3.9 % in the amount of Zn2+ released by 24 hours. Overall, these
results agree with dissolution trends noted in the literature and are consistent with the
kinetic profiles observed for these nZnO formulations in nanopure water (Fig. S3.4 in ESI).
One limitation of the extracellular dissolution and intracellular free Zn2+ assays
discussed above is that they do not address zinc associated with cells as non-ionic
complexed forms of nZnO [17, 31, 41, 45]. To address this, an assay was developed to
isolate intact cells and subsequently measure the total cell associated zinc including
nanomaterial attached to the outer membrane and all forms of intracellular zinc. Following

146

nZnO treatment, Jurkat cells were isolated from unbound nZnO by FACS sorting, and
equivalent numbers of cells mechanically lysed and chemically digested to ensure that any
zinc associated with the cells would be in an ionic form. Following filtration to remove
cellular debris, zinc concentrations were determined by ICP-MS. Additionally, control
experiments verified that the cell sorting procedure did not capture any un-associated
nanomaterial. At 4 hours, the cell-associated zinc varied with no significant trends apparent
amongst the synthesis methods or particle morphology (Fig. 3.5). By 24 hours, a few
patterns emerged. First, within the wet chemical synthesis group, the amount of cellassociated zinc follows the inverse trend observed for cytotoxicity. Specifically, the most
toxic NPs (DEG) contained the least cell-associated zinc while the least toxic formulation
in that group (NaOH) had the most. This pattern was mirrored in nZnO samples created
using high temperature conditions (>1000 °C) including the FSPS, FSPR, SiO2-FSPR and
bulk samples. Of interest are the observed inconsistencies between the intracellular free
zinc data (Fig. 3.4) and cell-associated zinc experiments (Fig. 3.5). One might expect that
NP formulations with higher amounts of intracellular free zinc would also contain higher
amounts of cell-associated zinc; however, the opposite was found to be true.
It is evident from the extracellular, intracellular and cell-associated Zn2+
measurements, that there are other zinc species contributing to the cell-associated levels
other than intracellular free zinc. Since nZnO readily aggregates into amorphous
precipitates containing nZnO, mixed phosphate/carbonate phases and serum proteins
within the extracellular environment [77-79], it is probable that large amounts of zinc will
attach to or enter cells in non-ionic zinc forms. To characterize the nature and composition
of these forms, FTIR and XPS analysis was employed. FTIR analysis of agglomerates
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isolated from cellular media demonstrated the time-dependent evolution of these
amorphous precipitates (Fig. S3.5 in ESI and Fig. 3.6(a)) through the disappearance of
peaks associated with the surface adsorbed groups and the appearance of the amide I
vibrational mode at 1651 cm-1 indicative of bound serum proteins or crystalline water [8082]. Furthermore, the development of zinc phosphate is evidenced by the broad band
convolution of phosphate bending and stretching modes at 1031 cm-1 and phosphate
shoulder peaks between 502 and 637 cm-1 [44, 80, 83, 84], whereas complexed carbonate
phases are evidenced by the vs(CO32-) anion and the C-O stretching modes at 1405 cm-1
and 1535 cm-1, respectively [43, 85]. XPS confirmed these compositional changes with the
atomic additions of nitrogen and phosphorous and increases in the relative intensity of
carbon and oxygen observed in the survey spectra (Fig. S3.7 in ESI). In addition, the single
Zn2P3/2 peak present at 1021.6 eV in the as-prepared samples was replaced by two peaks
due to a chemical shift consistent with a Zn-P peak overlapping with the Zn-O peak with
an approximate difference of +2-eV (Fig. 3.7(d)).
To quantify the intensity variations observed between the different formulations,
the ratio of crystalline nZnO to the amount of phosphate in the precipitates (ZnO/PO43-)
was determined by calculating the integrated area ratio of the nZnO peak to the broad
phosphate band at 1031 cm-1 (Fig. 3.6). Since the broad peak from ~ 350 – 700 cm-1 is no
longer solely representative of pure ZnO vibrational modes, peak deconvolution was
employed to separate the integrated area associated with phosphate species from that of
pure nZnO vibrational modes (Fig. 3.6(b & c), Fig. S3.6 and Table S3.3 in ESI).
Interestingly, the area ratios (black spheres in Fig. 3.7(a & b)) increased as the amount of
cell-associated zinc increased and mirrored the geometric trend established with the cell-
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associated zinc levels. As corroboration, calculated Zn/P ratios obtained from XPS survey
spectra atomic concentrations, (white triangles in Fig. 3.7(a & b)) were generally consistent
with the ZnO/PO43- values obtained from the FTIR experiment. A notable exception was
the Zn/P ratio obtained for SiO2-FSPR nZnO sample which was negligible in comparison
to the ZnO/PO43- ratio. Considering the slow dissolution kinetics of the SiO2-FSPR nZnO
in cellular media, any agglomerates formed will likely have high protein content with lower
zinc phosphate/carbonate formation thus resulting in the observed zinc and phosphate
values below the detection limit (<0.1 %).
Qualitative evidence of the FTIR and XPS results can be seen in the high resolution
TEM images collected on the precipitates (Fig. S3.8 - Fig. S3.15 in ESI). Agglomerates of
crystalline nZnO, confirmed by the lattice fringes observed in the high-resolution images,
can be seen embedded in an organic matrix within all the nZnO and control samples.
Furthermore, the more soluble nZnO formulations (DEG and EG) contained smaller, more
porous nZnO aggregates with larger amounts of visible amorphous material compared to
the denser ZnO agglomerates observed in less soluble samples. Additionally, the FSPR and
SiO2-FSPR formulations retained much of their rod-shaped morphology even up to 24
hours. Taken with the ZnO/PO43- and Zn/P calculations, these observations suggest that
large increases in cell-associated zinc can be attributed to non-ionic zinc complexes.
Dosimetry
Increasing nZnO agglomerate size results in many downstream effects including
decreased dissolution, increased sedimentation, and changes in the overall dosimetry of the
NPs [86]. The in vitro sedimentation, diffusion and dosimetry (ISDD) computational
model [61] was employed to determine the fraction of nanomaterial (in µg) that is deposited
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onto an adherent cell layer for a given time frame. Figure 3.8(a) demonstrates that
formulation-specific differences exist in the amount of nZnO deposited over 30 hours with
differences likely due to stronger sedimentation effects exerted by nZnO with large
hydrodynamic diameters (Table 3.1 and Fig. 3.8(b)). The deposition differences at 24 hours
when plotted with the hydrodynamic diameters of the NPs illustrated this connection (Fig.
3.8(b)). It is noteworthy that the geometric trend observed for these measurements was
nearly identical to that observed for the cell-associated trend (Fig, 3.5 and Fig. 3.7). The
SSA measurements obtained by BET were also plotted in Fig 3.8b to evaluate potential
connection between dosimetry, hydrodynamic diameter and SSA. No clear patterns,
however, were observed between these measures. While hydrodynamic diameter appears
to correlate strongly to both dosimetry and cell-associated zinc in this study, there are
cautions that need to be considered with the discussion of hydrodynamic size. One common
artefact is the possible presence of very large agglomerates which may mask the detection
of smaller agglomerates in the dispersion thus skewing the average hydrodynamic
diameter. Additionally, agglomerates with a loosely packed open structure, allowing for
exposed NP surface area within the agglomerates, may alter NP dissolution kinetics or
mass transport in unpredictable ways. Despite these potential artefacts, hydrodynamic
diameter appears to be a significant variable in NP-induced toxicity, but should be
considered as part of a broader characterization protocol including BET, TEM and
dosimetry measurements.
Principal Component Analysis
Given the highly correlated and complex nature of our multivariate data set, 2D
principal component analysis (PCA) was used to determine if the individual formulations
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could be quantitatively separated based on their material properties. The 2D analysis
identified two statistically independent principal components (PCs) that accounted for
74 % of the observed experimental variability. From the table (Fig. 3.9(a)), the individual
experimental factors appear to be grouped by their contribution to either oxidative stress
responses (PC1; 51 %) or agglomeration potential (PC2; 23 %). At first glance, the
inclusion of photocatalysis with PC2 appears anomalous; however, increasing aggregation
behavior decreases photon absorption leading to fewer electron-hole pairs and less ROS
generation [87]. Qualitative groupings based on similar component scores (colored ellipses
in Fig. 3.9(b)), revealed some interesting patterns. Not surprisingly, the bulk sample (purple
ellipse) scored high for PC1 given its large hydrodynamic sizes and cell-associated zinc
values. Whereas the SiO2-FSPR formulation (pink ellipse) associated negatively with both
PCs due to decreased dissolution potential, ROS production, aggregation potential and
photocatalytic activity. Amongst the uncoated nanosized samples, the most toxic samples,
DEG and EG (yellow ellipse), scored positively for both PCs and is likely a consequence
of high intracellular Zn2+ levels, stronger surface reactivity and faster photocatalytic
activity. In contrast, the other samples (blue ellipse), with lower toxicity, demonstrate less
surface reactivity thus lowering their oxidative stress contributions.
Discussion
This work sought to expand upon previous results demonstrating the importance of
synthesis method in modulating surface reactivity, NP-induced toxicity and oxidative
stress [25]. The goal of this research was two-fold: 1) to thoroughly characterize the surface
reactivity, and dissolution potential of the nZnO panel and 2) identify the relative
contributions of these material properties in NP-induced toxicity and oxidative stress. Upon
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assessing the toxicity of the nZnO panel against Jurkat leukemic and primary CD4+ T cells,
it was observed that NPs synthesized through wet chemical methods imparted greater
toxicity to both cell types than those synthesized using FSP methods (Fig. 3.1). Several
possible scenarios may explain these discrepancies.
First, the dissolution kinetics are remarkably different amongst the nZnO
formulations. The more toxic samples demonstrate faster dissolution kinetics within the
extracellular environment (Fig. 3.4). Consequently, these nZnO exhibit decreased
agglomeration potential (Table 3.1) and increased intracellular zinc levels (Fig. 3.4). In
comparison, as the toxicity of the nZnO formulations decreased, the kinetic balance shifted
from extracellular dissolution towards more agglomerate formation and the cellular
adherence of large amounts of non-ionic zinc as evidenced by the cell-associated zinc (Fig.
3.5 and 3.7) and dosimetry (Fig. 3.8) data. Ultimately, both extracellular and cellassociated zinc contribute to increased levels of intracellular free zinc and disruption of the
zinc homeostasis of the cell [13, 28, 29, 66]. However, identifying the source of
intracellular free zinc levels can be difficult. One proposed mechanism is that large pools
of extracellular ionic zinc that are liberated from the nZnO are taken up by the cell [32, 41,
42]. This hypothesis is consistent with our extracellular/intracellular zinc data. While these
results suggest that rapid increases in extracellular free zinc give rise to corresponding
increases in intracellular free zinc, our experiments cannot definitively verify this
correlation. Indeed, it is highly probable that some of the intracellular zinc levels observed
may result from dissolution of non-ionic zinc intracellularly [17, 18, 28, 29, 31, 88], which
would occur more rapidly for smaller nZnO agglomerates. Alternatively, studies have also
shown that increased intracellular zinc in cells treated with highly toxic nZnO [13, 28, 89-
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91] results from disruption of cellular membranes by lipid peroxidation or by nZnO
translocation into the cell [13, 28, 80-82].
Secondly, the variable synthesis methods resulted in differing surface reactivity.
The hydrolysis based synthesis methods used here are known to produce NPs with multiple
defects such as oxygen vacancies and interstitial zinc and oxygen atoms [92]. Additionally,
singly and doubly ionized oxygen vacancies give rise to higher overall positive charge
through increased OH surface absorption and excess Zn2+ [25, 93]. The presence of these
synthesis method induced defects is validated through the high positive surface charge
(Table 3.1 and Fig. S3.3) and faster photocatalytic rates (Fig. 3.3) observed for the wet
chemical formulations and the direct correlation of this surface reactivity to the toxicity
and ROS findings. (Fig. 3.1 and 3.2).
Dissolution kinetics and surface reactivity are often viewed as competing
mechanisms for NP-induced toxicity. We contend, however, that these processes work
concurrently as suggested by the principal component analysis. The PCA reduced the
complexity of this data into two statistically independent principal components (PC1 and
PC2) (Fig. 3.9). The first PC represents the material properties that are direct contributors
of oxidative stress; specifically, increased ζ-potentials, extracellular and intracellular
dissolution, and cellular mitochondrial superoxide production. The second PC was more
representative of agglomeration potential, with strong contributions coming from
hydrodynamic size and cell-associated zinc. Regression analysis of the IC50 values for
Jurkat cells as a linear function of PC1 and PC2 revealed that both PCs contribute
significantly to the model (p < 0.05; Table S3.2 in ESI).
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As the model suggests, PC1 (oxidative stress contributors) increases the NPinduced toxicity; while PC2 (agglomeration potential) works to decrease these effects.
Additionally, PC score associations also appear to be related to the synthesis method
employed, as two of our most toxic wet-chemically synthesized formulations (yellow
ellipse in Fig. 3.9(b)), aligned strongly with PC1 when compared to less toxic samples. The
following mechanistic scenario described below highlights the synergistic contribution
from the two PCs. In the more toxic samples (higher PC1 vs PC2 scores), it is possible that
the higher positive surface charges (aligned with PC1) for the wet chemical samples results
in increased electrostatic interactions with both anionic lipids and protein domains,
potentially leading to increased nZnO uptake and increases in the total intracellular zinc.
Additionally, nZnO with intrinsic surface defects have higher ROS generating capability
abiotically allowing for increased lipid peroxidation and passive cellular uptake. Once
internalized, interactions between a more reactive formulation of nZnO and various cellular
components would lead to heightened ROS generation and increased oxidation events
within the cell. As for PC2 contributions, the smaller agglomerate sizes increase the
extracellular dissolution potential and decrease non-ionic complex formation. A
combination of zinc transporters and fluid phase pinocytosis pulling in larger amounts of
free zinc, can elevate intracellular free zinc levels directly from liberated free zinc within
the media [28-30, 94]. This scenario demonstrates that while these PCs are statistically
independent, they are not mutually exclusive. Even the most toxic of the nZnO
formulations exhibited agglomeration and sedimentation potential and measurable cellassociated zinc (PC2), however those variables associated with PC1 were more influential
in the toxic response.
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Conclusions
Identifying the physicochemical properties that most influence NP-induced toxicity
has been a challenging endeavour in nanotoxicology. This investigation sought to resolve
this question by evaluating a diverse panel of pristine nZnO samples. Through extensive
analysis and mathematical modelling, two consistent sets of properties emerged as strong
contributors to cytotoxicity. The first set of variables relating to surface reactivity,
extracellular and intracellular Zn2+ dissolution, and oxidative stress responses has long
been suggested as the primary mechanistic contributor to NP-induced toxicity. The second
set (agglomeration tendencies, non-ionic zinc complexes and cell associated zinc levels)
has also been implicated, but to a lesser degree. Collectively, our experimental results and
the PCA model suggest that both sets of experimental variables contribute to nZnO
cytotoxicity. Additionally, these findings suggest that the NP fabrication method employed
results in differential material properties and resulting cellular responses. Wet chemically
synthesized nanomaterials demonstrate increased surface reactivity and dissolution
potential and decreased agglomeration potentially leading to the uptake of large amounts
of non-ionic zinc complexes. Given that disruption of cellular zinc homeostasis and cell
death will occur at a critical level of internalized zinc regardless of the NP formulation
employed, other toxic mechanisms, such as surface reactivity, are likely responsible for the
differential toxicity observed in our samples. This underscores the need for additional
studies to evaluate how changes to specific NP physicochemical properties alter cellular
uptake mechanisms, genotoxicity, apoptosis, and ROS-mediation pathways.
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Tables and Figures

TOC 3.1
nZnO synthesis approach results in unique surface chemistries which
influence agglomeration tendencies, dissolution potential, oxidative stress responses
and NP-induced toxicity.
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Schematic 3.1

Illustration depicting the nZnO dissolution processes and
interactions with cells after NP treatment.
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Table 3.1
Physical properties of ZnO formulations measured via TEM, BET,
UV-Vis, and DLS. Wet chemically and FSP synthesized formulations are shaded
green and blue, respectively, while the control samples are indicated with the dark
grey. The average size values are based on a minimum of 100 measured NPs on
TEM images. The hydrodynamic diameters were determined by measuring the
number of particles within each size bin in the histogram distribution.
ζ-Potential (mV)a
Formulation
(Band Gap; eV)

Average
Size
(nm)

Specific
Surface
Area (m2/g)

Water

Media (4 h)
(24 h)

DEG
(3.36)
EG
(3.36)
EtOH
(3.36)

33  7

34.5

29.7  0.19

29  5

22.5

27.6 ± 0.37

16  2

67.1

23.0 ± 0.25

38

18.9 ± 0.18

25

18.9 ± 0.18

41.0

17.8 ± 0.12

55.0

-44.1 ± 0.23

1.25

7.23 ± 2.84

NaOH

L: 79  25

(3.31)

W: 21  5

FSPS
(3.38)

43  10

FSPR

L: 94  24

(3.38)

W: 26  5

SiO2-FSPR

L: 106 
19

(3.39)
Bulk
(3.39)

W: 30  8
852  350

-5.71  0.49
-6.80  0.85
-5.58  0.85
-6.68  0.46
-5.86  0.90
-6.69  0.48
-6.28  0.34
-6.89  0.11
-6.11  0.72
-6.53  0.65
-6.29  066
-6.36  0.70
-1.45  0.46
-6.18  0.50
-6.67  0.39
-6.30  0.23

Hydrodynamic
Diameter
(Media)
(nm)

221.7 ± 14.16

544.9 ± 120

630.4 ± 32.5

623.2 ± 128

227.2 ± 15.6

669.7 ± 119

148.0 ± 1.26

2039.5 ± 137.7

The pH values of the nZnO dispersions varied from 7.5 – 7.7 for all dispersions used for ζ-Potential
measurements.
a
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Figure 3.1
NP-induced toxicity values for (a) Jurkat leukemic cell and (b) normal
primary CD4+ T cell viability at 24 hours after treatment with the wet chemical
method (green bars; wet), flame spray pyrolysis (blue bars; FSP) nZnO formulations
and the SiO2-FSPR and bulk controls (black bars; control). The white labels on the
histogram bars depict the IC50values obtained for the indicated sample. The
histogram bars were ordered from lowest to highest IC50 for both cell types to depict
the synthesis method trends observed for the NP-induced toxicity. Cultures were
treated concurrently with varying concentrations of nZnO dispersed in nanopure
water/RPMI for 24 hours and cell viability was evaluated (means ± standard error,
minimum of n = 3) using Alamar blue staining (Jurkat Cells) or flow cytometry with
PI staining (CD4+ T cells). Statistical analysis was performed using repeated measures
analysis of variance and model-based means post hoc test (p < 0.05) with differing
letters denoting statistical significance. Linear contrast models were used to
determine statistical significance between the wet chemical, flame spray pyrolysis and
control samples.
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Figure 3.2
nZnO samples generated ROS in a formulation-dependent manner.
Mitochondrial superoxide generation by all nZnO at 24-hour post treatment with 32.4
µg/mL ZnO using flow cytometry and MitoSox™ Red staining. Statistical analysis
was performed using repeated measures analysis of variance and model-based means
post hoc test (p < 0.05) with differing letters denoting statistical significance.

171

Figure 3.3
Surface property characterization for the powered samples ((a) and
(b)). and catalytic activity plots ((c) and (d)) depicting the UV/Vis monitored
fluorescence of the model sulfo-Rhodamine B dye and the average dye degradation
kinetic values obtained for the evaluated treatment conditions. FTIR spectra for (a)
wet chemical synthesis methods, and (b) heat treatment methods illustrate the peaks
observed and the corresponding wavenumber values. The graph in (c) is
representative of the time-dependent plots obtained and demonstrate the
photocatalytic decomposition of sulfo-Rhodamine B dye in nanopure water after
treatment with EG NPs. The histogram in (d) depicts the average catalytic rate
constants (k, min-1) for the nZnO and control samples. Statistical analysis in (d) was
performed using repeated measures analysis of variance and model-based means post
hoc test (p < 0.05) with differing letters denoting statistical significance. Histogram
bars represent n=3 replicates with error bars indicating s.e.
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Figure 3.4
nZnO formulations display similar dissolution kinetic trends in cellular
media at 4 and 24 hours. Extracellular (EC) Zn2+ concentrations (µg/mL) measured
via ICP-MS (bars and left y-axis) and intracellular Zn2+ concentrations measured via
flow cytometry and expressed as mean fluorescence intensity (MFI) of the zinc
specific dye FluoZin-3 AM (line graphs and right y-axis) evaluated at 4 hours (top
graph) and 24 hours (bottom graph). Control samples, designated as the left most bar
or line graph symbol were RPMI-based cellular media (EC assay) and NT cells
(Intracellular (IC) assay). Statistical analysis was performed for the extracellular zinc
measurements (histogram bars) using repeated measures analysis of variance and
model-based means post hoc test (p < 0.05) with differing letters denoting statistical
significance. Histogram bars or line graph circles represent the average of n = 4
replicates with error bars depicting s.e.

173

Figure 3.5
Cell-associated (CA) Zn2+concentrations (µg/L) measured at 4 and 24
hours via ICP-MS. A control sample designated as the left most grey bar, were nontreated cells grown in cellular media. Statistical analysis was performed using
repeated measures analysis of variance and model-based means post hoc test
(p < 0.05) with differing letters denoting statistical significance. Histogram bars
represent the average of n = 4 replicates with s.e. error bars.
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Figure 3.6
Representative samples highlighting the FTIR region from 1800 to 350
-1
cm and the ZnO peak deconvolution. The figure includes (a) FTIR spectra from
1800 to 350 cm-1 for the EG nZnO sample at 4 hours (blue) and 24 hours (red) and
peak deconvolution of the broad FTIR band from 750-350 cm-1 for the EG nZnO
sample at (b) 4-hour and (c) 24-hour time points. Samples were introduced to cellular
media at a concentration of 32 µg/mL and incubated for the indicated time points.
After incubation, the dispersions were centrifuged and the precipitate retained and
dried overnight at 60 °C.
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Figure 3.7
The integrated area ratio of ZnO to PO43- from the FTIR spectra and the atomic concentration ratio of Zn/P
from the XPS survey spectra of the insoluble zinc amorphous precipitates isolated from nZnO dispersions in cellular media post
incubated for 4 and 24 hours. The left-hand side of the figure represents the integrated area ratio of ZnO to PO43- from the FTIR
spectra (line graphs with circles and first right y-axis) and the atomic concentration ratio of Zn/P from the XPS survey spectra
(line graphs with tringles and second right y-axis) evaluated at (a) 4 hours and (b) 24 hours. The faded histogram bars
represented the CA zinc results presented in Fig. 3.5 and are included for reference. The right-hand side of the figure represents
the XPS spectra from 1027eV to 1018.5 eV illustrating the deconvolution of the Zn2p 3/2 peak for the (c) EG nZnO as prepared
sample and the (d) EG nZnO in cellular media at the 4-hour time point.

Figure 3.8
The time-dependent deposition nZnO onto the bottom of a well in a 96-well culture plate as determined by ISDD
dosimetry modelling for the individual nZnO formulations. The total amount of nZnO introduced to the cellular media was 6.48
µg (32.4 µg/mL introduced into 0.2 mL of RPMI-based cellular media). The curves in (a) represent the calculated nZnO
deposition over a 30-hour period. The histogram bars (left y-axis) in (b) demonstrate the modelled concentration of nZnO
deposited at the 24-hour time point with the half white/half black circles (firs right y-axis) correlating to hydrodynamic size and
the red triangles (second right y-axis) representing the specific surface area (SSA) as measured by BET. Error bars in (b)
represent s.e. with n = 3 replicates.
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(a)

(b)
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Figure 3.9
PCA model-generated values for both PC1 and PC2 and a graphical representation of the PC scores and Jurkat
cells IC50 values for each evaluated sample. The table in (a) represents the loading values (x 100) for each measured variable,
eigenvalues and the percent variation explained for each PC. The indicated abbreviations refer to hydrodynamic size
(hydrosize), intracellular zinc [IC Zn2+], cell-associated-zinc [CA Zn2+], and extracellular zinc [EC Zn2+] concentrations. The
green cubes (wet chemical methods), blue spheres (FSP method) and black tetrahedrons (controls samples) depicted in the 3D
graph in (b) represent PC1 scores versus IC50 values versus PC2 scores. The colored ellipses denote sample grouping based on
similar PC1 and/or PC2 scores.
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Electronic Supplementary Information
XRD, XPS and TEM Images
XRD (Fig. S3.1(a) and (b)), TEM (Fig. S3.1(c) through Fig. S3.1(j)) and XPS (Fig.
S3.2) and were performed to verify the crystal structure, chemical composition, average
size and morphology of the NP samples.
Cellular Toxicity
Table S3.1 includes IC50 values for the Jurkat leukemic cells and the primary CD4+
T cells (see Fig. 3.1) expressed in millimolar concentration units. Also included is the
calculated therapeutic index for each nZnO formulation.
Dissolution Kinetics for Nanopure Water Stock Solutions
Prior to conducting experiments with cells, we first investigated the kinetic
behavior of the panel of nZnO formulations in nanopure water at concentrations identical
to the NP stock solutions used in biological assays. Nanopure water dispersions containing
486 µg/mL of each ZnO formulation were prepared and stirred continuously at room
temperature for a total of 24 hours. At several time points, individual aliquots were
extracted and prepared for analysis with ICP-MS. The results of this analysis can be seen
in Fig. S3.4. All the samples exhibit similar kinetic behavior throughout most of the
experimental time frame. The kinetic pattern generally suggests that the dissolution rate of
the NPs is faster from 0.5 to 6 hours and then decreases gradually as the process approaches
a dynamic equilibrium. Additionally, this data directly correlates with the measured
hydrodynamic sizes of the NP agglomerates in water (R2 = 0.88) validating experimental
evidence for the dependence of measured Zn2+ concentration on hydrodynamic size. While
these results cannot be used to make inferences as to dissolution kinetics of the nZnO under
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biological assay conditions, these results confirm that at early time points, dissolution of
all nZnO samples demonstrate similar kinetic behavior.
FTIR and FTIR Peak Deconvolution
For this assay, the evaluated samples were incubated in RPMI-based cellular media
at a concentration of 32.4 µg/mL and sampled at 4 and 24 hours. Post incubation, the
resulting precipitate was isolated and dried overnight. Figure S3.5 illustrates the vibrational
modes present for all samples at 4- and 24-hours. The graphs in Fig. S3.6 represent the
deconvolution of the broad ZnO band present at approximately 350-700 cm-1 for all
samples at the 24-hour time point. To eliminate zinc phosphate peak overlap with zinc
oxide normal modes (Table S3.3), only those peaks identified below 500 cm-1 were
included in the ratio of crystalline ZnO to phosphate (ZnO/PO43-) calculations. Likewise,
only the integrated area of the broad phosphate band at 1031 cm-1 was considered in the
ratio to eliminate any interference from ZnO in the phosphate determinations.
XPS Spectra of Samples in Cellular Media
XPS was used to confirm the chemical compostion for all samples post incubation
in cellular media for 4 and 24 hours (Fig. S3.7). Survey spectra illustrated the presence of
zinc, oxygen, nitrogen, carbon and phosphorous in all samples. The SiO2-FSPR sample
also contains silica as expected.
TEM
The following figures, (Fig. S3.8 through Fig. S3.15), represent low and high
resolution TEM images obtained for the samples described above in the FTIR section. Low
resolution images revealed that large nZnO agglomerates (darker areas) were surrounded
by an organic matrix. The higher resolution scans provided confirmation that the darker
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regions of the TEM images were composed of primarily crystalline ZnO due to the
presence of observed lattice fringes representing the individual planes of the ordered ZnO.
Principal Component Analysis
Table S3.2 describes the results of the linear contrast model predictions for Jurkat
cells IC50 as a function of PC1 and PC2.
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Tables and Figures – Electronic Supplementary Material

Figure S3.1 Crystal phase composition, size and morphology characterization for
nZnO NPs. XRD spectra for (a) nZnO synthesized through wet chemical synthesis
methods and (b) nZnO synthesized through flame spray pyrolysis (FSP) synthesis
methods. TEM images for (c) DEG, (d) EG (e) EtOH, (f) NaOH, (g) FSPS, (h) FSPR,
(i) SiO2-FSPR and (j) bulk samples were used to identify morphology and average NP
size and distribution.
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Table S3.1 The Jurkat and primary CD4+ T cell IC50 values converted to
millimolar (mM) concentrations and the calculated therapeutic index.

Therapeutic Index

Jurkat Cell

Primary T Cell

IC50 (mM)

IC50 (mM)

DEG

0.26

4.0

16

EG

0.45

5.8

13

EtOH

0.52

6.3

12

NaOH

0.60

18.4

30

FSPS

0.77

22.7

30

FSPR

1.07

30.9

29

SiO2-FSPR

2.10

30.9

15

Bulk

13.07

30.9

2

Formulation

(

𝑇 𝑐𝑒𝑙𝑙 𝐼𝐶50
)
𝐽𝑢𝑟𝑘𝑎𝑡 𝑐𝑒𝑙𝑙 𝐼𝐶50
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Figure S3.2

XPS survey scans for all tested powder samples
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Figure S3.3 IC50 (µg/mL) values plotted as a function of the nZnO zeta potential
(mV) in aqueous conditions depicting the linear correlation between the two measures
variables for wet chemical and FSP synthesized nZnO.
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Figure S3.4 Dissolution kinetics for nanopure water dispersions for all tested
formulations
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Figure S3.5 FTIR spectra obtained for the amorphous precipitate material
retained at the 4-hour [(a) and (c)] and 24-hour [(b) and (d)] time points. Samples
were introduced to cellular media at a concentration of 32 µg/mL and incubated for
the indicated time points. After incubation, the dispersions were centrifuged and the
precipitate retained and dried overnight at 60 °C.
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Figure S3.6 FTIR peak deconvolution results for all powdered samples post
incubation in cellular media for 24 hours. Each graph is labeled with the sample name
with legend numbers corresponding to the peak position (in nm) for each identified
peak during the deconvolution process.
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Figure S3.7 XPS survey scans for all tested samples incubated in cellular media for
(a) 4 hours and (b) 24 hours.
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(a)

(b)

(c)

(d)

Figure S3.8 Low (a) and (c) and high (b) and (d) resolution TEM images for the
DEG sample precipitates isolated from RPMI-based cellular media at (a) and (b) 4hour and (c) and (d) 24-hour time points.
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(a)

(b)

(c)

(d)

Figure S3.9 Low (a) and (c) and high (b) and (d) resolution TEM images for the EG
sample precipitates isolated from RPMI-based cellular media at (a) and (b) 4-hour
and (c) and (d) 24-hour time points.
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(a)

(b)

(c)

(d)

Figure S3.10 Low (a) and (c) and high (b) and (d) resolution TEM images for the
EtOH sample precipitates isolated from RPMI-based cellular media at (a) and (b) 4hour and (c) and (d) 24-hour time points.
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(a)

(b)

(c)

(d)

Figure S3.11 Low (a) and (c) and high (b) and (d) resolution TEM images for the
NaOH sample precipitates isolated from RPMI-based cellular media at (a) and (b) 4hour and (c) and (d) 24-hour time points.
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(a)

(b)

(c)

(d)

Figure S3.12 Low (a) and (c) and high (b) and (d) resolution TEM images for the
FSPS sample precipitates isolated from RPMI-based cellular media at (a) and (b) 4hour and (c) and (d) 24-hour time points.
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(a)

(b)

(c)

(d)

Figure S3.13 Low (a) and (c) and high (b) and (d) resolution TEM images for the
FSPR sample precipitates isolated from RPMI-based cellular media at (a) and (b) 4hour and (c) and (d) 24-hour time points.
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(a)

(b)

(c)

(d)

Figure S3.14 Low (a) and (c) and high (b) and (d) resolution TEM images for the
SiO2 – FSPR sample precipitates isolated from RPMI-based cellular media at (a) and
(b) 4-hour and (c) and (d) 24-hour time points.
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(a)

(b)

(c)

(d)

Figure S3.15 Low (a) and (c) and high (b) and (d) resolution TEM images for the
Bulk sample precipitates isolated from RPMI-based cellular media at (a) and (b) 4hour and (c) and (d) 24-hour time points.
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Table S3.2

Linear regression model for IC50 as a linear function of PC1 and PC2.
Term

Estimate (S.E.)2

Intercept

-0.11 (0.05)

PC1

-0.64 (0.08)

PC2

0.48 (0.07)

1

Overall model for IC50 as a linear function of PC1 and PC2 is statistically significant

(F2, 21 = 39.91, p < 0.0001) with 24 observations and is presented as:
𝑱𝒖𝒓𝒌𝒂𝒕 𝑰𝑪𝟓𝟎 = −𝟎. 𝟏𝟏 − 𝟎. 𝟔𝟒(𝑷𝑪𝟏) + 𝟎. 𝟒𝟖(𝑷𝑪𝟐)

2

All statistically significant at p < 0.05
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Table S3.3
Identified FTIR peaks for the 24-hour precipitate analysis after deconvolution of the broad ZnO band (350-750
-1
cm ) including the possible peak assignment and reference
DEG

EG

EtOH

397
417

415

NaOH

FSPS

FSPR

SiO2-FSPR

Bulk

Peak Assignment

Reference

390

403

400

405

398

A1(TO)

[1-3]

424

426

426

432

426

E1(TO)

[1-6]

E2 high (Raman)

[2, 3, 6]

Lower surface phonon

[4, 6]

Zn-O vibrational mode

[7-11]

502

v4 phosphate mode

[12]

539

v4 phosphate mode

[12]

v4 phosphate mode

[12]

v4 phosphate mode

[12]

449

444
460

497

460
500

520

507

519

551

553

551

482

463

480

494
516
557

559

538
595

629

623
700

624

614

637

621

700

701

629

630

C-H bending
682

Si-H

[13]

775

O-C rocking

[14]

816

Si-O-Si bending

[15]

882

Si2O3

[16, 17]
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CHAPTER 4

CELLULAR TRANSCRIPTOME RESPONSES IN JURKAT

LEUKEMIC AND PRIMARY CD4+ T CELLS FOLLOWING ZNO
NANOPARTICLE TREATMENT

Introduction
Cancer, known as a condition of uncontrolled cell differentiation, has major impact
globally. In 2016, it was estimated that 1.6 million new cancer diagnoses would be made
in the United States alone with approximately 600,000 mortalities [1]. For decades,
preferred treatments have included chemotherapy, radiation and surgery [2]. Significant
progress has been made in the past 25 years towards the development of effective
chemotherapeutic agents [2, 3]. Many challenges remain in controlling collateral damage
to normal healthy cells while selectively killing cancerous cells, such as limiting acquired
chemotherapy resistance in cancer cells and reducing undesirable side effects [4, 5]. Metalbased nanoparticles (NPs) have emerged as promising drug-delivery vectors to improve
drug solubility [4], increase drug payload at targeted tumor cells [6, 7], enhance bioimaging
[8-11] and mediate hyperthermia-induced toxicity [12-14]. Although many NP systems are
considered safe to biological systems [4], nZnO possesses an inherent natural toxicity
related to its material properties [15-17]. As such, considerable attention in nZnO research
over the past decade has focused on exploiting this inherent toxicity as a potential
chemotherapeutic treatment.
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Several research studies in the past decade have investigated the potential selective
toxicity of nZnO towards mammalian cancer cells when compared to their un-transformed
primary cell counterparts including glioma, breast, prostate and immune system cell types
[18-23]. Among these studies, zinc oxide NPs (ZnO NP), 6-8 nm in size, demonstrated a
preferential toxicity (IC50 of ~0.17-0.21 mM) towards cancerous T cells (28-35 fold
increase) while leaving normal quiescent T cells essentially unaffected [18, 23]. In contrast,
this NP-mediated selectivity towards immune system cancers appears to exceed ex vivo
therapeutic indices (<10) reported for chemotherapeutic agents, such as doxorubicin and
cisplatin, commonly used for the treatment of acute myeloid leukemia and non-Hodgkin's
lymphoma [24].
While multiple studies have demonstrated that nZnO NPs show preferential
cytotoxicity towards cancer cells, the exact mechanism of the selectivity remains
undetermined. Many potential hypotheses have been put forth to including both specific
nanomaterial properties associated with the nZnO core or surface composition, and nonspecific interactions relating to NP size and surface area-to-volume ratios [25]. The surface
structure of nZnO is strongly dependent upon the formation of an adsorbed neutral
hydroxide layer which influences the surface charge of the nZnO at neutral pH and the
formation of the biomolecular corona [26, 27]. nZnO has an isoelectric point at a pH of
~9.5 which leads to a cationic surface potential at neutral pH which would increase
electrostatic interactions between the nZnO and the anionic cellular membranes of cancer
cells [28]. Additionally, the biomolecular corona formation partially determines the
biological character of NP agglomerates, adhesion to cellular membranes and potential
cellular uptake mechanisms [29-31]. Furthermore, these surface changes influence the

203

solubility of nZnO agglomerates in both the extracellular environment and intracellular
compartments. Internalized extracellular zinc or the release of soluble zinc ions within the
cell contribute to signaling cascades that may contribute to the toxic response [22, 32].
Additionally, it has been shown that nZnO undergoes rapid preferential dissolution in
acidic cancer microenvironment leading to oxidative stress, mitochondrial damage and cell
cycle arrest proceeding cell death [22].
In addition to the differential effects imparted by nZnO material properties, specific
cellular mechanisms have also been suggested as contributing factors in this selective
toxicity. One proposed cellular mechanism implicates the differential reactive oxygen
species (ROS) production observed in proliferating cancerous cells compared to primary
cells [18, 19, 33, 34]. Since cancerous cells are known to express higher amounts of ROS
and ROS-associated signaling proteins due to their increased metabolism [35], exposure to
low concentrations of nZnO significantly increases cellular ROS production inducing rapid
cell death [32]. On the other hand, in normal cells basal levels of ROS are much lower with
fewer available signaling molecules available to ramp up ROS production in response to
external stressors. Thus, the level of ROS induced by nZnO treatment in primary cells may
be insufficient to cause cell death [35].
The goal of this study was to investigate whether the preferential nZnO toxicity
observed in Jurkat leukemic and primary CD4+ T cells results from differential
transcriptional regulation of cellular processes. Since zinc is a necessary component of
many critical cellular processes, excess zinc could have deleterious effects on cellular
function. Towards this end, the gene expression of Jurkat leukemic and primary CD4+ T
cells was evaluated using Illumina’s Human HT-12 BeadChip arrays microarray to
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determine how nZnO treatment differentially modulates the transcriptome in a manner that
could explain the discordant cytotoxicity observed between these cells. Using Ingenuity
Pathway Analysis (IPA), differential gene and signaling pathway regulation were
evaluated to discern possible transcriptome contributions to the differential toxicity.
Microarray platforms facilitate the analysis of numerous genes simultaneously and the
identification of potential transcriptional regulators of NP-induced toxicity. To date, our
results have identified several key groups of gene transcripts, including proteins
responsible for zinc sequestration and transport, oxidative stress and cell death signaling
molecules, inflammatory and stress response cytokines, metabolism proteins, and cell
cycle regulators that may be potentially involved in the cancer cell selectivity. Future
studies are needed to validate these preliminary findings including reverse transcription
polymerase chain reaction (RT-PCR) to verify mRNA expression levels, western blotting
to assess proteome changes, and ultimately studies involving gain or loss of function.
Materials and Methods
Zinc Oxide Synthesis and Characterization
nZnO was fabricated using forced hydrolysis method. Briefly, a zinc acetate
precursor was added to a DEG solvent and the resulting mixture was heated while stirring
to approximately 80 °C. A desired amount of nanopure water was introduced and the
temperature increased to 150 °C for 90 minutes. The resulting colloid was then cooled to
room temperature and the NPs collected through centrifugation at 21,000 rpm, washed with
ethanol, and the resulting precipitate dried overnight at 60 °C. Prior to use in downstream
biological assays, the NPs were thoroughly characterized. A Rigaku Miniflex 600 X-ray
diffractometer using Rigaku PDXL analysis software version 1.8.0.3 was employed to
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collect XRD spectra and determine crystal structure and phase, lattice parameters, and
average crystalline size. Average particle size and morphology were obtained using a JEOL
JEM-2100 HR analytical transmission electron microscope. FTIR using a Bruker Tensor
27 spectrometer was used to evaluate surface structure and room-temperature optical
spectra in the ultraviolet and visible light wavelengths were collected using a CARY 5000
spectrophotometer to evaluate band gap and NP sedimentation. A Malvern Zetasizer
NanoZS was used to determine ζ-potential and hydrodynamic size, respectively. To
determine the isoelectric point (IEP), zeta potentials of the nZnO were measured in
nanopure water as a function of pH. The pH of the room temperature NP dispersion was
varied from a pH of 6 to a pH value of 12 using 1.0 N HCl and 1.0 N NaOH prior to
collecting the data. At least six data collections per run were performed on three separate
aliquots of the ZnO suspension for each sample.
Extracellular Dissolution
For extracellular dissolution experiments, nZnO stock dispersions were prepared as
previously described at 6 mM concentrations. To simulate cellular assay conditions, an
aliquot of each stock dispersion was added to cellular media at a final nZnO concentration
of 0.6 mM. All dispersions were stirred continuously to prevent nZnO sedimentation. At
desired time points, an aliquot of the sample was removed and centrifuged at 5,000 x g for
20 minutes using an Amicon™ Ultra-4 Centrifugal Filter Unit with a 3-Kd molecular
weight cutoff (0.1 nm pore size) to remove any undissolved nZnO while allowing free zinc
ions to pass through. Quantitative analysis of the dissolved Zn2+ ions was conducted on a
Thermo X Series 2 quadrupole inductively-coupled plasma mass spectrometer (ICP-MS)
under normal operating conditions (i.e., no CCT) with the Xt cone set. Instrument
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performance was evaluated and optimized for each run. The instrument was calibrated
using multi-element calibration standards containing Zn, Cr, Mn, Fe, Co and Ni in 2 %
HNO3 at concentrations of approximately 1, 10, 100 and 1000 ppb. Instrument drift was
monitored and corrected using 20 ppb indium as an internal standard introduced online.
Cell Culture and Toxicity Experiments
For this study, Jurkat leukemic and primary CD4+ T cell line were employed. Jurkat
leukemic cells (ATCC, Rockville, MD) were cultured in RPMI 1640 containing 10 mM
HEPES and supplemented with 10 % FBS, 1 % penicillin/streptomycin, and 2 mM Lglutamine per manufacturer’s recommendations. Cells were maintained in log phase and
seeded at a concentration of 5 × 105 cells/mL in a 96-well plate for viability assays. The
nZnO solutions were created by suspending the NPs in autoclaved nanopure water and
sonicated for 30 minutes using a power of 1.05 W to deliver a determined sonication energy
[36] of 181 J/mL to obtain stable nZnO dispersions [37]. Working stock dilutions were
prepared by introducing the NP stock to cellular media and vortex mixing for 30 seconds.
The NPs were then added to cells (5 x 105 cells/mL) and cultured for 6 and 24 hours at 37
°C and 5 % CO2. For the alamar blue metabolic assay, 10 % v/v alamar Blue was introduced
to cells 4 hours prior to the desired endpoint (e.g. at 20 hours after treatment with NPs for
24-hour assay) and incubated at 37 °C and 5 % CO2. The fluorescence intensity was then
determined at 24 hours by a Biotek Synergy MX plate reader using excitation/emission at
530/590 nm.
For CD4+ T cell viability experiments, written informed consent was obtained from
all blood donors and the University Institutional Review Board approved this study.
PBMCs (peripheral blood mononuclear cells) were obtained from healthy human blood

207

samples via Ficoll-Hypaque density centrifugation (Histopaque-1077, Sigma, St Louis,
MO), and CD4+ T cells isolated by negative immunomagnetic selection [18]. The purified
CD4+ T cells (>95 % purity) were cultured in RPMI medium with 10 % FBS at a
concentration of 1 x 106 cells/ml. CD4+ T cells were then incubated for 6 and 24 hours with
nZnO dispersions prepared as described above to establish an IC50. CD4+ T cells were then
stained and viability analyzed by flow cytometry. After the treatment period, cells were
washed with PBS and resuspended in FACS buffer (PBS/15 % FBS/0.02 % NaN3) and
stained with a FITC labeled anti-HLA ABC antibody (BD Biosciences, San Jose, CA).
Cells were subsequently washed, and stained propidium iodide (PI) to detect dead cells
using a BD FACS Calibur flow cytometer.
RNA Isolation
Total RNA was extracted from nZnO treated Jurkat leukemic and primary CD4+ T
cells using the RNeasy Kit (Qiagen, Inc, Valencia, CA) according to the manufacturer’s
protocol. Bleach gels and a Biotek Synergy MX® plate reader fitted with a micro-volume
analysis plate were employed to ensure the resulting RNA was free of contaminating
proteins and genomic DNA. Bleach gels were prepared according to the protocol published
by Arlanda et al. (2012) which involves the addition of 1.0 % v/v Clorox® bleach (e.g. 0.5
mL in 50 mL) into a 1.0 % w/v agarose solution in 1 x TAE buffer (e.g. 0.5 g in 50 mL)
[38]. The resulting mixture was heated in a microwave until the agarose had melted and
cooled prior to the addition of ethidium bromide to a final concentration of 0.5 μg/mL.
Solidified gels were submerged with 1 x TAE buffer and loaded with 1 µg total RNA with
a 1 x DNA loading buffer. The gels were run for 30 minutes at 100 V prior to imaging
under UV transillumination. Samples were considered acceptable if the bleach gels showed
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only minimal traces of genomic DNA and the absorbance ratio A260/A280 fell between
1.8 – 2.0. Additional testing was performed at the National Institute for Occupational
Safety and Health (NIOSH) in Morgantown, WV using an Agilent 2100 Bioanalyzer
(Agilent Technologies, Palo Alto, CA) to confirm RNA integrity (RIN>8) and
concentration. Acceptable samples were then combined to reduce biological variation and
increase the total amount of mRNA.
Microarray Analysis of Global Gene Expression Profile
The following analysis was performed at the National Institute for Occupational
Safety and Health (NIOSH) in Morgantown, WV. The global gene expression profile for
the isolated Jurkat and CD4+ RNA was obtained using Human HT-12_v3_BeadChip arrays
(Illumina, Inc, San Diego, CA) and experiments conducted in compliance with Minimal
Information About a Microarray Experiment (MIAME) protocols. An Illumina Totalprep
RNA Amplification Kit (Ambion, Inc.) was used to obtain biotin labeled cDNA followed
by Chip hybridizations, washings and Cy3-streptavidin staining. The Beadstation 500
platform (Illumina, Inc) was employed for chip scanning according to the manufacturer’s
protocol. Prior to loading into the Beadstudio (Framework version 3.0.19.0) Gene
Expression module v.3.0.14, metric files confirmed that the samples fluoresced at
comparable levels. Proper chip detection was verified using housekeeping, hybridization
control, stringency, and negative control genes. Illumina BeadArray expression data were
exported into flat files comprised of mean fluorescent intensity across like beads and bead
variance estimates and analyzed in Bioconductor. The microarray array was processed
using the ‘lumi’ Bioconductor package to obtain normalized and annotated expression data
followed by ‘limma’ package analysis to obtain FDR p values and log fold changes [39].
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Significantly differentially expressed genes (SDEG), to be used for subsequent analysis,
were selected based on fold change values (FC) > 1.5 and false discovery rate (FDR) pvalues < 0.05. Ingenuity Pathway Analysis (IPA, Ingenuity Systems, www.ingenuity.com)
was used for subsequent bioinformatics analysis.
Results
nZnO Characterization
Size, Morphology and Composition
Zinc oxide NPs were prepared using a forced hydrolysis method that has known
selective toxicity towards Jurkat leukemic cells when compared to primary CD4+ T cells
[18, 23]. Prior to use in downstream biologicals assays, the nZnO was thoroughly
characterized. X-ray diffraction revealed that the nZnO contained a wurtzite crystal
structure with no identifiable phase impurities (Figure 4.1A). Transmission electron
microscopy (TEM) confirmed the expected spherical morphology of the nZnO (Figure
4.1B). Additionally, size measurements from the resulting TEM images demonstrated that
the average NP to be 9.7 ± 0.3 nm. The atomic composition of the nanomaterial powder
was analyzed using x-ray photoelectron spectroscopy (XPS) and identified zinc, oxygen
and carbon species (Figure 4.1C).
Surface Structure Analysis
The forced hydrolysis method employed to synthesize the nZnO used in this study
is known to deposit surface-adsorbed functional groups, related to the synthesis
components, onto the NP surface [37, 40]. FTIR was utilized to identify these surfaceadsorbed components (Figure 4.2A). Evidence of the synthesis precursor (zinc acetate)
remnants was observed with the presence of the vs(COO-) and vas(COO-) carboxylic acid
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vibrational modes at 1412 cm-1 and 1591 cm-1, respectively [41-43]. The O-H bending
mode at 910 cm-1 and the v(C-OH) mode at 1076 cm-1at [42, 43] could also be secondary
to the synthesis precursor or molecular fragments remaining from the DEG reaction solvent
[40]. Additionally, the DEG sample displayed a broad FTIR peak associated with surface
adsorbed OH groups at 3410 cm-1 [41-44].
Surface-adsorbed molecules plus intrinsic surface defects influence the charge
density and ionization potential of the nZnO. These changes result in augmented surface
charge which can be evaluated through electrophoretic mobility measurement [40]. The
isoelectric point of nanomaterials refers to the pH at which the ζ-potential value is equal to
zero. Figure 4.2B demonstrates the pH dependent changes in the ζ-potential of the nZnO.
The established IEP for this sample is ~9.5 and is consistent with nZnO made with this
synthesis method [37, 40]. Below this point, the ζ-potential values trend towards positive
values with a maximum value of 39.3 ± 0.7 observed at a pH of 8.0. At pH values above
the IEP, negative ζ-potential values were measured. This characteristic IEP plot results
from the surface-adsorbed neutral hydroxyl groups that form M−OH surface layers, as can
be seen in FTIR data (Figure 4.2A). Above the IEP (higher pH values), chemisorbed
protons (H+) migrate from the NP surface into the aqueous medium resulting in partially
bonded oxygen atoms (M−O−) and the observed negative ζ-potential measurements [26,
40]. In more the acidic conditions below the IEP, aqueous protons migrate to the nZnO
surface to form a surface adsorbed water layer (M−OH2+) groups and a positively charged
surface layer [26, 40].
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Agglomeration Behavior and Dissolution Potential
ZnO NPs are known to exhibit strong agglomeration behavior in a variety of
biologically relevant solutions [37]. Therefore, an important consideration in nZnO toxicity
studies is the stability of the treatment dispersions during the evaluation time frame. To
access this stability, FBS/PBS nZnO stock dispersion were introduced into RPMI-based
cellular media at a concentration of 486 µg/mL. The hydrodynamic diameters of the
suspended agglomerates were measured at regular intervals over a 24-time frame via
dynamic light scattering (DLS). Figure 4.3A illustrates the hydrodynamic size distributions
at several time periods. The initial size distribution (0 hours) demonstrates that the
dispersion is composed of agglomerates primarily centered around 300 nm. While most of
the agglomerates are narrowly distributed from ~200 – 475 nm, there is a small percentage
of agglomerates between 10 – 40 nm. At later time points (6 and 12 hours), the overall size
distribution remained centered at ~350 nm although had broadened indicating the existence
of larger agglomerates in dispersion. This broadening distribution trend continued through
the remainder of the evaluation period. These results indicate that the agglomeration
behavior of the nZnO dispersion is somewhat variable with increasing time, however; a
large percentage of particles persist within a stable hydrodynamic range during the several
hours it takes to complete the assay.
Another critical material property of nZnO is its solubility in many solution systems
[45]. The ionic zinc released from the nZnO is considered a primary mechanism in NPinduced toxicity. Ionic zinc levels for nZnO dispersions utilized in the cellular toxicity
assays were evaluated using ICP-MS at several time points over 48 hours (Figure 4.3B). A
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time-dependent linear increase in released Zn2+ was observed over 48 hours with ionic zinc
values approaching ~20 µg/mL of Zn2+ or roughly 5 % of the initial concentration.
Effects of nZnO on Jurkat Leukemic and Primary CD4+ Cell Transcriptomes
Based on previous data, nZnO is known to exhibit preferentially toxicity towards
Jurkat leukemic T cells when compared to primary CD4+ T cells [18, 23, 34]. Several
hypotheses have been put forth to explain this selective toxicity including increased
oxidative stress, proliferation, or dissolution in the acidic environment of cancerous cells
[18, 20, 22, 46]. However, no definitive mechanisms have been identified thus far. To
address this question, genome-wide transcriptional profiling was employed at 6 hours to
potentially identify early to intermediate transcriptional changes caused by nZnO
treatment. Several nZnO concentrations were chosen including those above and below the
IC25 at 6 hours and the IC50 at 24 hours for both cell types. Importantly, the IC50 at 24 hours
and the IC25 at 6 hours were found to be nearly identical for both cell types, which helps to
validate the concentration ranges used in this study (Figure 4.4A and B). In this study,
mRNA was isolated at 6 hours post nZnO treatment to identify genes that are differentially
expressed at a relatively early time point that precedes the considerable cell death observed
at 24h. Thus, nZnO concentrations of 6.1, 12.2, 24.4, 40.7, and 61.0 µg/mL were used for
Jurkat leukemic cells, and 61.0, 122.0, 244.0, and 407.0 µg/mL used for primary CD4+ T
cells. The lowest nZnO concentration used in each cell group produced little to no toxicity
at 24 hours, while the highest dose caused considerable toxicity. Expression BeadChips
were used to determine global expression levels for three replicate experiments for all
treatment conditions.
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Initial analysis focused on general trends observed within the transcriptome
analysis. Limma statistical analysis in Bioconductor [39] was employed to determine the
significantly differentially expressed genes (SDEGs) following nZnO exposure. Fold
change values were determined by comparing the normalized fluorescent data to the
control treatment group (no nZnO). FDR p-values were determined by evaluating the spot
signal intensity to the signal intensity of background or non-specific gene binding
microarray spots. Genes that had fold change values of at least 1.5 and FDR p-values less
than 0.05 were chosen for further analysis (Figure 4.3C). The number of SDEGs for both
cell types increased in a dose-dependent manner. Primary CD4+ T cells showed
significantly more differentially expressed genes compared to cancerous Jurkat cells
(Figure 4.3C). The number of differentially expressed genes at the lowest nZnO
concentration evaluated in each cell type (6.1 and 61.0 µg/mL for the Jurkat and CD4 + T
cells, respectively) was 12 for Jurkat cells and 1,041 for the primary CD4+ T cells. At the
highest NP concentrations (61.0 and 407.0 µg/mL for the Jurkat and CD4+ T cells,
respectively), the number of SDEGs was 781 for Jurkat cells and 2,161 for primary T cells.
As the concentration of NPs increased beyond the IC25 in the Jurkat cells, the number of
SDEGs did not increase appreciably; however, the number of expressed genes continued
to increase incrementally through the evaluated concentration range.
An analysis of the up- and down-regulated genes revealed a similar dose-dependent
pattern for the total number of expressed genes (Figure 4.4D). In general, there are no
significant differences in the relative number of up-regulated versus down-regulated genes
for any one NP concentration or cell type. For the Jurkat cells, the lower nZnO
concentrations (6.1 and 12.2 µg/mL) had more up-regulated genes when compared to
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concentrations at or above the IC50 value (24.4, 40.7 and 61.0 µg/mL). In the primary cells,
more down-regulated genes were observed for the 244.0 and 407.0 µg/mL NP treatments.
The Ingenuity Pathway Analysis (IPA) knowledgebase was used to classify the
expressed genes into functional classes (Table 4.1) It is noteworthy that in primary cells
the number of SDEGs in several of the functional classes (i.e., enzymes, G-protein coupled
receptors, ion channels, phosphatases, transcriptional and translational regulators, and
genes belonging to the other category) is roughly double that that in Jurkat cells. There
were also substantially more cytokine and enzyme genes differentially expressed in
primary cells. The functional class with the most SDEGs was designated as ‘other’ and
includes metallothioneins and other zinc binding proteins, and zinc transporters.
Transcriptional regulators were also enriched within both cells types as were transcripts
encoding enzymes, kinases and phosphatases.
Metallothioneins
Considering the role that metallothioneins (MT) have in buffering intracellular
zinc, numerous studies have investigated the MT transcriptome in response to sub-lethal
[47-53] and lethal concentrations [54-57] of zinc. Even at low doses of zinc or nZnO,
metallothionein expression is upregulated. Among the differentially expressed genes in
Jurkat and primary cells, 11 MT genes were identified (Figure 4.4). As a heterogeneous
family of proteins, MTs contain several isoforms and sub-isoforms which differ in
structure, cellular location and, to a limited extent, function [58, 59]. MTF1 is the most
widely studied metallothionein. It responds to small changes in intracellular zinc and upon
zinc binding, travels to the nucleus where it acts as a transcription factor for other MT
genes [58]. Of the major gene isoforms, the MT-1 and MT-2 families, are widely
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distributed throughout mammalian tissues where they contribute to copper and zinc
regulation, heavy metal detoxification, immune system function, digestive tract functions,
and cell transcription [59]. A minor isoform is MT-3 which is primarily localized to the
central nervous system,[59], and research on this isoform is sparse. In our data set the MT1 gene sub-isoforms (MTF1, MT1A, MT1E, MT1G, MT1H, MT1M, MT1JP and MT1X)
were the most prominently upregulated MT genes for both cell types, however the degree
of upregulation was significantly higher in primary T cells, especially for MT1G, MT1H
and MT1M (Figure 4.4). While some of the individual sub-isoforms have recently been
linked to certain disease states, definite explanations for the variable differentiation of these
MT-1 sub-isoforms is lacking [60]. Additionally, MT2A is upregulated in both cell types
and increased MT3 expression was observed exclusively in primary cells.
Solute-Linked Carrier Proteins
The solute-linked carrier family of proteins is a rather large and diverse group of
proteins responsible for the transport and regulation of multiple substances essential for
normal cell function. Many of these proteins transport xenobiotics and various drugs
making them promising targets for disease remediation [61, 62]. Within the SLC proteins
six families of genes regulate the transport of metal ions (SLC11, SLC30, SLC31, SLC39,
SLC40, and SLC41) [62]. When Jurkat and primary CD4+ T cells were exposed to nZnO,
four of these families were differentially expressed (Figure 4.5). SLC30A1 and SLC30A2
(commonly ZnT1 and ZnT2) are responsible for Zn2+ efflux from the cytosol to the
extracellular spaces and into lysosomes, respectively [63]. Given their role in maintaining
intracellular zinc steady state concentrations, it is not surprising that these genes were
upregulated following nZnO treatment (Figure 4.5). SLC30A1, the most widely distributed
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ZnT protein, was upregulated in both cell types with expression levels in primary cells
three or more times higher than in Jurkat cells. ZnT2, however, was only upregulated in
the Jurkat cells.
In contrast to the SLC30 transport family, the SLC39 family, commonly referred to
as Zips, controls zinc import into the cytosol of the cell [63, 64]. SLC39A1 or Zip1 was
upregulated in all samples following nZnO treatment; however, SLC39A10 was
downregulated. The upregulation of Zip1 is somewhat surprising as this would work to
increase extracellular zinc levels; however, Zips are responsive to other signaling
molecules such as hormones and cytokines [64]. Indeed, cytosolic zinc concentrations have
been shown to increase substantially within minutes after T cell activation and the
enhanced expression of numerous Zip proteins [65]. Therefore, it is possible that the
expression of this transcript could be under the control of factors other than ionic zinc.
The ion transporters SLC11A2 and SLC40A1 also have demonstrated ability to
regulate zinc levels. SLC11A2 is a metal cation/proton exchange protein found in most
human cell types [62]. SLC40A1 is commonly known as a ferroportin in that its primary
function is to maintain iron homeostasis. Iron, however, binds protein in multiple forms
including oxo-diiron (Fe-O-Fe), oxo-iron-zinc (Fe-O-Zn), iron-sulfur clusters (Fe-S) and
heme, thus playing a secondary role in zinc transport [66]. In primary cells, both
transporters were downregulated. In the Jurkat cells, however, the expression of SLC11A2
is downregulated in concentrations at and below the IC50 but upregulated in the higher
treatment conditions.
The last SLC family that was differentially regulated by nZnO was the SLC31
copper ion transporters [67]. While these transporters do not contribute to the control of
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zinc homeostasis, they are critical for the function of copper containing enzymes such as
the ROS scavenger Cu/Zn superoxide dismutase (Cu/ZnSOD1) [67]. The upregulation of
SLC31A1 and SLC31A2 observed in the primary CD4+ T cells could be associated with the
oxidative stress experienced by the cells following nZnO treatment. SLC31A1 was also
upregulated in Jurkat cells, however, SLC31A2 was downregulated.
Another group of differentially expressed transcripts belonged to SLC families
responsible for the uptake of various sugar molecules. As quiescent cells, CD4+
lymphocytes have very low energy requirements and utilize oxidative phosphorylation
within the mitochondria to generate any needed ATP [68]. Upon activation, T cells
dramatically increase energy stores by increasing both glucose intake and oxygen
consumption. However, activated primary T cells and cancerous T cells prefer to use
aerobic glycolysis following the upregulation of glucose transporters [68]. SLC2A1 or
GLUT 1 is normally responsible for increases in glucose uptake in activated T cells;
however, SLC2A3, and SLC2A6 also demonstrate differential regulation following T cell
activation [69]. Following nZnO treatment, SLC2A1 was downregulated in both cell types.
In contrast, SLC2A3, SLC2A6 and SLC2A14 were upregulated (Figure 4.6). The remaining
two glucose transporters, SLC45A4 and SLC50A1, were both downregulated in Jurkat cells.
In primary cells, SLC45A4 demonstrated decreased expression, while SLC50A1 was
upregulated. While the function of the SLC2A1 is well characterized in immune system
cells, little is known regarding the function of the remaining transcripts. Therefore, it is not
possible to predict the net result of glucose uptake in nZnO treated Jurkat or CD4+ T cells.
The final group of SLC families that were differentially expressed post nZnO
treatment are responsible for the cellular transport of amino acids and small peptides. The
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first six of these transcripts (SLC1A4, SLC1A5, SLC3A2, SLC7A1, SLC7A5, and SLC7A11)
were essentially upregulated in both cell types (Figure 4.8). However, the SLC1A5
transcript was downregulated at the lowest concentration of nZnO treatment in the Jurkat
cells. The tripeptide glutathione (GSH) is an integral component of T cell activation with
increases in GSH associated with T cell proliferation [70]. Since quiescent T cells have
little need use for exogenous sources of cysteine (Cys) or cystine (Cys 2) needed for the
enhanced GSH production, activated T cells require a means to obtain these amino acids
[70]. The primary way by which activated T cells accomplish this is through the
upregulation of the SLC1A4, SLC1A5, SLC3A2, and SLC7A11 genes. SLC1A4 and
SLC1A5, also known as ASCT1 and ASCT2, respectively, transport cysteine, while
SLC3A2 (CD98) and SLC7A11 comprise a cystine/glutamate antiporter [70].
Additionally, the glutamine importer SLC7A, and the SLC7A5 (LAT1) leucine transporter
are upregulated during TCR activation and are involved in lymphocyte metabolic
reprograming for T cell differentiation [71, 72]. The remaining two SDEGS in this SLC
family, SLC15A3, and SLC15A4, were significantly downregulated in the primary T cells,
while only the SLC15A4 transcript was downregulated in the Jurkat cells (Figure 4.8).
These small peptide transporters are known to assist in the cellular endocytosis of NOD1
and NOD2 ligands and signaling pathways involved in inflammation [73].
Discussion
The goal of this study was to identify potential genetic targets likely to account for
the cancer cell selectivity of nZnO. Towards this goal, Jurkat leukemic and CD4+ T cells
were treated with varying concentrations of nZnO above and below the established IC 50
(Figure 4.3B). At 6 hours post-treatment, mRNA was isolated from the treated cells, and a
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microarray was utilized to identify significantly differentiated changes in cellular
transcription responses. IPA was then conducted to evaluate these changes in relationship
to cell type and treatment concentration. From this analysis, several genes have been
selected for further analysis.
Our initial analysis focused on a general overview of the transcriptome response
and specific gene targets involved in the regulation of zinc homeostasis. Metallothioneins,
responsible for maintaining zinc steady state conditions, were among the most highly
upregulated genes identified (Figure 4.4). While these transcripts were upregulated in both
cell types in a dose-dependent manner, their expression levels were significantly higher in
the primary cells. Of these, MTF1 is of primary interest as it functions as a transcription
factor for the MRE and ARE promoters responsible for the expression of all other MT
proteins. The remaining MT SDEGs are also relevant as MT proteins sequester excess zinc
and contribute to ROS remediation. Therefore, the increased expression of these genes,
specifically in primary cells, may allow cells to remove excess zinc and reduce oxidative
stress thereby preventing toxicity.
The other group of proteins involved in zinc homeostasis maintenance are those
belonging to the SLC30 (ZnTs) and SLC39 (Zips) family of genes. Two genes, SCL30A1
and SLC 39A1 are of particular interest in this study. The SCL30A1 efflux transcript was
significantly enhanced (up to 3 times) in primary cells over Jurkat cells. Since ZnT1 is
localized primarily to the cellular membrane, increased expression of this protein would
result in greater efflux of ionic zinc out of the cell. SLC39A1, or Zip1, functions as an
importer of zinc into the cell which seems counterintuitive under conditions of excess zinc.
However, this gene is important given that T cell activation results in the upregulation of
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Zip proteins. Additionally, the cation/proton exchange protein gene SLC11A2 is
noteworthy as it was upregulated in primary cells yet regulated differently in Jurkat cells
depending on nZnO concentration. Finally, the copper transporter gene SLC31A2 and its
potential connection to the ROS scavenger Cu/Zn superoxide dismutase (Cu/ZnSOD1)
draws attention because of its potential contribution to oxidative stress remediation. This
is especially relevant considering this transcript was upregulated in only the primary cells.
Two other types of differentially expressed transporters, sugar and amino acid
transporters were also identified within the broad SLC family of genes. The regulation of
glucose/sugar transporters in T lymphocytes, are generally associated with T cell activation
and increased cellular metabolism. Within our SDEGs, two sugar transporters were
particularly noteworthy, SLC2A3, and SLC50A1. The expression levels for the SLC2A3
gene were much higher for the Jurkat cells than the primary cells which is counter to the
expression patterns observed for the remaining glucose transporters. The SLC50A1 gene,
identified as a sugar efflux transport gene in plants and some mammals [74], was
downregulated in the Jurkat cells yet upregulated in the primary cells. The differential
regulation of the glucose transporters, especially in the CD4+ T cells, suggests that nZnO
could potentially influence the activation state of T lymphocytes. Additional evidence of
this was observed with the upregulation of numerous amino acid transporters (SLC1A4,
SLC1A5, SLC3A2, SLC7A1, SLC7A5, and SLC7A11). During T cell activation, the amino
acid demands of the T cells significantly increase to meet the proteomic needs of increased
metabolism, cell survival, cellular proliferation and differentiation [75].
In addition to the above-mentioned genes, many other gene transcripts attracted
attention and have been grouped within Table 4.2 into three broad categories, inflammatory
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mediators, T cell activation and cellular stress responses. Numerous research studies have
investigated the ability of nZnO to affect immune activation in a variety of cells [17, 7678]. Indeed, cellular transcriptome and proteome changes post nZnO treatment have
indicated that inflammatory responses may contribute to the toxic mechanism; however,
the precise inflammatory mediators detected across the literature have not been consistent.
Our initial analysis revealed several pro-inflammatory mediators (Table 4.2; Inflammatory
Mediators) that were differentially expressed in primary cells indicating a potential role for
these factors in the cytotoxicity. For example, the inflammatory genes included in Table
4.2 code for proteins involved in signaling pathways that promote T cell proliferation and
survival [79].
Additional research has linked NP-induced cytotoxicity to cellular proliferation and
the activation status of hematopoietic cells ([23] and unpublished data). Indeed, NP
cytotoxicity has been linked to the proliferative capacity of the cell with the highest degree
of toxicity associated with the most rapidly dividing cells (unpublished data). Considering
this, it is important to ascertain if nZnO can influence the activation state of naïve primary
T cells. Interestingly, several SDEGS relating to T cell activation were identified within
our data set including upregulated transcripts for early activation markers such as CD69
(Table 4.2; T Cell Activation). Future studies are needed to verify that the observed SDEGS
are associated with cellular activation responses.
Finally, Table 4.2 (Cellular Stress Responses) lists several gene transcripts
associated with stress-induced proteins. Several of these genes are associated with heat
shock proteins which facilitate the removal of misfolded proteins. Another interesting
target is the HMOX1, or heme oxygenase 1 gene, which encodes an essential enzyme for
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heme catabolism, and had upregulated fold change values ~50 times higher in primary T
cells than in Jurkat cells. It is noteworthy that HMOX1 deficient cells have demonstrated
susceptibility to oxidative stress, and its upregulation is considered an adaptive mechanism
that may protect cells from oxidative damage [80].
Although several of the above-mentioned transcriptional changes may relate to the
selective toxicity mechanism of nZnO, many additional studies are needed to confirm their
potential significance. First, RT-PCR is needed to verify key results of the initial analysis.
Secondly, western blot studies can confirm the actual protein expression levels of the
SDEGs in question. Additionally, as many of these genes initiate signaling pathways that
may contribute to the toxicity mechanism, evaluation of the expression and function of key
downstream signaling proteins will be critical to the final analysis. Finally, gain or loss of
function studies will be needed to confirm the functional significance of transcripts and
mechanistic pathways found to be critical to the cancer cell selectivity of nZnO.
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Tables and Figures

C

Figure 4.1
Size, morphology and composition analysis for the nZnO. A) represents the XRD spectrum used to
verify crystal structure and phase purity. TEM analysis (B) was employed to confirm NP morphology and average
particle size. The atomic composition of the powered nanomaterial was determined using XPS (C).
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Figure 4.2
Surface structure analysis of the nZnO. A) Surface adsorbed groups were evaluated using FTIR and B) ζ-potential
and IEP were determined using DLS.
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Figure 4.3
The A) agglomeration tendencies and B) dissolution potential of nZnO dispersions were evaluated utilizing DLS
measurements and ICP-MS, respectively. The nZnO dispersions utilized for both assays were created by introducing a nZnO
FBS/PBS stock solution introduced to RPMI-based cellular media at a concentration of 486 µg/mL. Error bars in (B) represent
the standard deviation of n = 3 replicates.
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Figure 4.4
nZnO induced toxicity in Jurkat leukemic (green squares and line) and
primary CD4+ T cells (blue circles and line) measured at A) 6 hours and B) 24 hours
post treatment. The dashed lines in both plots represent the mathematical fit for the
plotted data points. The bottom axis represents nZnO concentrations for Jurkat cells
and the top axis depicts nZnO concentrations for the CD4+ T cells. C) The number of
significantly differentially expressed genes for Jurkat leukemic (green patterned
bars) and primary CD4+ T cells (blue patterned bars) determined using cutoff values
of (fold change) FC > 1.5 and (false discovery rate) FDR p < 0.05. D) The number of
up- and down-regulated differentially expressed genes for Jurkat (green patterned
bars) and primary CD4+ T cells (blue patterned bars). Up-regulated genes are
represented as positive values and down-regulated genes as negative values.
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Table 4.1
The number of SDEGs in each functional class. Functional classes
were designated by Ingenuity Pathway Analysis (IPA) knowledge base. The yellow
bars represented the nZnO treatment concentration closest to the IC50 for each cell
type.
Number of Genes
nZnO Concentration (µg/mL)

Jurkat
6.1

1

1

2

3

61.
0
16

39

114

116

115

245

243

322

410

G-protein coupled receptor

2

6

6

6

11

14

19

21

Growth Factor

1

4

5

5

1

1

3

7

Ion channel

1

4

4

3

8

7

9

11

Kinase

3

18

19

20

59

56

186

101

1

1

1

1

1

2

Cytokine
Enzyme

1

12.2

Primary

24.4 40.7

61.0

Ligand-dependent nuclear receptor
Micro-RNA
Other

122.
0
14

244. 407.
0
0
15
16

1
108

333

369

375

548

560

806

Peptidase

1

6

6

6

24

20

39

100
5
116

Phosphatase

7

11

14

12

18

17

26

30

Transcription Regulator

19

88

87

98

118

111

163

215

Translation regulator

1

4

4

5

9

8

16

17

Transmembrane Receptor

7

12

11

11

36

38

46

60

12

32

31

29

56

59

79

102

Transporter

9

2

Figure 4.5
Differential expression of metallothionein genes in Jurkat and primary CD4 + T cells treated with
varying concentrations of nZnO for 6 hours. All displayed genes statistically significant (FC > 1.5 and FDR p <0.05)
and represent the average of four replicates.
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Figure 4.6
The expression of genes from the SLC30, SLC39, SLC31, SLC11 and SLC40 transporter families in Jurkat
and primary CD4+ T cells treated with varying concentrations of nZnO for 6 hours. All displayed genes statistically
significant (FC > 1.5 and FDR p <0.05) and represent the average of four replicates.
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Figure 4.7
The expression of genes from the SLC2A, SLC45A, and SLC50A transporter families in Jurkat and primary CD4+
T cells treated with varying concentrations of nZnO for 6 hours. All displayed genes statistically significant (FC > 1.5 and FDR
p <0.05) and represent the average of four replicates
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Figure 4.8
The expression of genes from the SLC1A, SLC3A, SLC7A, and SLC15A transporter families in Jurkat and
primary CD4+ T cells treated with varying concentrations of nZnO for 6 hours. All displayed genes statistically significant
(FC > 1.5 and FDR p <0.05) and represent the average of four replicates
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Table 4.2

Fold change values for selected genes relating to inflammation, T cell activation and cellular stress.
nZnO Treatment Concentration (µg/mL)

Gene

Description

CD4+ T cells

Jurkat Cells
6.1

12.2

24.4

40.7

61

61

122

244

407

Inflammatory Mediators
IL1A

Interleukin 1 alpha

1.684

1.434

1.55

1.516

IL1B

Interleukin 1 beta

3.687

2.623

2.602

2.49

TNF-α

Tumor necrosis factor

2.783

2.919

3.434

4.378

T Cell Activation
EGR1

Early growth response

CD69
CTLA4
ICOS
Table 4.2

1.034

1.285

2.826

3.809

4.601

1.766

1.885

2.315

2.835

-1.002

2.131

5.681

6.132

5.748

5.701

5.689

7.012

8.941

-2.054

-2.129

-2.328

-2.611

1.111

1.081

-1.001

-1.041

Activation genes
-1.02

1.551

1.509

1.413

1.363

Fold change values for selected genes relating to inflammation, T cell activation and cellular stress.
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AARS

Alanyl-tRNA synthetase

1.189

1.748

2.064

1.81

1.726

2.226

2.376

2.264

2.236

IARS

Isoleucyl-tRNA synthetase

1.004

1.08

1.152

1.173

1.194

1.807

1.713

1.698

1.779

MARS

Methionyl-tRNA synthetase

-1.001

1.261

1.357

1.304

1.272

2.042

2.086

1.96

2.035

TARS

Threonyl-tRNA synthetase

1.003

1.468

1.87

1.928

1.942

4.664

4.602

4.968

5.382

CARS

Cysteinyl-tRNA synthetase

-1.024

1.325

1.677

1.623

1.617

1.903

1.974

1.91

1.856

GARS

Glycyl-tRNA synthetase

1.044

1.368

1.658

1.548

1.574

2.53

2.585

2.687

2.744

BIN1

Bridging integrator 3

-2.029

-1.841

-2.112

-1.903

TOB1

TNF superfamily member
17

-1.031

1.094

1.234

1.26

1.224

-2.018

-2.011

-2.058

-2.144

LTA

TNF-β

1.096

1.209

1.164

1.115

1.143

2.241

2.484

2.614

2.803

NFKB1A

NF-κβ

-1.029

1.398

1.677

1.663

1.58

4.41

4.407

5.198

5.485

-1.022

1.102

1.188

1.175

1.146

1.881

2.045

2.422

2.842

1.007

1.025

1.138

1.193

1.172

1.66

1.8

2.22

2.748

NFKBIE

-1.041

-1.041

1.001

1.436

1.536

1.625

3.839

3.881

4.724

NFKBIZ

-1.003

1.001

1.051

1.042

1.035

2.047

2.053

1.995

2.412

NFKBIB
NFKBID

Fold change values for selected genes relating to inflammation, T cell activation and cellular stress.
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NF-κβ inhibitors

NKIRAS1

NFKB inhibitor interacting
Ras

1.012

1.234

1.774

1.824

1.93

1.709

1.742

2.109

2.418

1.012

1.117

1.125

1.106

1.108

2.228

2.224

2.359

2.691

RELB

1.028

1.263

1.67

1.684

1.656

10.24

10.058

9.944

12.417

JUN

1.134

3.486

13.359

15.789

16.698

6.612

8.14

9.903

13.986

JUNB

-1.03

-1.125

-1.035

1.057

1.098

1.112

1.073

1.337

1.818

1.226

1.972

3.405

3.54

3.629

1.301

1.441

1.663

1.712

FOS

1.01

1.776

8.55

14.441

20.317

14.999

18.153

28.127

48.1

FOSB

1.001

1.447

7.228

12.283

15.014

9.91

12.701

15.503

28.943

REL

JUND

NF-κβ subunits

AP-1 transcription factor
subunits

c-Myc transcription factor

1.055

-1.724

-6.81

-9.666

-10.705

-1.679

-1.839

-2.291

-2.99

LCK

LCK proto-oncogene

-1.062

-1.093

-1.027

1.003

1.062

-1.203

-1.232

-1.269

-1.194

LAG3

Lymphocyte activating 3

-1.857

-1.665

-1.796

-1.779

RAC1

Ras-related gene

-1.007

-1.014

-1.041

-1.092

-1.106

-1.234

-1.226

-1.253

-1.363

RAC2

Ras-related gene

1.039

-1.138

-1.287

-1.317

-1.227

-1.393

-1.366

-1.344

-1.401

RASA3

Ras-related gene

-1.012

-1.105

-1.099

-1.063

-1.039

-1.543

-1.515

-1.727

-1.686

Table 4.2

Fold change values for selected genes relating to inflammation, T cell activation and cellular stress.

242

MYC

RASD1

Ras-related gene

SLAMF1

Signaling lymphocytic
activation molecule

CABIN1

Calcineurin binding protein
1

1.06

-1.027

1.011

-1.001

CALR

calreticulin

-1.048

-1.203

-1.144

-1

-1.276

1.044

1.113

CAMK2G
CAMK2N1

Calcium/calmodulin protein
related genes

1.066

1.115

1.379

1.668

1.925

1.844

2.103

2.778

3.414

-1.303

-1.386

-1.456

-1.747

1.035

-2.318

-2.128

-2.377

-2.448

-1.06

-1.087

1.421

1.36

1.493

1.505

-1.236

-1.138

-1.076

-2.033

-2.263

-2.594

-2.976

1.123

1.09

1.118

1.16

1.244

1.338

1.344

1.12

1.067

1.161

1.168

CAMK4
CAMSAP1

1.059

-1.009

-1.012

-1.02

1.028

-1.551

-1.598

-1.643

-1.833

CALHM2

Calcium homeostasis
modulator

-1.08

-1.048

-1.058

-1.069

-1.014

-1.767

-1.778

-1.818

-1.758

PMAIP1

Pro-apoptotic member of
the Bcl-2 protein family

1.06

2.238

3.47

3.562

3.444

10.743

10.827

12.349

16.39

-1.093

-1.255

-1.098

1.047

1.053

1.685

1.64

1.822

1.955

-1.033

-1.199

-1.173

-1.173

-1.101

2.168

2.334

2.881

3.866

PIM2
PIM3

Fold change values for selected genes relating to inflammation, T cell activation and cellular stress.
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Pim-2 proto-oncogenes,
serine/threonine kinase

MAP3K4

MEKK4

1.023

-1.188

-1.172

-1.093

-1.077

-1.471

-1.485

-1.562

-1.598

MAP3K5

ASK1

1.026

-1.047

-1.086

-1.077

-1.041

-1.61

-1.622

-1.73

-1.897

MAP3K6

ASK2

-1.015

1.026

1.047

1.093

1.116

-1.522

-1.539

-1.588

-1.682

MAP3K8

tpl-2, TPL2, COT, AURA2

1.056

1.428

1.19

1.046

1.023

2.402

2.118

2.104

1.979

MAP4K1

HPK1

1.004

1.006

1.128

1.124

1.102

-1.964

-1.857

-2.033

-2.016

1.003

-1.215

-1.195

-1.199

-1.194

-1.412

-1.383

-1.592

-1.629

1.055

8.429

38.521

43.314

49.866

34.024

41.029

57.326

96.021

1.38

11.343

18.903

17.874

19.273

24.557

28.633

34.486

38.712

1.022

3.033

11.044

14.15

14.957

7.322

8.909

10.497

19.054

MAPKAPK3

Stress Induced Protein
HSPA6

Heat shock protein family
(Hsp70)

HSPA1A/
HSPA1B
HSPA7

Heat shock protein family
(Hsp70)

HSPH1

Heat shock protein family
(Hsp110)

1.51

3.729

4.856

4.852

4.717

13.155

14.108

17.1

19.917

HSPE1

Heat shock protein family
(Hsp10)

1.042

1.395

1.538

1.528

1.543

5.525

5.823

6.172

7.821
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Fold change values for selected genes relating to inflammation, T cell activation and cellular stress.

DNAJB1
DNAJA1

DnaJ heat shock protein
family (Hsp40)

DNAJB4

-1.005

5.927

13.259

13.742

13.743

4.372

4.827

6.73

8.526

1.172

1.615

1.878

1.818

1.859

5.663

5.859

6.606

7.612

1.028

1.48

1.967

2.02

1.792

4.253

4.029

5.396

6.926

HSPB1

Heat shock protein family B

1.035

1.343

1.543

1.527

1.462

4.943

5.819

6.077

6.857

STIP1

Stress induced
phosphoprotein 1

1.153

1.781

2.258

2.03

2.076

4.287

4.974

5.322

6.758

HMOX1

Heme oxygenase 1

1.03

1.262

2.073

2.205

2.368

54.142

58.963

76.719

84.388

HIF1A

Hypoxia inducible factor

1.031

-1.006

-1.086

-1.066

-1.061

1.965

1.804

2.043

2.138

DRAM1

DNA damage regulated
autophagy modulator 1

1.625

1.615

1.63

1.844

SQSTM1

sequestosome 1

3.236

3.408

3.784

4.046

-1.023

1.125

1.281

1.323

1.297
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CHAPTER 5

CONCLUSIONS

nZnO has a promising future in biomedical applications if clear mechanisms of
toxicity can be identified. This study sought to explore these potential mechanisms from
two distinct perspectives. First, we explored how the physicochemical properties of nZnO
influence NP-induced cytotoxicity and cellular oxidative stress. Secondly, we analyzed the
cellular transcriptome changes in response to nZnO treatment to potentially elucidate
cellular processes that contribute to nZnO selective toxicity towards cancer cells.
Several important findings reveal that the physicochemical properties of nZnO
influence NP-induced toxicity. The agglomeration and sedimentation behavior of unstable
NP dispersions adversely alters the results of downstream biological assays. Obtaining
stable nZnO dispersions with the use of FBS proteins significantly changes the assay results
in both suspension and adherent cell models compared to findings with unstable
dispersions. These results confirm our hypothesis that achieving stable NP dispersion
stability is a critical factor in obtaining reliable and reproducible findings.
When the material properties of a panel of differently synthesized nZnO were
analyzed, the synthesis method was identified as a contributing factor to cytotoxicity.
Indeed, nZnO synthesized using wet chemical methods demonstrates greater surface
reactivity, extracellular dissolution potential and significantly greater cytotoxicity than
nZnO synthesized through high temperature methods. Additionally, our results underscore
the importance of extensive material characterization as no one specific physicochemical
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property was found to contribute solely to the observed cytotoxicity. Rather a combination
of material properties appears to influence the toxic potential of nZnO.
Finally, preliminary analysis of the transcriptome changes in cancerous and
primary T cells post-treatment with nZnO reveal several potential gene targets that may
regulate the selective toxicity of nZnO against cancer cells. Significant differences between
the cancer and primary T cells are present in the expression of genes involved in the
regulation of zinc homeostasis, ion transport, cellular metabolism, inflammation, T cell
activation, and cellular stress responses. Additional experiments are needed to verify these
initial findings and confirm the importance of these transcriptome changes in the
preferentially selectively of nZnO towards cancer cells.
Together, the results of this dissertation confirm that nZnO toxicity is strongly
influenced by the NP fabrication methods, material properties and differential cellular
responses. Further studies are needed to connect specific material properties to unique
cellular responses and mechanisms of cell death. This knowledge would potentially enable
the development of a “design rule” for the fabrication of nZnO to achieve environmentally
safe NPs for consumer products and NPs with maximal selective toxicity for use in
alternative cancer therapeutics.
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